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RIASSUNTO 
La replicazione del DNA è un processo fondamentale alla base della proliferazione 
cellulare. Di fatto nelle molecole di DNA, che fanno parte dei cromosomi, sono 
contenute tutte le informazioni necessarie alla cellula per crescere, duplicarsi e 
portare a termine tutti i compiti che le sono richiesti all’interno di un organismo 
altamente evoluto. Il meccanismo di replicazione del DNA in eucarioti si è 
progressivamente sviluppato e specializzato, al fine di evitare una duplicazione non 
corretta della informazione genica e per evitare che, in seguito ad una perdita o 
parziale mutazione di tale importante informazione, la cellula o addirittura l’intero 
organismo possano subire danni irreparabili. 
Cdc45 è un fattore fondamentale coinvolto nel processo di replicazione del DNA in 
tutti gli organismi eucariotici. Esso è implicato sia nella fase di inizio della 
replicazione sia nella successiva fase di elongazione e rimane costantemente 
associato alla forcina replicativa per tutta la durata del processo di duplicazione del 
DNA. E’ stato dimostrato che la proteina umana Cdc45 è un antigene associato alla 
proliferazione cellulare, in accordo con il suo coinvolgimento nel processo di 
replicazione del DNA. Negli esseri umani tale fattore è quasi totalmente assente nei 
normali tessuti cellulari adulti ed è presente solo nei tessuti con cellule attive dal 
punto di vista della proliferazione. La proteina è altamente espressa in tutte le cellule 
cancerose. In normali cellule proliferanti i livelli di Cdc45 restano costanti durante 
tutta la durata del ciclo cellulare, anche se un picco di espressione dell’mRNA 
codificante per la proteina è stato osservato al confine tra la fase G1 e la fase S.   
E’ stato osservato che il caricamento di Cdc45 sulla cromatina coincide con il firing, 
ovvero con l’attivazione, delle origini di replicazione. Le origini di replicazione sono 
dei punti specifici sul genoma dove la duplicazione del DNA può avere inizio. Un 
complesso specializzato di 6 proteine, noto come complesso ORC (origin recognition 
complex) è in grado di legare la cromatina specificamente alle origini di replicazione 
già durante la fine della fase M e durante la fase G1 del ciclo cellulare. Al complesso 
ORC si associano altri due fattori, Cdc6 e Cdt1, che sono indispensabili per il 
caricamento sulla forcina replicativa del complesso etero-esamerico MCM2-7. Tale 
complesso, composto da sei proteine paraloghe che hanno la capacità di legare ed 
idrolizzare molecole di ATP, rappresenta il motore molecolare dell’attività DNA 
elicasica, necessaria alla forcina replicativa per svolgere i due filamenti del DNA da 
duplicare. Il complesso MCM2-7 diventa cataliticamente attivo solo quando altri due 
co-fattori, il complesso etero-tetramerico GINS e Cdc45, vi si associano, formando il 
cosiddetto complesso CMG (Cdc45/MCM2-7/GINS) che è in grado di fornire l’attività 
DNA elicasica indispensabile per lo svolgimento dell’elica di DNA. In seguito 
all’attivazione del complesso CMG la replicazione può avere inizio. Il meccanismo 
molecolare tramite cui Cdc45 è caricato sulla cromatina e si associa alla forcina 
replicativa non è ancora chiarito in dettaglio, ma è noto che altri fattori, come ad 
esempio MCM10, sono coinvolti in tale processo e che l’attività enzimatica delle 
protein chinasi CDK2 e DDK è indispensabile affinchè questo processo avvenga.  
Quando abbiamo iniziato il nostro lavoro sulla proteina umana Cdc45 davvero poco 
era noto, soprattutto riguardo l’aspetto biochimico di questa proteina. Non era 
disponibile alcun dato strutturale e non c’erano altri fattori che potessero essere 
messi in relazione con Cdc45 da un punto di vista strutturale o funzionale. Abbiamo 
focalizzato la nostra attenzione sul complesso CMG, il complesso DNA elicasico di 
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cui Cdc45 fa parte, e siamo partiti tracciando un parallelo tra il macchinario 
replicativo degli organismi eucariotici e quello di Archaea. Infatti è noto che il sistema 
replicativo di questi ultimi è simile a quello eucariotico di cui costituisce una versione 
semplificata. Ad esempio per le sei proteine eucariotiche paraloghe che costituiscono 
l’etero-esamero del complesso MCM2-7 è presente in Archaea come controparte, 
una singola proteina MCM, omologa alle proteine MCM eucariotiche ed in grado di 
formare strutture omo-esameriche. Per quanto riguarda GINS, quattro differenti 
proteine compongono questo complesso negli organismi eucariotici, mentre in 
Archaea esso è formato solo da due proteine, GINS15 e GINS23, ancora una volta 
correlate alle proteine GINS eucariotiche, ed in grado di formare strutture 
tetrameriche. Tuttavia nel sistema replicativo degli Archaea non era nota alcuna 
proteina omologa o che in qualche modo potesse essere relazionabile al fattore 
eucariotico Cdc45 e questo risultava alquanto strano dato il ruolo fondamentale 
giocato da Cdc45 nella replicazione del DNA. 
Abbiamo dunque cominciato la nostra attività sperimentale facendo una ricerca 
tramite l’algoritmo BLAST per individuare eventuali proteine omologhe a Cdc45 in 
Archaea. La sequenza amminoacidica della proteina umana Cdc45 è stata utilizzata 
come query e la ricerca è stata effettuata in un database genomico di Archaea. Il 
risultato ottenuto indicava un certo grado di similarità tra la proteina umana Cdc45 ed 
una proteina archeale appartenente alla famiglia delle proteine DHH. Si tratta di una 
famiglia di fosfoesterasi ad ampio raggio, diffuse in tutti i tipi di organismi: Eucarioti, 
Archaea e Batteri. Queste proteine sono anche note come proteine RecJ-like dal 
nome della DNA esonucleasi RecJ di Escherichia coli, una delle proteine più 
rappresentative di questa famiglia. Abbiamo comparato tramite allineamento multiplo 
le sequenze amminoacidiche di varie proteine Cdc45 eucariotiche e varie proteine 
RecJ-like dal mondo archeale e batterico. Il risultato di tale allineamento mostra che 
la proteina umana Cdc45, ed in generale tutte le omologhe proteine eucariotiche, 
presentano un buon grado di similarità con quelle batteriche ed archeali, solo nella 
porzione N-terminale. Confrontando però i motivi di struttura secondaria conservati 
nel core strutturale della proteina RecJ-like di Thermus thermophilus, di cui è nota la 
struttura cristallografica ai raggi X, con quelli predetti per la proteina umana, si può 
osservare un buon grado di similarità per tutta la lunghezza delle proteine. 
Abbiamo prodotto e purificato la proteina umana Cdc45 in forma ricombinante da 
cellule batteriche. Abbiamo analizzato mediante SAXS la struttura della proteina 
ricombinante in soluzione in collaborazione con la Dr Silvia Onesti (Elettra 
Sincrotrone, Trieste). I dati raccolti ci hanno permesso di costruire un modello della 
struttura tridimensionale di Cdc45. La proteina sembra essere strutturata a forma di 
cornetto, con una porzione centrale più grossa e compatta, e due estensioni laterali 
che si diramano ai due lati opposti. Abbiamo dimostrato che la struttura del core della 
proteina RecJ-like da Thermus thermophilus può essere sovrapposta, in maniera 
altamente coincidente, con la porzione centrale del modello di struttura da noi 
predetto per la proteina umana Cdc45. Dunque la porzione centrale sembrerebbe 
essere realmente relazionabile al core proteico delle proteine DHH, mentre le due 
estensioni laterali sono verosimilmente attribuibili a due inserzioni amminoacidiche, 
una presente solo nella sequenza delle proteine eucariotiche Cdc45, l’altra presente 
anche nei fattori RecJ-like di Archaea ma non in quelli batterici. 
Nelle proteine DHH, una serie di motivi strutturali altamente conservati sono coinvolti 
nella coordinazione di due ioni metallici bivalenti, che sono necessari a queste 
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proteine per l’attività enzimatica fosfoesterasica. Nonostante nella sequenza della 
proteina umana Cdc45 siano conservati solo alcuni dei residui amminoacidici 
coinvolti nel legame dei metalli nelle proteine DHH, abbiamo ritenuto ugualmente 
opportuno indagare l’eventuale presenza di ioni metallici ad essa legati. I risultati 
ottenuti tramite tecniche diverse, indicano che Cdc45 non lega alcuno ione metallico. 
In accordo con questo dato abbiamo verificato che Cdc45 umana non possiede né 
attività pirofosfatasica né DNA esonucleasica, questa ultima tipica delle proteine 
RecJ-like. E’ stata inoltre valutata la capacità della proteina umana Cdc45 di legare il 
DNA e si è trovato che essa mostra affinità di legame per DNA a singolo filamento, 
mentre non ha affinità per il DNA a doppio filamento o per molecole di RNA.  
Tutti questi risultati sono in accordo con l’ipotesi da noi proposta che Cdc45 si sia 
evoluta da una proteina DHH ancestore. La proteina nel corso della evoluzione  
avrebbe perso molti dei residui amminoacidici che erano coinvolti nel legame degli 
ioni metallici, perdendo di conseguenza anche la propria attività catalitica. Un ricordo 
delle proteine RecJ-like rimane nella capacità di Cdc45 di legare DNA a singolo 
filamento proprio come molte delle DNA esonucleasi RecJ-like. Ad ogni modo, la 
porzione centrale e compatta del nostro modello per la struttura tridimensionale di 
Cdc45 non lascia dubbi sulla forte similarità che intercorre col core proteico delle 
proteine RecJ-like. 
Nella sequenza della proteina umana Cdc45 mancano motivi strutturali che sono 
solitamente presenti nelle proteine che legano il DNA. Abbiamo ipotizzato che la 
capactià di Cdc45 di legare DNA a singolo filamento potesse dipendere dalla 
presenza di una serie di amminoacidi carichi positivamente nella porzione C-
terminale della proteina. Per valutare e validare questa ipotesi, sono stati prodotti  
due costrutti esprimenti due diverse forme tronche della proteina umana. La prima 
forma tronca corrisponde alla porzione N-termiale della proteina (amminoacidi 1-258) 
mentre la seconda codifica per la porzione C-terminale di Cdc45 (amminoacidi 394-
566). Entrambi i costrutti sono stati espressi in cellule batteriche. Il mutante N-
terminale è risultato essere stabile e solubile, ed è per tanto stato purificato in 
maniera efficiente, mentre il mutante C-terminale è risultato essere altamente 
instabile e non è stato possibile purificarlo. Ad ogni modo, il mutante esprimente la 
porzione N-terminale di Cdc45 è stato impiegato per dei saggi di legame al DNA e i 
risultati ottenuti indicano che questa forma tronca non è più in grado di legare il DNA 
così come la proteina intera. Questo indicherebbe che effettivamente la regione di 
Cdc45 impiegata nel legame al DNA è la porzione C-terminale della proteina.  
Per studiare il ruolo di Cdc45 quale subunità accessoria della DNA elicasi replicativa 
abbiamo lavorato a lungo per ottimizzare la produzione del complesso umano CMG 
in forma ricombinante. Il metodo impiegato a tale scopo è stato quello delle cellule di 
insetto (nello specifico Sf9) infettate con baculoviruses ricombinanti. Nei primi 
tentativi di ottimizzazione di questo sistema di produzione 11 baculoviruses differenti, 
codificanti per le singole 11 subunità che costituiscono il complesso CMG, erano 
impiegati per un ciclo di infezione delle cellule di insetto. Baculoviruses codificanti per 
i diversi fattori proteici costituenti il complesso CMG, fusi a tags diversi, sono stati 
impiegati nei vari tentativi di produzione, così come diversi approcci sono stati 
impiegati per il primo passaggio di purificazione che consisteva in una cromatografia 
d’affinità. Nello specifico si è cercato di sfruttare, per la purificazione del complesso 
CMG, il FLAG-tag fuso alla subunità MCM7 o in alternativa uno STREP-tag fuso ad 
MCM2 o MCM3. Seguendo questo tipo di protocollo di produzione, solitamente si 
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otteneva l’espressione di tutti gli 11 fattori costituenti il complesso CMG nell’estratto 
solubile derivante dalle cellule infettate, come indicato dalle analisi di western blot. 
Nonostante ciò nelle frazioni eluite specificamente dalla resina di affinità non era 
possibile individuare tutte le componenti del complesso CMG. Dunque tutte le 
proteine risultavano essere espresse in cellule di insetto in seguito all’infezione 
virale, ma tali fattori non sembravano associarsi a formare un complesso stabile. 
Verosimilmente ciò dipendeva dal fatto che il sistema basato sulla co-infezione con 
11 virus non consentiva la produzione coordinata e contemporanea in tutte le cellule 
infettate (o almeno in buona parte di esse) degli 11 fattori proteici formanti il 
complesso CMG. E’ inoltre noto che le proteine MCM possono associarsi a formare 
dei sotto-complessi diversi dal complesso MCM2-7, come ad esempio MCM 2/4/6/7, 
MCM 4/6/7, MCM 3/5. La formazione di questi sotto-complessi può rappresentare un 
ulteriore impedimento nei termini di una produzione efficiente per il complesso CMG. 
Per cercare di ovviare almeno in parte a queste problematiche, abbiamo impiegato 
un nuovo sistema (Multi BacTurbo System) che ci ha permesso di ottenere dei 
baculoviruses multi-genici in grado di co-esprimere in cellule di insetto diversi prodotti 
proteici. In particolare è stato prodotto un baculovirus codificante 
contemporaneamente per MCM2, MCM4 ed MCM6, un secondo baculovirus 
codificante per MCM3 (+FLAG tag), MCM5 ed MCM7, ed infine un baculovirus 
codificante per Cdc45 e le quattro subunità del complesso GINS: Psf1, Psf2, Psf3 e 
Sld5 (+GST tag). L’impiego di questi baculoviruses codificanti per più proteine ci ha 
consentito di diminuire il numero di virus impiegati per ogni singolo ciclo di infezione, 
favorendo una espressione contemporanea e maggiormente coordinata delle singole 
proteine prodotte in ciascuna cellula infettata. Inoltre le sequenze codificanti per le 
varie proteine del complesso MCM2-7 sono state inserite in due virus separati in una 
disposizione tale da minimizzare la formazione di sotto-complessi da parte delle 
proteine MCM. Impiegando questi tre baculoviruses per l’infezione di circa 400 x 106 
cellule Sf9 siamo riusciti ad ottenere la produzione di un complesso CMG stabile che 
è stato isolato dall’estratto totale mediante cromatografia d’affinità, sfruttando il 
FLAG-tag fuso alla subunità MCM3. Nonostante tutto, la quantità di complesso 
ottenuta è davvero esigua e il materiale isolato non può essere impiegato per 
successivi passaggi di purificazione o per analisi strutturali e/o funzionali del 
complesso. 
Un altro sistema che è stato impiegato per analizzare il ruolo di Cdc45 nel processo 
di replicazione del DNA è quello degli estratti di uova di Xenopus laevis. Si tratta di 
un sistema molto utile impiegato da anni in particolare per lo studio della replicazione 
negli organismi eucariotici. Gli estratti ottenuti dalle uova di X. laevis sono ricchi di 
fattori coinvolti nella replicazione del DNA. Se il DNA cromatinico, proveniente dai 
nuclei spermatici privati di membrana della rana maschio, è aggiunto a questi estratti, 
la cromatina spermatica comincia a decondensare la sua struttura compatta e una 
sorta di membrana nucleare chimerica si forma attorno a tale materiale genetico. A 
questo punto comincia una vera e propria replicazione del DNA in vitro che può 
essere monitorata seguendo l’incorporazione di nucleotidi marcati radioattivamente o 
con molecole fluorescenti. Inoltre con questo sistema il fattore replicativo di  
interesse può essere eliminato dagli estratti mediante l’impiego di anticorpi specifici. 
A questo punto la replicazione può essere saggiata per analizzare l’effetto della 
eliminazione di quello specifico fattore, oppure mutanti della proteina di interesse 
possono essere sostituiti alla proteina wild type per valutarne l’effetto. Nel mio caso, 
avendo deciso di impiegare questo sistema per analizzare una proteina eterologa, ho 
dovuto prima di tutto verificare che la proteina umana Cdc45 potesse essere 
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impiegata nell’estratto dello Xenopus. I saggi di replicazione effettuati hanno 
dimostrato che la proteina ricombinante umana era in grado di ripristinare, così come 
la proteina ricombinante di rana, l’attività replicativa negli estratti immuno-privati del 
fattore endogeno mediante l’utilizzo di anticopri specifici. Allo scopo di indagare, con 
questo sistema sperimentale, il ruolo svolto dalle due estensioni laterali di Cdc45, 
non presenti nel core conservato delle proteine DHH, ho prodotto tre mutanti tronchi 
della proteina umana. In un primo mutante, A1_LP_1, circa il 70% dell’inserzione 
amminoacidica L1, quella presente solo nelle proteine Cdc45 eucariotiche, è stato 
eliminato. In un secondo mutante, ΔL1 la sequenza L1 è stata eliminata per intero. 
Nell’ultimo mutante ΔL2, l’altra inserzione amminoacidica L2, presente sia nelle 
proteine eucariotiche che in quelle archeali, è stata totalmente eliminata. I mutanti 
ΔL1 e ΔL2 non si sono potuti utilizzare per il lavoro con gli estratti di X. laevis in 
quanto formano aggregati in soluzione e dunque non sono più nello stato fisiologico 
proprio della proteina monomerica wild type. Il mutante A1_LP_1 è stato invece 
impiegato per dei saggi di replicazione del DNA negli estratti immuno-privati del 
fattore Cdc45 endogeno. I risultati ottenuti indicano che questo mutante può 
ripristinare, come la proteina umana wild type, la replicazione del DNA negli estratti 
immuno-privati del fattore endogeno. Questo implicherebbe che la sequenza 
eliminata nella forma tronca di Cdc45 non è indispensabile per il funzionamento di 
tale fattore nella  replicazione del DNA in condizioni non perturbate. 
Data la specificità di espressione di Cdc45 in cellule proliferanti, come le cellule 
tumorali, negli ultimi anni la comunità scientifica sta focalizzando l’attenzione su 
questo fattore e lo si comincia a valutare come possibile target per eventuali terapie 
molecolari anti-cancro. Dato il ruolo fondamentale di Cdc45 nella regolazione 
dell’inizio del processo di replicazione del DNA, una terapia molecolare che inibisca 
in maniera specifica l’associazione di Cdc45 alla forcina replicativa, causando un 
blocco altamente specifico delle cellule proliferanti, potrebbe rappresentare una 
valida alternativa alle metodiche farmacologiche attualmente in uso che prevedono 
l’impiego di agenti chemioterapici. 
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SUMMARY 
DNA replication is a crucial step for cell survival. All the information useful for the 
cells to propagate and complete their tasks is indeed kept in the DNA molecules that 
are needed to be duplicated in a proper way. Cdc45 is a fundamental factor involved 
both in the initiation and in the elongation phases of the DNA replication process. 
According to its function in the DNA replication mechanism it has been shown to be a 
proliferation-associated antigen and in fact it is expressed only in proliferating cells. 
Even if a peak for the mRNA codifying for Cdc45 can be observed at the G1/S 
border, levels of Cdc45 are stable throughout the cell cycle in proliferating cells.  
The loading of Cdc45 onto the chromatin has been shown to coincide with the origin 
firing (i.e. replication origins activation). During late M and G1 phases of the cell 
cycle, replication origins, the peculiar sequences on the genome where DNA 
replication process is supposed to start, are bound by the Origin Recognition 
Complex (ORC). This latter is itself bound by two other factors, Cdc6 and Cdt1, 
which are involved in the loading onto the chromatin of the MCM2-7 complex. This 
complex represents the molecular motor of the replicative DNA helicase, but at this 
stage it remains in an inactive state. At the G1/S border the GINS complex and 
Cdc45 are recruited at the replicative forks and associate with the MCM2-7 complex, 
bringing to the formation of the so called CMG complex, which is finally able to start 
working as DNA helicase, unwinding the DNA helix which can now be duplicated by 
the DNA polymerases. Even if the peculiar mechanism by which Cdc45 is loaded 
onto DNA is not fully understood, it is known that the activity of CDK2 and DDK 
kinases is required to this purpose. Cdc45 is the last factor to be loaded onto 
chromatin at the replicative fork and it is actually used by cells to switch on the DNA 
replication process. Once DNA replication has started, Cdc45 will keep on moving 
with the replicative fork co-operating together with GINS and MCM2-7 to provide 
DNA helicase activity. 
When we started our analyses on the human Cdc45 factor, not much was known 
about the biochemistry of this protein. Indeed, no structural data were available for 
Cdc45 and no enzymatic activity was known to be associated with it. We carried out 
a Blast search, using the human Cdc45 aminoacidic sequence as query, looking into  
archaeal genome databases. We started from the observation that all the other 
factors forming the eukaryotic CMG complex were found to have a counterpart in the 
archaeal DNA replication machinery, while no homologous was known for Cdc45 in 
these organisms. The result we got was actually highlighting a match between the 
human Cdc45 protein and an archaeal protein belonging to the DHH protein super-
family, which includes a wide range of phosphoesterases present in all organisms 
(i.e. Bacteria, Archaea and Eukarya). Comparing the human Cdc45 primary 
sequence with the ones from many other bacterial and archaeal DHH super-family 
members, a good degree of similarity can be observed in the N-terminal portion of 
these sequences. Comparison of the secondary structure elements of the core of 
DHH proteins with the predicted secondary structure motifs for the human Cdc45 
protein, a good degree of similarity can be observed along the whole sequences. We 
produced and purified human Cdc45 from E. coli cells in recombinant form and we 
carried out SAXS analyses on this protein, in collaboration with Dr. Silvia Onesti 
(Sincrotrone, Trieste). The reconstruction model based on the results of these 
analyses shown that human Cdc45 seems to be folded in a kind of cornet shape, 
with a more compact central core and two long lateral extensions. The crystal 
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structure of the Thermus thermophilus RecJ-like protein (a DHH phopshoesterase) 
can be properly superimposed with the central compact core of the hCdc45 predicted 
structure. Instead the two lateral extensions can be attributed to two long aminoacidic 
insertions which are not present in the bacterial proteins. Since DHH 
phosphoesterases usually bind two metal ions that are required for their catalytic 
activity, we checked if also the human Cdc45 protein was able to bind any kind of 
metal ion. According to the absence of most of the aminoacidic residues responsible 
for binding metal ions in the DHH proteins, Cdc45 was found not to bind any metal 
ion and, in agreement with this finding, it was found to show neither 
phyrophosphatase nor DNA exonuclease activity. We demonstrated that human 
Cdc45 has the ability to bind single-stranded DNA, while it shows no affinity for 
double-stranded DNA or RNA molecules. All these results were in agreement with 
the idea that Cdc45 has evolved from an ancestor DHH protein, that lost the 
enzymatic activity and just retained the ability to bind single-stranded DNA. 
We demonstrated that the N-terminal region of Cdc45 is not involved in the DNA 
binding activity, which can be likely ascribed to the C-terminal portion of the protein. 
Moreover, by using the Xenopus laevis egg extract experimental system we 
demonstrated that the “L1 loop”, a long aminoacidic insertion which is unique to the 
eukaryal Cdc45 proteins and is absent in the related archaeal and bacterial proteins, 
is not needed for the role played by Cdc45 in DNA replication in not perturbed 
conditions. 
To study the role played by Cdc45 in association with GINS and MCM2-7, we finally 
set up a method to produce the CMG complex in insect cells co-infected with multi-
genic baculoviruses.  
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INTRODUCTION 
Cell proliferation is the paramount mechanism for the maintenance and the 
propagation of life. Depending on their tasks, cells can differentiate, get older and die 
or they can undergo cell division to proliferate. Omnis cellula e cellula: as the famous 
quotation summarizes, a cell can only originate from another cell which has divided 
itself to generate two daughter cells. 
Daughter cells need to possess all the material that was present in the mother cell to 
have a proper development and life cycle. The most important thing is to stably 
maintain the genetic information contained in the DNA molecules. Indeed the 
information coming from DNA is the base for life, providing instructions to the cells on 
how to live, how to grow up, how to interact with the other cells, how to divide into 
two daughter cells, how to replicate DNA before cell division and so how to keep the 
informations contained in the same molecular structure which is the base for this 
information. 
The series of events actually leading a cell during all its life are tightly regulated by 
means of a number of proteins. These proteins can be factors involved in 
mechanisms dictating the cell life progression timing, factors that work as molecular 
motors for the progression of cell life’s phases or these can be proteins which 
actually work as molecular controllers on this progression of phases. All these factors 
are indeed involved in the regulation of what we call Cell Cycle, which is tightly 
regulated and shows different timing on the basis of the cell type and the moment of 
cell life. 
 
The eukaryotic cell cycle 
The series of events by which cells grow and prepare all the material to proliferate is 
named Cell Cycle. In eukaryotic organisms this process is the basis for the 
propagation of unicellular species. In complex multi-celluar organisms it is 
indispensable not only for the propagation of these species, but also for the correct 
growing and physiology of the living organism. In complex organisms some cells, 
such as skin cells, continuously go trough cell cycle undergoing a number of cell 
divisions, while other cells, more differentiated, such as neurons, just stop growing 
and dividing once they are mature and so definitively differentiated.  
In active proliferating cells mitosis, the process by which a cell eventually divides into 
two identical daughter cells, represents only the final step of the cell cycle. All the 
remaining phases of the cell cycle are included in the so called interphase (Fig. 1).  
The interphase is characterized by a continuous growing process and is itself divided 
into three different sequential steps. The first one is called G1 (gap 1) phase and it 
starts just after the previous mitotic phase. It is characterized by active RNAs and 
proteins production, which are the basis for cell growing and sustenance. 
Differentiated cells, such as neurons, are in a prolonged G1 phase also named G0 
phase. 
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In this case cells are not growing anymore and they just keep on producing all the 
RNA molecules and proteins needful for their life and to complete their tasks. Then 
there is the S (synthesis) phase during which all the chromatin, so the genetic 
information present in cells, is completely duplicated. Eventually a G2 (gap 2) phase 
separates the S phase from the next mitosis step. It is actually a preparation phase 
for the cell before it undergoes mitosis. In general it does not last for long. 
After the G2 step cells eventually enter in the M (mitotic) phase. Chromosomes, 
which have been previously duplicated, and all the other materials indispensable for 
cell’s life are equally divided into the two nascent daughter cells. The mother cell 
divide itself through a process named cytokinesis. 
 
The DNA replication process 
DNA replication process is a critical step in cell’s life because all the information 
contained in the chromosomes has to be correctly transferred to the daughter cells. 
Indeed cells have evolved a number of strictly controlled mechanisms to ensure a 
high-fidelity and complete replication of the genome and to avoid re-replication of the 
same DNA sequences. Here below I am going to focus on the eukaryotic DNA 
replication machinery. 
DNA replication only starts at very specific points on the genome named replication 
origins. Although in humans no recognizable sequences are known to be usually 
present in the replication origins so far, factors involved in the recognition of origins 
are known. Starting from the late M phase and during the G1 phase a complex of 6 
proteins, named ORC (origin recognition complex), is able to bind replication origins 
on chromatin. This complex shows ATP-ase activity and it is indispensable for the 
loading on chromatin of all the subsequent replicative factors [1-3]. Indeed the ORC 
complex directly binds the DNA and it is bound itself by two other factors: Cdc6 (Cell 
division cycle protein 6) and Cdt1 (Cdc10-dependent transcript 1). Cdc6, as the ORC 
complex subunits, is an ATP-binding protein belonging to the AAA+ super-family 
(ATPases associated with a variety of cellular activities). Cdc6 and Cdt1 are directly 
involved in the chromatin loading of the hetero-hexameric MCM2-7 complex, formed 
Figure 1 – Schematic representation of the cell cycle. During interphase cells grow and duplicate 
their DNA by three main steps. At the end they divide into two new daughter cells during the mitotic 
phase. 
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by the six paralogous Mini-Chromosome Maintenance proteins (MCM 2,3,4,5,6 and 
7) [2,4] (Fig. 2).  
 
This complex represents the molecular motor for the DNA unwinding activity but in 
this phase it remains in an inactive state. The super-complex, which has just formed 
at this step and comprises ORC, Cdc6, Cdt1 and the MCM2-7 complex, is named 
pre-Replicative Complex (pre-RC) [2,4]. The peculiar mechanism by which Cdc6 and 
Cdt1 bring MCM2-7 onto chromatin is called origin licensing, because now that 
specific replication origin is authorized to go on with the next steps of the replication 
process [5]. 
The next step consists in the origin firing (i.e. the real activation of the replicative 
fork). At the G1/S border of the cell cycle the pre-RC is converted to a pre-IC (pre-
Initiation Complex) by the adding of several factors to the previously formed pre-RC. 
The MCM2-7 complex will be activated through the association with two other 
important factors. The first one is the hetero-tetrameric GINS complex composed by 
4 different proteins: Psf1, Psf2, Psf3 (Partner of Sld five) and Sld5 (Synthetically 
lethal with Dpb11). The second one is the Cdc45 (Cell division cycle 45) protein. 
Eventually a CMG complex is formed, composed by the MCM2-7 complex, the GINS 
complex and Cdc45 and it comes to be the real replicative DNA helicase. Other 
factors are thought to intervene in the formation of the pre-IC and a full map has not 
yet been drawn [2,6]. What is clear is that the formation of the pre-IC requires the 
action of two serine/threonine kinases: the Cyclin-Dependent Kinase 2 (CDK2) and 
the Dbf4 (Dumbbell former 4)-Dependent Kinase (DDK) (Fig. 3) [7-9].  
 
Figure 2  – Pre-RC formation. During the G1 phase Cdc6 and Cdt1 recruit the MCM2-7 complex 
onto chromatin at a replication origin which has been recognized and bound by the ORC complex. 
Figure 3 – Pre-IC formation. At the G1/S border the pre-RC complex undergoes phosphorylation by 
CDKs and DDK. This allows the association of GINS and Cdc45 bringing to the formation of the pre-
IC. 
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In particular the action of the CDKs is fundamental to dictate the timing of these 
mechanisms. Indeed CDKs are functional only when associated with their activating 
counterparts known as cyclins. Cyclins are proteins whose level in the cell is tightly 
regulated depending on the phase of the cell cycle. The combination of a specific 
cyclin with a CDK precisely determines the phase of the cycle [10]. Hence the activity 
of CDK2 and DDK is indispensable for the loading of Cdc45 and the GINS complex 
onto chromatin even if the complete map of the factors targeted by these protein 
kinases is not known. Once Cdc45 and the GINS complex are associated with the 
MCM2-7 complex at the replicative fork a stable and active CMG complex is formed 
which can start unwinding the DNA helix [11,12]. After this step DNA polymerases 
are loaded onto chromatin and they can start duplicate the two strands of the DNA. 
More precisely, three different DNA polymerases (DNA pols) are involved in the 
elongation step. The first one is the DNA pol α-primase composed by 4 different 
subunits. It is able to produce short RNA primers subsequently elongated with short 
RNA-DNA chains known as Okazaki fragments [13]. These fragments are 
indispensable for the activity of the other two DNA polymerases involved in the 
elongation phase: DNA pol ε and DNA pol δ. Indeed these two latter DNA 
polymerases are not able to start DNA polymerization without a primer already 
present on the template. During elongation of the nascent DNA, DNA pol ε will 
specifically work duplicating the leading strand of the DNA while DNA pol δ is 
involved in the elongation of the lagging strand [14] (Fig. 4).  
 
 
 
The MCM2-7 complex 
The genes codifying for the 6 MCM proteins (MCM2 to MCM7) were first discovered 
in budding yeast during extensive genetic screenings by a group of researchers 
looking for genes involved in plasmids stability. They are conserved in all eukaryotes 
[15,16]. All six proteins are homologous and belong to the large family of AAA+ 
ATPases, as several ORC subunits and Cdc6 [17,18]. These proteins contain a 
region of homology which is called the MCM box [17,19] (Fig. 5).  
 
Figure 4 – The elongation phase. When Cdc45 and GINS associate with MCM2-7 to form an active 
CMG complex, DNA is unwound and DNA replication can start by the action of three different DNA 
polymerases. 
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Walker A and Walker B ATPase motifs together with an Arginine finger motif are 
located in this conserved region. 
The Saccharomyces cerevisiae and Schizosaccharomyces pombe MCM2 to MCM7 
proteins are nuclear during G1 and S phases and are actively transported from the 
cell nucleus to the cytosol during the G2 and M phases. In contrast, in higher 
eukaryotes MCM2 to MCM7 proteins are constitutively in the nucleus and their 
association with chromatin is regulated during the cell cycle diminishing with 
progression of these cells through S phase [17]. 
The eukaryotic MCM proteins form a hetero-hexameric complex (MCM2,3,4,5,6,7), 
which is also named MCM complex [17,18]. In addition they can associate with each 
other in different ways forming various sub-complexes such as those containing the 
proteins MCM2,4,6,7, MCM3-5 and MCM4,6,7 [17,18,20]. The activities of the MCM 
proteins are essential for the initiation and elongation steps of eukaryiotic DNA 
replication, but the molecular mechanism of their functions in DNA replication is still 
unsolved [21-23]. The recombinant MCM2-7 complexes from Saccharomyces 
cerevisiae, Drosophila melanogaster and Homo sapiens, reconstituted in vitro, show 
intrinsic ATPase activity [24,12,25]. ATPase hydrolysis is a requirement for helicase 
activity. Indeed all helicases show DNA-dependent ATPase activity. Although the 
MCM2-7 complex exhibits several features expected for a replicative DNA helicase 
only the sub-complex containing MCM4, MCM6 and MCM7 has been shown to 
contain a weak DNA helicase activity in vitro [17,26]. The helicase activity of these 
three proteins, which also form a hetero-hexamer (two trimers), is stimulated by DNA 
molecules with a fork-like structure. These latter molecules are also the preferred 
substrates for strand displacement activity [27]. However, genetic, cell biological and 
biochemical data in various model systems indicate that all six subunits of the 
MCM2-7 complex are necessary for the initiation and elongation phases of DNA 
replication [28-31]. Despite the progress of investigations on the MCM proteins and 
their enzymatic activities, these studies have been complicated by the abundance of 
the MCM proteins both in free and chromatin-bound state. In the cell-free Xenopus 
replication system 20 to 40 MCM2-7 complexes per each ORC complex are loaded 
onto chromatin although only two MCM complexes are sufficient to give full 
replication activity [32]. A similar situation can be found in yeast where more than 10 
MCM complexes seem to be associated with each replication origin at the beginning 
of the S phase [17]. Despite all this, the stoichiometry of Cdc45, which is actually 
involved in the activation of the replicative helicase, seems to be of about two 
Figure 5 – MCM proteins. Schematic alignment of the six paralogous human MCM proteins from 2 to 7. 
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molecules per each ORC complex in both these systems [17] suggesting that Cdc45 
works as a molecular trigger for the activation of the MCM2-7 complex. These 
evidences are consistent with the model according to which MCM2-7 together with 
Cdc45 and GINS forms the real replicative DNA helicase [31-33]. This model is 
supported by the finding that in Drosophila melanogaster a complex called CMG 
consisting of Cdc45, MCM2-7 and GINS possesses DNA unwinding activity. This 
suggests that GINS and Cdc45 would regulate the helicase activity of the MCM 
proteins in vivo [34].  
More recently, the D. melanogaster CMG complex, and the human one as well, have 
been reconstituted in recombinant form using the baculovirus-insect cells system. 
These complexes were found to possess DNA helicase activity and increased 
ATPase and DNA binding affinity if compared with the Mcm2-7 complex alone 
[12,25].  
 
The Cdc45 DNA replication factor 
The Cdc45 gene was first identified by Botstein’s group with a genetic screening for 
cold-sensitive cell cycle mutants in budding yeast together with Cdc46 and Cdc47 
(synonyms for MCM5 and MCM7) [35]. The replication factor Cdc45 is essential both 
for the initiation and the elongation phase of eukaryotic DNA replication. It associates 
with chromatin in the G1 phase of the cell cycle when the pre-IC complex is 
established [2,20,23,29]. The association of Cdc45 with replication origins coincides 
with origin activation (i.e. origin firing) [36]. It was recently shown in yeast and 
Drosophila that Cdc45 forms a multi-subunit complex with MCM2-7 and GINS (i.e. 
CMG complex), as also found in various other eukaryotic organisms including fission 
yeast, Xenopus laevis, Mus muris and Homo sapiens [31,33,34,37,38]. 
Cdc45 levels are stable throughout the cell cycle in human cells even if the mRNA 
codifying for the protein peaks at the G1/S border. On the basis of western blot 
analyses after cellular fractionation and immuno-fluorescence-based localization 
studies it has been observed that Cdc45 is present in both the cytosolic and nuclear 
fractions [42]. A significant fraction of the protein starts to be nuclear-localized at the 
G1/S border with a sort of diffuse staining into the nucleus. During the S-phase a 
different pattern can be observed where Cdc45 seems to associate with replication 
foci (i.e. active DNA replication sites) co-localizing with other factors known to be 
present at these sites [37,42,58]. 
The physical and functional interaction of Cdc45 and the MCM2-7 complex is highly 
conserved in eukaryotes but interactions of Cdc45 with other important replication 
factors have not yet been clearly established. The interaction between Cdc45 and 
RPA, the most abundant single strand binding protein involved in the stabilization of 
the single-stranded DNA during replication, has been detected in a variety of 
organisms from lower to higher eukaryotes. The same is true for the interaction with 
DNA Pol ε, whereas the physical interaction between Cdc45 and DNA polα-primase 
is still under discussion. Cdc45 from fission yeast and X. laevis has been shown to 
physically interact with DNA pol α, while these factors do not associate in budding 
yeast, D. melanogaster and H. sapiens [37,39,40]. Moreover, in several organisms 
an interaction has been shown between Cdc45 and DNA pol δ, MCM10, TopBP1, 
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Claspin (Mrc1 in budding yeast) and other factors involved in the S-phase checkpoint 
/ DNA damage repair pathways [6,37,41,42,43].  
The interaction between Cdc45 and DNA pol δ can be detected later in S-phase 
respect to the one with DNA pol ε and the extended association of Cdc45 and DNA 
pol δ during the cell cycle could suggest an involvement of these proteins in the 
maturation of Okazaki fragments or in post-replicative DNA repair reactions [37].  
MCM10 was first discovered in the same genetic screening by which all the other 
MCM proteins were identified [71]. Despite this, there is no structural and functional 
similarity between MCM10 and all the other MCM proteins. Comparing the function of 
this protein with Cdc45, studies in yeast suggest that Cdc45 and MCM10 are 
involved in the same cellular pathway and both proteins interact with the same 
regions of MCM5 and MCM7 [6]. MCM10 seems to be involved in the loading of 
Cdc45 onto DNA replication origins and in the recruitment of DNA pol α at the same 
sites [44,45].  
TopBP1 (DNA Topoisomerase II binding protein 1) is a fundamental factor for several 
aspects of cellular life, such as DNA replication and DNA damage checkpoint 
activation. Thus it interacts with Cdc45 intervening somehow in the first steps of DNA 
replication process. 
Claspin is a protein known to work as a mediator of the S-phase checkpoint. 
Eukaryotic cells have evolved very complex control systems to stably maintain the 
integrity of their genomes. These control mechanisms stop the cell cycle, if a DNA 
damage has occurred, until the lesion will be repaired. These DNA damage-
dependent signal transduction pathways are called checkpoints [46,47]. Importantly 
they seem to be conserved from yeast to humans, where they may have a role in the 
control of cancer development [48,49]. Depending on the type of DNA damage, 
different checkpoint pathways become activated in the cell: DNA double-strand 
breaks formation mainly triggers the ATM-Chk2 pathway, whereas ultraviolet 
irradiation and stalled replication forks primarily promote the ATR-Chk1 pathway 
[52,53]. ATM (Ataxia telangiectasia mutated) and ATR (Ataxia-telangiectasia and 
Rad3-related protein) are members of the phosphoinositides kinase-related family of 
protein-kinases [54]. ATR and ATM are responsible for phosphorylation-mediated 
activation of the downstream kinases Chk1 and Chk2, respectively [55-57]. Recently 
it has been shown that Cdc45 is involved in the regulation of DNA replication after 
the activation of the S-phase checkpoint due to DNA damage [6,41,50,51]. It has 
been shown by means of experiments carried out in the X. leavis egg extracts 
experimental system that after DNA damage, replication is prevented by the inhibition 
of Cdc45 loading onto chromatin [50]. This control mechanism seems to be 
conserved also in humans. Indeed it was shown that in H. sapiens there is a DNA 
damage-dependent regulation of Cdc45 loading onto chromatin and this occurs in a 
Chk1 (checkpoint kinase 1)-dependent manner [51]. Chk1 is one of the factors 
involved in the final steps of the S-phase checkpoint activation (i.e. checkpoint 
effectors) [52].  
Not much is known about the biochemistry and the physiology of Cdc45 so far, 
despite its fundamental importance in various DNA transactions. 
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The GINS complex 
The GINS complex is an hetero-tetrameric complex composed by four proteins: Sld5, 
Psf1, Psf2 and Psf3 [61]. They are conserved in all eukaryotic organisms and the 
complex they form has been named after the acronym of the Japanese words “Go-
Ichi-Ni-San” which mean “five-one-two-three” representing the final numbers of the 
names of the four proteins. 
The genes codifying for these factors were first identified in S. cerevisiae by means 
of several genetic screenings. Sld5 (Synthetically lethal with Dpb11) was discovered 
as a novel interactor of Dpb11, an initiation factor responsible for the recruitment of 
DNA pol ε at the replication fork through the interaction with Dpb2, one of the 
subunits of this polymerase. By means of two-hybrid screenings Psf1, Psf2 and Psf3 
were then identified as Partners of Sld Five [59]. In the same period Kubota and co-
workers identified the homologous complex in X. laevis. These authors proposed that 
the GINS complex may have a role in DNA replication, because a reduction of the 
dNTPs incorporation could be observed in DNA replication after the immuno-
depletion of the GINS complex from the extract used for the in vitro assays [60]. 
Either in S. cerevisiae or in X. laevis the GINS complex was shown to be associated 
with the chromatin and to interact with Cdc45 and the MCM2-7 complex [59,60]. 
The crystallographic structure of the complex has been solved by three different 
groups, showing a trapezoidal shape with Sld5 and Psf1 associated in the top layer 
and Psf2 and Psf3 associated at the bottom. This confirmed the subunit arrangement 
proposed on the basis of two-hybrid screenings and mapping with monoclonal 
antibodies [59,62]. The structure retains a central hole which is actually funnel-
shaped because its diameter is about 70Å on a side and about 25Å on the other side 
[62-65]. The human GINS complex has been shown to preferentially bind single-
stranded DNA (ssDNA) [62]. 
Several studies revealed that the GINS complex is indispensable not only for the 
initiation but also for the elongation steps of the DNA replication process. Indeed 
GINS has been shown to be part of the so called Replisome Progression Complex 
(RPC) together with MCM2-7, Cdc45 and other factors associated to the replication 
fork during S phase [30,31]. The interaction between GINS and MCM2-7 has also 
been demonstrated in S. cerevisiae and these two complexes have been shown to 
be part of the RPC together with Cdc45 by mass spectrometry analysis [33].  
Moreover, a complex containing Cdc45, GINS and MCM2-7 was isolated from D. 
melanogaster embryos and more recentely, as I have stated above, the D. 
Melanogaster CMG complex, and the human one as well, have been reconstituted in 
recombinant form using the baculovirus-insect cells system [12,25,34].  
 
The CMG complex 
DNA unwinding is a fundamental activity of the DNA replication machinery. DNA helix 
has to be opened to let DNA polymerases work. In eukaryotic cells the CMG complex  
has been definitively identified as the real replicative DNA helicase. Within this multi-
subunit complex, the six MCM proteins form a hexameric ring-structure that 
represents the molecular motor of the DNA helicase. Indeed all the MCM proteins 
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retain ATPase activity that is needed for the DNA unwinding function [17,18]. Thus 
Cdc45 and the GINS complex are believed to be auxiliary factors needed to activate 
the helicase motor [12,25].  
The CMG complex was first purified from Drosophila melanogaster embryo extracts. 
Moyer and co-workers carried out an immuno-affinity pull down of Cdc45 from the 
extracts and they were able to detect in the pulled-down fraction 10 Cdc45-
interacting proteins, which were analysed by mass spectrometry and were identified 
to be the 6 MCM proteins (i.e. the MCM2-7 complex), plus the 4 proteins composing 
the GINS compex (Sld5, Psf1, Psf2, Psf3). Moreover they demonstrated that the 
complex purified from these extracts possesses DNA helicase activity in vitro [11]. 
Some years later Ilves and co-workers were able to produce a stable recombinant D. 
melanogaster CMG complex by co-infecting insect cells with 11 baculoviruses 
codifying for the 11 single subunits of the complex. They purified the recombinant 
CMG complex and compared its enzymatic properties with those of the MCM2-7 
complex produced in insect cells [12]. The ATP hydrolysis rate by the MCM2-7 
complex was shown to be enhanced by 300 folds when the latter was associated 
with Cdc45 and GINS. Since neither Cdc45 nor the GINS proteins are ATPases, 
these Authors proposed that the increased ATPase activity could be due to an 
allosteric remodelling of the MCM2-7 complex after the association with these 
auxiliary factors. Moreover the CMG complex was shown to have an improved DNA 
binding activity in comparison with the MCM2-7 complex and interestingly its DNA 
binding activity was found to be ATP-dependent, while the one of the MCM2-7 
complex was not. Most important, a robust in vitro DNA helicase activity was shown 
to be associated with the CMG complex, while the MCM2-7 complex alone did not 
show at all this activity [12]. 
In a subsequent work the D. melanogaster CMG complex obtained with the same 
procedure was used by Costa and co-workers to get structural data by single-particle 
electron microscopy analysis [66]. According to their model, the MCM2-7 complex 
would assume two different basic conformations. The first one is a spiral 
conformation with a gap occurring between the MCM2 and MCM5 subunits. In the 
other one, MCM2-7 has a planar ring-like structure and this conformation seems to 
be favourite when Cdc45 and GINS are associated whit it. It is important to notice 
that Cdc45 and GINS bind the MCM2-7 complex at the interface with MCM2 and 
MCM5 closing the gap between these two subunits [66] (Fig. 6).  
 
Figure 6 – Model for CMG complex. Schematic representation of the 
CMG complex according to the model proposed by Costa et al. [66]. 
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In 2012 the human CMG complex has been reconstituted in recombinant form by 
Kang et al. [25]. As the D. melanogaster complex, the human CMG complex has 
been produced in recombinant form in insect cells by co-infection with 11 
baculoviruses codifying for each subunit of the complex. As the D. melanogaster 
counterpart the human CMG complex was found to possess increased ATPase and 
DNA helicase activity. Moreover, with a very elegant experiment it was demonstrated 
that the helicase activity of the human CMG complex is coordinated with the 
synthetic function of DNA pol  on a small circular single-stranded DNA template, 
which was replicated several times in vitro with a rolling circle mechanism [25].  
Summarizing, it is well established so far that the CMG complex is the real eukaryotic 
replicative DNA helicase: the MCM2-7 complex represents the molecular motor of 
this enzymatic activity, but it needs to be activated by the association of Cdc45 and 
GINS; nevertheless only a speculation can be made about the mechanism by which 
these two co-factors activate the MCM2-7 activity. Additional studies are needed to 
fully understand the mechanism by which the CMG complex exerts the DNA 
unwinding activity and the specific role played by Cdc45 and GINS.  
 
The DHH family of phosphoesterases 
The DHH protein family is a wide spread group of phosphoesterases, including 
inorganic pyrophosphatases and RecJ ssDNA exonucleases, which are conserved in 
all kind of organisms (i.e. eukarya, archaea and bacteria) that was first described by 
Aravind and Koonin [74]. This protein family is defined by a number of conserved 
sequence motifs and it is usually split into two distinct clusters.  
The first one, identified as subfamily 1, is represented so far only in Archaea and 
Bacteria. The most representative member of this subfamily is the Escherichia coli 
RecJ protein, a 5’ to 3’ single-stranded DNA exonuclease. Therefore, these proteins 
are usually referred to as RecJ-like proteins. 
The subfamily 2 is also found in Eukarya and it includes the Drosophila melanogaster 
Prune protein and the Saccharomyces cerevisiae exopolyphosphatase PPX1 [74]. 
Crystallographic analysis carried out on several DHH proteins [75–77] have 
highlighted the presence of a catalytic protein core composed by two main domains: 
domain I and domain II (also named N-terminal and C-terminal domain). In the N-
terminal domain invariant residues (aspartic acid and histidine residues) are 
conserved and involved in the coordination of two metals ions (typically manganese 
ions). This would suggest a two-metal ions mediated hydrolysis activity for these 
proteins. 
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AIM OF THE THESIS WORK 
Dissecting the molecular pathways implied in the DNA replication is the basis for 
understanding the mechanisms by which cells proliferate. In humans the control of 
cellular proliferation is a dramatic and fundamental issue for the viability of the 
organism. If a cell escapes this kind of control it can start growing in an uncontrolled 
fashion. It means that now this cell is no anymore part of the organism from a 
physiological point of view and it starts to be lead by altered molecular mechanisms 
which can lead to tumorigenesis if the cell is still able to divide into two daughter 
cells. 
The Cdc45 replication factor has been shown to be a proliferation-associated antigen 
[67]. This protein is totally absent in quiescent or terminally differentiated cells while it 
is actively produced in proliferating cells, such as cancerous cells, during all the 
phases of the cell cycle [67,68]. Due to its role in the replication forks activation, 
Cdc45 comes to be one of the fundamental circuit-breakers used by the cell to switch 
on and off the DNA replication process. Indeed the association of Cdc45 with the pre-
RC coincides with origin firing [69]. Moreover, after the activation of the DNA-damage 
dependent checkpoint, Cdc45 is targeted for the dissociation from the replisome and 
this coincides with the stop of the replication process [50,51]. Thus studying Cdc45 
and the molecular mechanisms in which it is involved will provide useful information 
to understand how DNA replication is switched on or off in normal or perturbed 
conditions. 
Despite the central role of Cdc45 in the DNA replication mechanism not much is 
known about the biochemistry of this protein. The aim of my thesis work has been to 
study the Cdc45 protein from a biochemical point of view, both as a single molecule 
and in association with other proteins in the CMG complex. In fact, for what concerns 
the single protein, nothing was known about the structure and the putative enzymatic 
properties of this protein. No characteristic sequence motif was identified in the 
Cdc45 primary sequence and it was clear that Cdc45 could activate the DNA 
unwinding activity of the MCM2-7 complex together with GINS, but nothing was 
known about the specific mechanism. Furthermore the CMG complex had not been 
yet reconstituted to assay its activity in vitro.  
By a biotechnological point of view, the biochemical characterization of the Cdc45 
replication factor and the study of its role in the cell can provide a basic knowledge 
that can be exploited to set up novel anti-cancer therapeutics. This would form the 
basis for a completely new approach for cancer treatment according to a strategy 
alternative to the traditional ones. Currently, cancer therapy is mainly based on the 
use of chemotherapeutics, which actually damage the genome of the proliferating 
cells. A molecular therapy, based on small molecules that could interfere with the 
activity of Cdc45, would be more powerful and specific. Indeed Cdc45 inactivation 
would actually stop all cell proliferation and this would happen in a very specific 
manner due to the fact that the protein is almost absent in differentiated cells and 
tissues.  
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EXPERIMENTAL PROCEDURES 
 
Human Cdc45 protein expression and purification 
A previously produced plasmid construct was used for the production of the wild type 
recombinant hCdc45 protein with a C-terminal 6xHis-FLAG tag cleavable with 
tobacco etch virus (TEV) protease (pNIC-CTHF-hCdc45) [70].  
Expression of hCdc45 was carried out in Escherichia coli BL21 (DE3)-R3-Rosetta 
cells (SGC, Oxford) grown overnight at 25°C in LB broth, following induction with 0.1 
mM isopropyl 1-thio-β-D-galactopyranoside (IPTG). A frozen cell pellet 
(corresponding to 1 litre of culture) was resuspended in 100 ml of buffer A (50mM 
sodium phosphate buffer, pH 7.4, 1 M NaCl, 10% (v/v) glycerol, 2mM β-
mercaptoethanol) containing EDTA-free protease inhibitor mixture (Roche Applied 
Science), 50 units/ml benzonase nuclease (Novagen), and 1 mg/ml lysozyme 
(Sigma-Aldrich), and incubated for 2 h at 4 °C. Cells were further disrupted by 
sonication (Bandelin Sonopuls HD3200 ultrasonic homogenizer).  
 
 
 
Figure 7 – Nickel affinity chromatography. Chromatogram of the nickel affinity chromatography 
carried out as first step for the purification of recombinant hCdc45. In green the imidazole step-
gradient is shown. In the second step of the gradient a sharp peak can be observed that corresponds 
to hCdc45 protein eluted from the resin. 
 
The insoluble material was removed by centrifugation (17,000 rpm for 1 h at 4 °C, 
Beckman Allegra 64R), and the supernatant was loaded onto a 5-ml HiTrap chelating 
column (GE Healthcare) previously charged with Ni2+ (NiSO4) and equilibrated with 
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buffer A. An imidazole step-gradient (25 mM, 250 mM, and 500 mM) was applied, 
and protein elution was achieved using buffer A plus 250 mM imidazole (Fig. 7).  
Fractions containing the hCdc45 protein were pooled and subsequently loaded onto 
a Superdex 200 16/60 size-exclusion column (GE Healthcare) equilibrated with buffer 
B (50 mM sodium phosphate, pH 7.0, 150 mM NaCl, 5% (v/v) glycerol, 2 mM β-
mercaptoethanol) (Fig. 8). 
 
 
Figure 8 – Size-exclusion chromatography profile for hCdc45. The chromatogram of this 
purification step is shown. On the right a huge peak can be observed corresponding to hCdc45 exit 
from the Superdex 200 16/60 column. 
 
 
The eluted protein was incubated at 4 °C overnight with the tobacco etch virus (TEV) 
protease for tag cleavage. SDS-PAGE (12% polyacrylamide:bis 29:1) was carried out 
to check that the cleavage was complete. The hCdc45-TEV protease mix was loaded 
onto a 5-ml Heparin column (GE Healthcare), previously equilibrated with buffer B. 
The cleaved hCdc45 was eluted from the column applying a linear (150 mM to 1 M) 
NaCl gradient (Fig. 9). Finally the protein was subjected to size-exclusion 
chromatography in buffer D (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 5% (v/v) 
glycerol, 2 mM β-mercaptoethanol) (Fig. 10). 
The same procedure was used to express and purify all the other mutants of the 
hCdc45 protein. 
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Figure 9 – Heparin chromatography. Chromatogram of the Heparin column purification step: in blue 
the peak corresponding to hCdc45 is shown, while the green line depicts the salt gradient applied to 
the column. 
 
 
Figure 10 – Size-exclusion chromatography analysis of recombinant hCdc45. The 
chromatographic profile of hCdc45 on a Bio-Sil SEC-250 (Bio Rad) column is shown (upper part). 
Column calibration (with the following markers: tyroglobulin, bovine γ-globulin, chicken ovalbumin, 
equin myoglobin, vitamin B12) is shown in the lower part. Cdc45 peak eluted at a volume (8.78 ml) 
that corresponds to the molecular mass of the protein (68 kDa). 
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Production of human Cdc45 mutant derivatives 
Plasmid constructs for the expression of deletion mutants of the protein were 
produced by using three sequential PCRs (Fig. 11). 
 
 
In the first PCR two separate portions of the Cdc45 CDS (coding sequence) were 
amplified excluding the region codifying for the portion to be deleted. These 
sequences were amplified by using four different DNA primers. The reverse primer 
used for the amplification of the first region of the Cdc45 CDS was partially 
complementary to the forward primer used for the amplification of the second region. 
The complementary region shared by these two primers encodes a linker 
aminoacidic sequence (STGSSGTSGG) that substitutes for the deleted portion of the 
protein.  
In the second PCR the two previously amplified sequences were fused by means of 
the complementary regions. The forward primer used in the previous PCR for the 
amplification of the first sequence and the reverse primer used for the amplification of 
the second sequence were used in this reaction. 
The third PCR was used to clone the sequence amplified in the second reaction into 
the pNIC-CTHF vector by restriction free (RF) cloning. In this reaction the pNIC-
CTHF-hCdc45 (expressing the wild-type hCdc45 protein) was used as the template, 
while the construct amplified in the second PCR reaction was used as a mega-
primer. The amplification product was extensively digested with DpnI restriction 
enzyme (NEB) to eliminate the wild-type pNIC-CTHF-hCdc45 plasmid used as the 
template. A portion of this mixture was then used to transform E. coli DH5α cells 
(Invitrogen), which were then spread on plates containing kanamycine and incubated 
over night at 37 °C. Bacterial colonies grown on the plates were screened to identify 
recombinant clones harbouring the DNA fragment of interest.  
Figure 11 – Schematic representation of the three sequential PCRs used for constructing the 
Cdc45 deletion mutants. 
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By using this method plasmid constructs codifying for three mutants derivatives of the 
protein were cloned: 
- hCdc45_A1_LP_1 (a. a. from 138 to 182 substituted with STGSSGTSGG) 
- hCdc45-L1(a. a. from 113 to 181 substituted with STGSSGTSGG) 
- hCdc45-L2 (a. a. from 254 to 351 substituted with STGSSGTSGG). 
Plasmid constructs for the expression of truncated forms of Cdc45 were produced by 
using two sequential PCRs (Fig. 12).  
 
 
In the first PCR the region of interest of the Cdc45 CDS was amplified by using two 
different primers. Half-part of each primer was complementary to the Cdc45 CDS 
while the other part was complementary to the pET29a(+) (Novagen) sequence 
present in the chosen insertion site. In this first PCR the pNIC-CTHF-hCdc45 plasmid 
was used as the template. In the second PCR the amplification product from the 
previous reaction was used as a mega-primer and the empty pET29a(+) was used as 
template to get a restriction free cloning of the sequence of interest into this vector. 
The amplification product was extensively digested with the DpnI restriction enzyme 
(NEB) to eliminate the empty pET29a(+) vector used as the template. A portion of 
this mixture was then used to transform E. coli DH5α cells (Invitrogen), which were 
then spread on plates containing kanamycine and incubated over night at 37 °C. E. 
coli colonies grown on the plates were screened to identify recombinant clones.  
By using this method plasmid constructs codifying for two different truncated forms of 
the protein were cloned: 
- hCdc45-A13/1 (a. a. 1-258)  
- hCdc45-C-ter (a. a. 394-566) 
 
 
Figure 12 – Schematic representation of the two PCR steps used to construct plasmids 
expressing truncated forms of Cdc45. 
. 
 26 
 
Cloning, expression and purification of the recombinant Xenopus Cdc45 
protein 
An oligonucleotide sequence codifying for the Xenopus Cdc45 protein with 6xHis and 
3xFLAG tags at the C-terminus had been previously cloned into a pCR2.1-TOPO 
vector (Invitrogen) in our laboratory. 
I was able to sub-clone this sequence into a pET29a(+) bacterial expression vector 
(Novagen) by cutting both the pCR2.1-TOPO-xCdc45 construct and the empty 
pET29a(+) vector with BamHI and NdeI restriction enzymes (Roche). The digestion 
was carried out in buffer B (Roche). DNA fragments of interest were purified by gel 
extraction and employed for a ligation reaction using the T4 DNA ligase (Roche).  
Half of the ligase reaction mixture was then used to transform E. coli DH5α cells 
(Invitrogen) then spread on kanamycine plates and incubated over night at 37 °C. E. 
coli colonies  were screened  to get positive clones. 
Expression of the xCdc45-His-FLAG protein was carried out in (DE3)-R3-Rosetta 
cells (SGC, Oxford). Bacteria were grown up to an optical density of 2 and then the 
expression of the protein was induced by adding 0.1 mM IPTG to the cell medium. 
After the induction, cells were kept over night at 18 °C on shaking, then harvested by 
centrifugation for 15 minutes at 6,000 rpm in a F12-6x500Y rotor (Sorvall – RC 6+ 
centrifuge). 
Cell pellet from 3 liters of culture was re-suspended in 50 ml of Lysis Buffer (50 mM 
Tris/HCl pH 7.5, 200 mM NaCl, 10% (v/v) glycerol, 2 mM β-mercaptoethanol) 
supplemented with EDTA-free protease inhibitor cocktail (Roche). Cells were 
disrupted by 2 cycles of French Press and the crude extract obtained was treated 
with 50 units/ml Benzonase nuclease (Novagen) for 1h at 4°C on shaking. Whole cell 
extract was then clarified by centrifugation at 40,000 rpm for 40 minutes in a LE-80 
BECKMAN ultracentrifuge.  
The soluble extract obtained was incubated with 3 ml of Ni-NTA agarose resin 
(Qiagen) for 1 h at 4 °C on shaking. This mixture was then loaded on an affinity 
chromatography column and the unbound material let flow through. Resin was 
washed with 200 ml of Lysis Buffer and then 5 elution steps were carried out 
respectively with: 
- 10 ml of Lysis Buffer plus 10 mM imidazole 
- 10 ml of Lysis Buffer plus 25 mM imidazole 
- 10 ml of Lysis Buffer plus 50 mM imidazole 
- 10 ml of Lysis Buffer plus 100 mM imidazole 
- 10 ml of Lysis Buffer plus 250 mM imidazole 
The 50 mM imidazole elution fraction, which contained the peak of the protein eluted 
from the resin, was loaded on a MonoQ HR 16/10 column (GE Healthcare) 
previously equilibrated with Buffer A (25 mM Tris/HCl pH 7.5, 200 mM NaCl, 10% 
(v/v) glycerol, 2 mM β-mercaptoethanol). The elution was carried out with a linear salt 
gradient from 200 mM to 1M NaCl. 1-ml fractions were collected and analysed by 
SDS-PAGE to check the presence of the protein of interest.  
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Fractions containing xCdc45-His-FLAG were pooled and loaded on a Superdex 200 
16/60 column (GE Healthcare) for a size-exclusion chromatography step. The 
column had been previously equilibrated in Buffer D (20 mM Tris-HCl pH 7.5, 150 
mM NaCl, 5% (v/v) glycerol, 2 mM β-mercaptoethanol). After SDS-PAGE analysis, 
fractions containing the protein of interest were pooled and concentrated with a 
Vivaspin 2 device (30k MWCO – GE Healthcare) to reach a final concentration of 1 
mg/ml for xCdc45-His-FLAG protein. The result from the purification protocol is 
shown in Fig. 13. 
 
Figure 13 – Purification of xCdc45-His-FLAG. The indicated amounts of the purified recombinant 
protein are shown by Coomassie staining after SDS-PAGE. 
 
Electrophoretic mobility shift assays (EMSAs) 
The synthetic oligonucleotide used as single-stranded DNA had the following 
sequence: 5’-TCTACCTGGACGACCGGGTATATAGGGCCCTATATATAGGGCCAG 
CAGGTCCATCA-3’. A complementary synthetic oligonucleotide used to prepare the 
blunt DNA duplex had the following sequence: 5’-TGATGGACCTGCTGGCCCTATAT 
ATAGGGCCCTATATACCCGGTCGTCCAGGTAGA-3’. The first oligonucleotide was 
labeled using T4 polynucleotide kinase and [γ-32P]ATP and annealed to a 2-fold 
molar excess of the cold complementary strand to prepare the double-stranded DNA 
ligand. For the DNA mobility shift assays, 10-μl mixtures were prepared that 
contained 100 fmol of 32P-labeled DNA in 20 mM Tris-HCl, pH 7.5, and the indicated 
amounts of protein (0.5 – 5 μg). Following incubation for 20 min at 27 °C, complexes 
were separated by electrophoresis through 5% polyacrylamide/bis gels (19:1) in 0.5X 
TBE (1X TBE: 89 mM Tris Base, 89 mM Boric Acid, 2 mM EDTA, pH 8.3). Gels were 
dried down and analyzed by phosphorimaging. Experiments were performed in 
triplicate, and the results were averaged. The error bars on the graphs are the 
standard error. For the super-shift analysis assays were carried out after incubation 
of hCdc45-His-FLAG-DNA complexes with anti-FLAG monoclonal antibodies 
(Abcam). For these experiments 10-μl mixtures were prepared that contained 50 fmol 
of 32P-labeled oligonucleotide in 20mM Tris-HCl, pH 7.5, and 5 μg of hCdc45-His-
FLAG. Following incubation for 20 min at 27 °C, anti-FLAG antibody was added (0.5, 
1, and 2 μg in 2 μl of the following buffer: 10 mM sodium phosphate, pH 7.4, 150mM 
NaCl, 50% (v/v) glycerol; an equal volume of buffer (2 μl) was added into the samples 
where antibody was omitted, and the incubation was continued for additional 30 min. 
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The mixtures were subjected to electrophoresis, as previously described, and the 
gels were analyzed by phosphorimaging.  
EMSAs on a radio-labeled 20-mer synthetic single-stranded RNA (100 fmoles/assay) 
were carried out using the following single-stranded RNA sequence: 5’-
GAUCGGGAGAUCUCAGACCA-3’. The protocol used for the assay is the same 
used for single-stranded DNA. 
 
Analytical gel filtration and DNA-binding activity of hCdc45 
An aliquot of purified hCdc45 (1.9 mg) was loaded onto an analytical gel-filtration 
column (Bio-Sil SEC-250, Bio-Rad). The column was developed with 50mM Tris-HCl 
pH 8.0, 150 mM NaCl, 2 mM β-mercaptoethanol, 5% (v/v) glycerol at a flow rate of 
1.0 ml/min. Fractions (200 μl) were collected, and aliquots (5 μl) were run through an 
8% (w/v) polyacrylamide-SDS gel. The gel-filtration column was calibrated using the 
following markers: tyroglobulin, bovine γ-globulin, chicken ovalbumin, equin 
myoglobin, and vitamin B-12. The DNA binding activity of each peak fraction (aliquots 
of 1 μl) was analyzed by EMSAs using radio-labelled single-stranded DNA as a 
probe, as previously described.  
 
Pyrophosphatase activity assays 
Pyrophosphatase (PPase) activity was determined following the method described by 
Park et al. [92]. 
PPase activity was assessed for the hCdc45 protein in presence of different metal 
ions and at different pH conditions. Increasing amounts of recombinant hCdc45 
protein (from 100 ng to 5 μg) were added to reaction mixtures (volume: 300 μl) 
having the following composition: 50 mM Tris–HCl, pH 6.5 (or pH 7.5, or pH 8.5), 5 
mM MgCl2 (or MnCl2, or ZnCl2, or CoCl2), 1 mM inorganic pyrophosphate. The 
reaction was started by the addition of the recombinant protein and kept at 37 °C for 
15 min. Inorganic phosphate present in the mixture was detected by adding 700 μl of 
phosphate detection reagent (1.5% ascorbic acid (w/v), 1% ammonium molybdate, 
0.83 M Sulfuric Acid). After inorganic phosphate production a deep blue colour is 
developed due to the presence of a phosphomolybdate complex and its absorbance 
can be measured at 820 nm. The amount of inorganic phosphate can then be 
quantified using a phosphate standard curve obtained from serial dilutions of a 
NaH2PO4 standard solution.  
 
DNA exonuclease activity assays 
Assays were carried out to check for 5’ to 3’ exonuclease activity. hCdc45 
recombinant protein was incubated in presence of an oligonucleotide (having the 
following sequence 5’-GCCGTGATCACCAATGCAGATTGACGAACCTTTGCCCAC 
GT-3’) that was labelled with a Cy3 fluorescent molecule (PRIMM). Exonuclease 
activity was assessed for the hCdc45 protein in presence of different metal ions and 
at different pH conditions. Different amounts of recombinant hCdc45 protein (from 
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100 ng to 1 μg) were added to reaction mixtures (volume: 20 μl) with the following 
composition: 50 mM Tris–HCl, pH 6.5 (or pH 7.5, or pH 8.5), 5 mM MgCl2 (or MnCl2, 
or ZnCl2, or CoCl2), 150 mM NaCl, 20 nM DNA substrate. The reaction was started 
by the addition of the recombinant protein and kept at 37 °C for 30 min. Reactions 
were terminated by the addition of 5X Stop Solution (0.5% SDS, 40 mM EDTA, 0.5 
mg/ml proteinase K, 20% glycerol). The eventual degradation of the substrate was 
assessed by loading the reaction mix on a 8% polyacrylamide gel containing 0.1% 
SDS that run in 0.5X TBE buffer. Fluorescence was detected by using a VersaDoc 
instrument (Bio Rad). 
 
Production of recombinant baculoviruses 
The pFastBac derivatives harbouring the following human CDSs were provided by Dr 
Lori Frappier (University of Toronto, Toronto, Canada): MCM2 (6xHis tag), MCM2 
(STREP tag), MCM3, MCM4, MCM5, MCM6, MCM6 (HA+6xHis tag), MCM7 
(FLAG+6xHis tag). 
A baculovirus expressing the human Cdc45 protein fused to a 6xHis tag had been 
previously produced in the laboratory.  
A baculovirus expressing the MCM3 protein fused to a STREP tag and four 
baculoviruses expressing the four single subunits of the GINS complex (Psf1, Psf2, 
Psf3 and Sld5) were produced using the Gateway® System with the pENTR™ 
Directional TOPO® Cloning kit (Invitrogen). The CDSs of interest were amplified by 
using two different primers. The forward primer for each reaction was designed to 
start with a specific sequence (CACC) that is needed for the next topoisomerase 
reaction step. The forward primer used for cloning the MCM3 CDS contained the 
sequence codifying for the STREP tag (5’-ATGGCTAGCTGGAGTCATCCT 
CAATTCGAAAAA-3’). The amplified sequences were cloned into linearised pENTR 
vector by means of the Directional TOPO® Cloning system (Invitrogen). An aliquot of 
the TOPO® Cloning reaction was then used to transform One Shot® Competent E. 
coli cells (Invitrogen), which were then spread on plates containing kanamycine and 
incubated over night at 37 °C. E. coli colonies grown on plates were screened to 
identify recombinant clones. The recombinant pENTR plasmids were purified from E. 
coli cells and used in the subsequent Gateway® LR Recombination Reaction 
(Invitrogen). In this reaction the cloned sequences are transferred by the LR 
Clonase™ II Enzyme (Invitrogen) into the baculovirus linear DNA exploiting the attL 
and attR sites present in both the pENTR vector and in the baculovirus linear DNA. 
An aliquot of this reaction was then used to transfect Sf9 cells (Novagen) by using 
Cellfectin® II Reagent (Invitrogen) and Grace's Insect Medium Unsupplemented 
(GIBCO). After the transfection step, Sf9 cells were grown in Sf-900™ II SFM 
medium (GIBCO) supplemented with 10% FBS (Fetal Bovine Serum; Euroclone) and 
gentamicin (50 μg/ml; GIBCO). The viral stocks obtained from the transfection 
reactions were used for other two rounds of Sf9 cells infection to get high-titre viral 
stocks. These latters viral stocks were subjected to the plaque assay according to 
Invitrogen manual (BaculoDirect™ Baculovirus Expression System) to get a single 
viral population expressing the proteins of interest. Eventually the protein expression 
was assayed for each clone, after 72-h infection of Sf9 cells by means of western blot 
analysis.  
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Production of multi-gene baculoviruses with the MultiBacTurbo system 
Single baculoviruses co-expressing in insect cells more than one protein were 
produced using the MultiBacTurbo system. More precisely, one baculovirus expressing 
FLAG-tagged MCM3, MCM5 and MCM7 was produced (named Multi-MCM357). A 
second baculovirus was produced for the simultaneous expression of MCM2, MCM4 
and MCM6 (named Multi-MCM246). A third baculovirus was engineered for the co-
expression of Cdc45, Psf1, Psf2, Psf3 and Sld5, this latter fused to a GST-tag 
(named Multi-GINS/Cdc45).  
First of all, the single CDSs of interest were cloned into different plasmids useful for 
the next step of in vitro recombination. The method used for these cloning steps was 
the same restriction free cloning procedure described before for the production of the 
Cdc45 truncation mutants (Fig. 12). All the plasmid vectors were purchased from 
ATG biosynthetics GmbH (Merzhausen, Germany). Here below the plasmid vectors 
are reported into which each CDS of interest has been cloned: 
- MCM7 → pACEBac1 
- MCM5 → pIDC 
- FLAG-MCM3 → pIDK 
- MCM4 → pACEBac1 
- MCM2 → pIDC 
- MCM6 → pIDK 
- GST-Sld5 + Psf2 → pIDK (sequentially cloned via the homing 
endonuclease/BstXI) 
- Cdc45 → pIDC 
- Psf1 + Psf3 → pACEBac1 (sequentially cloned via the homing 
endonuclease/BstXI). 
The method of the homing endonuclease/BstXI to clone multiple sequences into the 
same plasmid vector is based on couples of enzymes (CeuI/BstXI for pACEBac1 and 
SceI/BstXI for pIDK). Digestion of plasmid DNA with CeuI and SceI releases sticky 
ends that are complementary to the ones obtained by digestion of the BstXI site. 
Thus a specific sequence can be cut from these vectors by using the couple 
CeuI/BstXI or SceI/BstXI and ligated into a vector previously digested only with BstXI 
enzyme. Cloning a CeuI/BstXI- or SceI/BstXI-cleaved DNA fragment into a BstXI 
linearized plasmid does not reproduce the BstXI recognition site at the CeuI- or SceI-
digested end, so that the BstXI site at the 3’-end of the inserted sequence can be 
used again for an additional cloning round.  
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The pACEBac1 is indicated by the ATG biosynthetics manual as acceptor vector 
since it can accept incoming cloning cassettes from the other vectors indicated as 
donor vectors (pIDC, pIDK) during a reaction catalysed by Cre recombinase enzyme, 
which works on the Lox P sites present on both the acceptor and the donor vectors 
(Fig. 14 and 15). With this method the pIDK-FLAG-MCM3 and the pIDC-MCM5 
plasmid constructs were fused with pACEBac1-MCM7, the pIDC-MCM2 and the 
pIDK-MCM6 constructs were fused with pACEBac1-MCM4 and the pIDC-Cdc45 and 
the pIDK-GST-Sld5/Psf2 constructs were fused with the pACEBac1-Psf1/Psf3 
plasmid. Detailed protocols can be found on the manual provided by the ATG 
biosynthetics (ACEMBL Expression System Series – MultiBacTurbo - Multi-Protein 
Expression in Insect Cells) which is downloadable from the website of the company 
(https://www.atg-biosynthetics.com).  
 
 
Figure 15 - Circle map representation of the pIDC and pIDK vectors. 
 
For each recombination reaction the final construct comes to have the pACEBac1 as 
base structure. Thus the Tn7L and Tn7R sequences present in the pACEBac1 
Figure 14 - Circle map representation of the pACEBac1 vector. 
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sequence can be exploited to get the transposition of the cloned sequences into the 
baculoviral genome contained in the DH10MultiBacTurbo cells (ATG biosynthetics). To 
this purpose DH10MultiBacTurbo cells were transformed with the in vitro recombination 
reaction mixture. DH10MultiBacTurbo cells also contain a helper plasmid, which 
encodes the transposase required for the transposition reaction. Transformed cells 
were spread on plates and incubated over night at 37 °C. At this step blue-white 
selection is used to select colonies containing recombinant baculoviral genome and 
resistance to several antibiotics allows to select cells, which contains markers 
derived not only from the baculoviral genome but also from the recombined plasmid 
constructs (e.g. pACEBac1, pIDC, pIDK). Positive clones were identified and the 
baculoviral DNA was purified from the E. coli cells. This DNA preparation was then 
used to transfect Sf9 cells (Novagen) by using Cellfectin® II Reagent (Invitrogen) and 
Grace's Insect Medium Unsupplemented (GIBCO). After the transfection step, Sf9 
cells were grown in Sf-900™ II SFM medium (GIBCO) supplemented with 10% FBS 
(Euroclone) and gentamicin (50 μg/ml; GIBCO). The viral stocks obtained from the 
transfection reactions were used for other two rounds of Sf9 cells infection to get 
high-titre viral stocks to be used for protein production. Expression of the 
recombinant proteins after insect cells infection was assayed by western blot analysis 
with specific antibody.   
 
Production of the recombinant CMG complex 
Three main different protocols were set up to reconstitute a recombinant CMG 
complex in insect cells infected with recombinant baculoviruses. 
Sf9 cells were grown in Sf-900™ II SFM medium (GIBCO) supplemented with 10% 
FBS (Euroclone) and gentamicin (50 μg/ml; GIBCO) at 27 °C. 
In the first protocol 400 x 106 Sf9 cells (20 x 106 cells in each of 20 dishes 
(150X25mm)) were infected with eleven baculoviruses codifying for the single 
subunits of the CMG complex. More precisely, the viruses codifying for the following 
proteins were employed: 
- MCM2 (6xHis-tag at the C-terminus) 
- MCM3 (No tag) 
- MCM4 (No tag) 
- MCM5 (No tag 
- MCM6 (6xHis + HA-tag at the N-terminus) 
- MCM7 (6xHis + 3xFLAG-tag at the N-terminus) 
- Cdc45 (6xHis-tag at the C-terminus) 
- Psf1 (No tag) 
- Psf2 (No tag) 
- Psf3 (No tag) 
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- Sld5 (No tag) 
The FLAG-tag present on MCM7 was exploited in the next affinity purification step. 
250 μl of each baculoviral stock was used to infect a single dish of cells for a total 
amount of 5 ml employed for each virus in the whole infection round. The infections 
were kept at 27° C. After 60 hours infected cells were collected, washed with PBS 
and kept at -80° C or directly employed to purify the recombinant CMG complex. The 
cell pellet from the previous step was re-suspended in a volume of 4 ml of Lysis 
Buffer (40 mM Hepes-NaOH, pH 7.5, 100 mM sodium acetate, 1 mM DTT 
(Dithiothreitol), 20 mM magnesium acetate, 1 mM EDTA, 0.01% NP-40) with the 
addition of protease inhibitors (Complete EDTA-free protease inhibitor cocktail; 
Roche) and phosphatase inhibitors (PhosSTOP phosphatase inibitor cocktail; 
Roche). Cells were disrupted by 4 rounds of sonication with an amplitude of 5 
microns (Soniprep MSE 150 sonicator; AL.BRA.) for 15 s each round. Crude extracts 
were clarified by centrifugation at 40,000 rpm for 40 min in a LE-80 BECKMAN 
ultracentrifuge.  
Soluble extract was then incubated with ANTI-FLAG M2 affinity gel resin (2 ml; 
SIGMA) for 1 h at 4 °C on shaking. This mixture was loaded on a chromatographic 
column and the unbound material was let flowing through. The resin was then 
washed with 100 ml of Lysis Buffer. Then, 5 elution steps were carried out by using 
each time 1 ml of Lysis Buffer supplemented with 200 μg/ml FLAG peptide (SIGMA). 
In each elution step the mixture (resin + elution buffer) was incubated for 15 min at 4° 
C on shaking. 
In the second protocol used in order to get a recombinant CMG complex a STREP-
tagged version of MCM2 or MCM3 were alternatively employed for the production of 
a complex. In this case 400 x 106 Sf9 cells were infected with 11 baculoviruses 
codifying for the subsequent recombinant proteins: 
- MCM2 (STREP-tag at the C-terminus) / MCM2 (6xHis-tag at the C-terminus) 
- MCM3 (No tag) / MCM3 (STREP-tag at the N-terminus) 
- MCM4 (No tag) 
- MCM5 (No tag 
- MCM6 (6xHis + HA-tag at the N-terminus) 
- MCM7 (6xHis + 3xFLAG-tag at the N-terminus) 
- Cdc45 (6xHis-tag at the C-terminus) 
- Psf1 (No tag) 
- Psf2 (No tag) 
- Psf3 (No tag) 
- Sld5 (No tag) 
Each of 20 dishes containing 20 x 106 Sf9 cells was infected with 20 μl of baculovirus 
codifying for MCM2 (STREP-tag at the C-terminus) or alternatively a baculovirus 
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codifying for MCM3 (STREP-tag at the N-terminus). Then 120 μl of each 
baculoviruses codifying for all the other MCM proteins and 240 μl of the viruses 
codifying for Cdc45 and the proteins forming the GINS complex were added. We 
tried to favor the formation of a stable CMG complex rather than of other sub-
complexes by balancing in this way the amount of viruses used in the infection. 
After 72 hours infected cells were collected, washed with PBS and kept at -80° C or 
directly employed for the purification of the recombinant CMG complex. 
The cell pellet from the previous step was re-suspended in a volume (4 ml) of Lysis 
Buffer (40 mM Hepes-NaOH, pH 7.5, 200 mM sodium acetate, 1 mM DTT, 10 mM 
magnesium acetate, 0.05% NP-40) with the addition of protease inhibitors (Complete 
EDTA-free protease inhibitor cocktail; Roche) and phosphatase inhibitors 
(PhosSTOP phosphatase inibitor cocktail; Roche). Cells were disrupted by 4 rounds 
of sonication with an amplitude of 5 microns (Soniprep MSE 150 sonicator; AL.BRA.) 
for 15 s each round. Crude extracts were clarified by centrifugation at 40,000 rpm for 
40 min in a LE-80 BECKMAN ultracentrifuge.  
Soluble extract was then incubated with Strep-Tactin Sepharose resin (2 ml; IBA) for 
1 h at 4°C on shaking. This mix was loaded on a chromatographic column and the 
unbound material was let flowing through. The resin was then washed with Lysis 
Buffer (120 ml) and 5 elution steps were carried out by using each time 1 ml of Lysis 
Buffer supplemented with 2.5 mM Desthiobiotin (IBA). In each step, the mixture 
(resin + elution buffer) was incubated for 10 min at 4° C on shaking.  
The last purification protocol was set up after the construction of the three multi-gene 
baculoviruses. In this case 400 x 106 Sf9 cells were infected with the following three 
baculoviruses: 
- Multi-MCM246 → codifying for MCM2 (no tag), MCM4 (no tag) and MCM6 (no 
tag). 
- Multi-MCM357 → codifying for MCM3 (FLAG-tag at N-terminus), MCM5 (no 
tag) and MCM7 (no tag) 
- Multi-GINS/Cdc45 → codifying for Cdc45 (no tag), Psf1 (no tag), Psf2 (no 
tag), Psf3 (no tag) and Sld5 (GST-tag at the N-terminus). 
700 μl of each viral stock was used to infect a single dish containing 20 x 106 Sf9 
cells (x 20 dishes).  
After 60 hours infected cells were collected, washed with PBS and kept at -80° C or 
directly employed for the purification of the recombinant CMG complex. 
The cell pellet from the previous infection step was re-suspended in 4 ml of Lysis 
Buffer (20 mM Hepes-NaOH, pH 7.5, 5 mM KCl, 1.5 mM MgCl2) with the addition of 
protease inhibitors (Complete EDTA-free protease inhibitor cocktail; Roche). Cells in 
suspension were kept on ice and disrupted by using a Dounce homogenizer (30-40 
strokes).  
Crude cell extract was then adjusted to 0.3 M potassium acetate and centrifuged at 
40,000 rpm for 40 min in a LE-80 BECKMAN ultracentrifuge.  
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Soluble extract was then incubated with anti-FLAG M2 affinity gel resin (1.5 ml; 
SIGMA) for 1 h at 4 °C on shaking. This mix was loaded on a chromatographic 
column and the unbound material was let flowing through. The resin was then 
washed with a volume (100 ml) of Wash Buffer (20 mM Hepes-NaOH, pH 7.5, 0.3 M 
potassium acetate, 1 mM DTT, 1 mM EDTA, 0.01% NP40, 10% glycerol). 5 elution 
steps were carried out by using for each step a volume (1 ml) of Elution Buffer (20 
mM Hepes-NaOH, pH 7.5, 150 mM potassium acetate, 1 mM DTT, 1 mM EDTA, 
0.01% NP-40, 10% glycerol) supplemented with 200 μg/ml 3xFLAG peptide 
(SIGMA). In each step the mixture (resin + Elution Buffer) was incubated with the 
resin for 15 min at 4° C on shaking.  
 
Preparation of extracts from Xenopus laevis eggs 
Female frogs (Xenopus laevis) were injected with 380-400 μl of 2500 U/ml of human 
chorionic gonadotropin (SIGMA) to stimulate ovulation. About 16 hours after the 
injection, eggs laid by the frogs were collected. A selection was carried based on the 
coloration of the egg cytoplasm: eggs that are completely white or spotted were 
removed, while eggs were kept that showed a typical bipartite coloration (with the 
vegetal pole more clear respect to the brown/black animal pole).  
For each set of eggs coming from a single frog, after the selection, the water in 
excess was removed and eggs were treated with 15 ml of De-jellying Buffer (20 mM 
Tris/HCl, pH 8.5, 110 mM NaCl, 5 mM DTT) at R/T (room temperature). Eggs were 
occasionally shaken during this treatment to facilitate the removal of the jelly layer 
from the eggs. Then, the De-jellying Buffer was replaced with fresh buffer for a 
treatment which did not last over 5 min. The proceeding of the dejellying process can 
be observed because eggs start to touch closely with each other. The de-jellied eggs 
were washed three times with abundant 1/4MMR (1/4MMR buffer was got by diluting 
20 folds a 5X MMR buffer stock: 100 mM Hepes/NaOH, pH 7.5, 2 M NaCl, 10 mM 
KCl, 5 mM MgSO4, 10 mM CaCl2, 0.5 mM EDTA). 
Unfertilized eggs are stuck at the metaphase of meiosis II. Eggs need to be activated 
and complete the meiotic cycle to get interphase extracts. To this purpose 2 μl of 10 
mM A23187 calcium ionophore solution (SIGMA) were added to a final volume of 20 
ml 1/4MMR buffer containing the eggs. Activation of the eggs can be checked by 
following the typical contraction of the pigment in the animal pole. Moreover, due to 
this contraction, the animal pole starts to appear darker and the separation between 
the two poles starts to be sharper. This activation process is supposed not to last for 
more than 5 min. Again, during this activation step, eggs that do not display the 
typical bipartite coloration can be highlighted and removed. 
After the activation step, eggs were quickly rinsed 3 times with abundant 1/4MMR 
buffer and, after the final wash, the excess buffer was removed as much as possible. 
Starting from this point eggs were kept on ice. Eggs were then washed several times 
with ice cold S-Buffer (50 mM Hepes/KOH, pH 7.5, 50 mM KCl, 2.5 mM MgCl2, 250 
mM sucrose) supplemented with 2 mM β-mercaptoethanol and 15 μg/ml leupeptin 
(SIGMA) as protease inhibitor. Eggs were eventually transferred into 2-ml tubes by 
using a plastic Pasteur pipet to avoid disturbing cells. 
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Tubes were centrifuged for 10 s at 6,000 rpm in a refrigerated micro-centrifuge to 
compact eggs and remove the excess of buffer. Then, tubes were centrifuged for 10 
min at 13,200 rpm to crush eggs and to get a first rough separation. At this step 
extracts appear to be divided into 3 main layers: an upper cap of fats and yolk, a 
central more clear cytoplasmatic extract and a bottom pigments layer (Fig. 16).  
 
Figure 16 – Schematic representation of the result got from the first crushing centrifugation 
 
A small hole in the fat layer was made by using a cut yellow tip (for P200 pipettes) 
and the central cytoplasmatic extract was collected into 15-ml tubes avoiding the 
upper fat layer and the pigments layer at the bottom. This extract was then 
supplemented with 40 μg/ml cytochalasin B (SIGMA) to avoid actin polymerization 
and then further centrifuged for 15 min at 70,000 rpm at 4 °C in an Optima Max-XP 
ultracentrifuge (Beckman) by using a TLA 100.3 rotor. This step of centrifugation 
provides a further clarification of the extract. Residual lipids will be stratified at the 
top, while mitochondria and residual pigments will be pushed at the bottom. Once 
again the central portion of the stratified extract is collected by using a cut yellow tip, 
transferred into new tubes and kept on ice. This final collected extract is 
supplemented with 15 mM creatin phosphate (SIGMA) and 150 μg/ml creatine 
phosphokinase (SIGMA), which will work as an ATP-regeneration system during the 
replication assays, and 10 μg/ml cycloheximide (SIGMA) to block protein synthesis. 
Moreover, glycerol to a final concentration of 3% (v/v) was added, before freezing the 
extracts in liquid nitrogen.  
 
Preparation of Xenopus laevis de-membranated sperm nuclei  
De-membranated sperm nuclei from male frogs were prepared following the method 
described by Blow and Laskey [91]. 
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Quality control of the Xenopus laevis egg extracts  
After each preparation egg extracts were checked for the competence to provide in 
vitro DNA replication. 
Aliquots (volume 20 l) of the freshly prepared extract were supplemented with Cy3-
dCTP (GE Healthcare) to a final concentration of 0.5 nM. To this cold-kept extract de-
membranated sperm nuclei were added to a final concentration of 3000 nuclei/μl of 
extract. After the addition of the sperm nuclei DNA replication is started by keeping 
the extract at 23 °C. After 30 min (and after additional 30 min), an aliquot (volume: 3 
μl) of this mixture was picked up, spotted on a microscope slide and fixed by the 
addition of 3 μl of Stop Buffer (15 mM PIPES, pH 7.2, 15 mM NaCl, 80 mM KCl, 10% 
formalin; 2 μg/ml Hoechst, 50% glycerol). De-condensation of the chromatin coming 
from the sperm nuclei and incorporation of Cy3-dCTP was checked by fluorescence 
microscopy to evaluate whether the extract was competent to provide in vitro DNA 
replication (Fig. 17). 
 
Figure 17 - Quality control of Xenopus laevis egg extracts after preparation. On the left DAPI-
staining of four different chromatin structures is shown for the sperm nuclei in the extracts. The 
structure reported as # 1 represents a sperm nucleus whose chromatin is still fully condensed. The 
structure reported as # 4 represents a sperm nucleus that has fully de-condensed its chromatin 
forming a chimeric nuclear structure. With # 2 and # 3 two intermediate structures between the two 
previous states are indicated. On the right the same field detected by Cy3-staining shows that dCTP is 
incorporated only into the structure # 4, where chromatin is fully de-condensed and DNA replication 
can occur. 
 
Extracts which could give the replication of the 90% of the nuclei visualized at the 
microscope were considered to be fully competent and used for DNA replication 
assays.  
 
Immuno-depletion of the endogenous Cdc45 factor from X. laevis egg extracts 
Rabbit polyclonal antibodies directed against the Cdc45 frog factor (α-xCdc45) used 
in this study were provided by Dr V. Costanzo (Cancer Research, UK). 
To immuno-deplete xCdc45 protein from 200 μl of egg extract, 80 μl of Protein A 
Sepharose Fast Flow beads (GE Healthcare) were employed. Beads were washed 3 
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times with PBS (Phosphate-Buffered Saline, LONZA) and then incubated with 80 μl 
of α-xCdc45 for 1 h at 4 °C. Then, beads were rinsed 3 times with 1 ml of PBS to 
wash away the unbound antibodies. Beads were then divided into 4 aliquots in 
different tubes which were used to get 4 sequential rounds of depletion on the same 
extract. 200 μl of egg extract were incubated with the first aliquot of conjugated 
beads and left at 4 °C for 1h on a slow rotating wheel. After 1 h the samples were 
centrifuged for 30 s at 3000 rpm in a refrigerated micro-centrifuge. The overlying 
extract was then collected and incubated with the second aliquot of beads for 45 min. 
The same procedure was repeated for the third and the fourth incubation that lasted 
30 min. After the last round of immuno-depletion beads were collected by 
centrifugation for 30 s at 3000 rpm and the overlying collected extract was ready to 
be used for our experiments. 
The efficacy of the immuno-depletion was checked each time by western blot 
analysis on the straight depleted extract. 
To get negative controls each time the same amount of extract was used for a mock 
immuno-depletion, according to the same protocol but using beads conjugated with 
rabbit pre-immune serum. 
 
DNA replication assays 
To check DNA replication activity with the Xenopus laevis egg extract system 
aliquots of extract (20 μl) were used for a single reaction. This extract aliquot was 
supplemented with 0.1 μl of [α-32P]dCTP (3000 Ci/mmol; Perkin Elmer) and 60000 
sperm nuclei while kept on ice.  
xCdc45 recombinant protein (or hCdc45 recombinant protein or hCdc45_A1_LP1 
mutant, as indicated) was added to the reaction mixture at a final concentration of 54 
ng/μl. In control reactions an equal amount of protein storage buffer was used (20 
mM Tris-HCl, pH 7.5, 150 mM NaCl, 5% (v/v) glycerol, 2 mM β-mercaptoethanol). 
DNA replication assays were started by keeping the reactions at 23 °C. After 1 or 2 h 
the reactions were stopped by the addition of 100 μl of DNA Stop Solution (80 mM 
Tris/HCl pH 8, 0.13% Phosphoric Acid, 10% Ficoll, 5% SDS, 0.2% BPB 
(Bromophenol Blue), 8 mM EDTA) supplemented with 2 mg/ml proteinase K (Roche). 
Stopped reactions were kept for 1 h at 50 °C or, alternatively, over night at 37 °C.  
Aliquots of each samples (30 μl) were loaded on an agarose gel (0.8% agarose in 1X 
TBE). The gel was run for 90 min at a constant voltage of 150 V in 1X TBE buffer. 
After the run the gel was incubated in a 10% TCA (Trichloroacetic Acid) bath for 10-
15 min to precipitate the DNA. Then, the agarose gel was dried by means of a 3-mm 
paper/tissue paper sandwich and the radioactivity revealed by phosphorimaging. 
 
 
 
 39 
 
RESULTS 
 
Cdc45 shows sequence similarity to archaeal proteins belonging to the DHH 
family of phosphoesterases 
As described in the Introduction section, Cdc45 is a fundamental factor for the 
initiation and the elongation phases of the DNA replication mechanism [2,36]. It is 
part of the CMG complex, the DNA replicative helicase, together with the MCM2-7 
and the GINS complexes [37,38].  
Most of the factors which form the DNA replication machinery in Eukarya are present 
as homologous proteins also in the archaeal system. Archaea are prokaryotic 
organisms that for many aspects of their cellular physiology present similarity with the 
eukaryotic organisms.  
Indeed, when we started focusing our attention on the CMG complex a counterpart 
was known for the MCM proteins in the archaeal system. In fact in most archaeal 
species a single MCM protein was identified, which is homologous to the eukaryotic 
MCM proteins, and can form homo-hexamers in its physiological state [72]. As for the 
GINS complex, two proteins are usually present in the archaeal species which are 
homologous to the eukaryotic ones and they can form tetrameric assemblies (i.e. 
dimers of dimers). One protein is named GINS15 because it is similar to eukaryotic 
Psf1 and Sld5 factors, while the other one is named GINS23 because it is related to 
the Psf2 and Psf3 subunits [73].  
Thus, looking at this general framework, it was pretty strange that there was no 
counterpart known in the archaeal system of the Cdc45 replication factor and to 
assess this point we started a bio-informatic analysis of the human Cdc45 factor.  
First of all, a database search was carried out using the human Cdc45 aminoacidic 
sequence as a query by means of the Position-Specific Interactive BLAST algorithm, 
using default parameters. The human Cdc45 protein was found to have a weak but 
significant degree of similarity with two archaeal sequences. The first protein was 
annotated as “phosphoesterase domain-containing protein” from the archaeon 
Candidatus korarchaeum cryptofilum OPF8 (E-value: 2x10-4). The second protein 
was indicated as “putative single-stranded DNA-specific exonuclease RecJ” from 
Methanocella paludicola SANAE (E-value: 3x10-4). Both proteins belong to the DHH 
family of phosphoesterases.  
These two sequences had been only recently added to the databases, explaining 
why the similarity with the eukaryotic Cdc45 proteins had not been previously 
identified.  
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Figure 18 - Sequence alignment between hCdc45, RecJ
Cdc45
 from T. kodakaraensis, and RecJ 
from T. thermophilus. The alignment presented here is based on an extended multiple alignment 
using 15 eukaryotic Cdc45 sequences, 16 archaeal sequences, and 10 bacterial RecJ sequences, 
selected from evolutionary diverse organisms. Only the RecJ core (residues 50–425, comprising 
domains I and II) has been used in the alignment. Residues that are conserved in more than 70% of 
the eukaryotic, archaeal, and bacterial sequences are highlighted in green, cyan, and yellow, 
respectively. The following groups of amino acid residues were considered similar: Asp/Glu, Lys/Arg, 
Phe/Tyr, Ser/Thr, Gly/Ala, and Val/Leu/Ile/Met. The position of the secondary structural elements in 
the T. thermophilus RecJ crystal structure (PDB code: 2ZXP) is indicated at the bottom, whereas the 
predicted secondary structure for human Cdc45 is shown at the top. Secondary structure elements are 
named according to the TthRecJ nomenclature [76]. The position of the characteristic RecJ motifs is 
shown by red boxes, with the residues conserved highlighted in bold. The alignment was carried out 
using the multiple sequence alignment program MUSCLE [78] and manually modified to take into 
account the structural constraints. Up to motif IV the similarity is strong enough to be detected based 
on sequence alone, whereas the second half of the alignment relies on the threading data, which 
identify similarity patterns in the absence of high sequence homology, as exemplified by the 
conservation of the patterns of hydrophobic residues and the excellent match between RecJ 
secondary structure elements and the prediction for Cdc45. An insertion unique to eukaryotic Cdc45 
orthologues and containing many charged amino acid residues is shown in magenta. The putative 
helical insertion present in both archaeal and eukaryotic proteins is shown in yellow. 
 
 
Although the sequence similarity detected by BLAST involved only the first 130-140 
residues, multiple alignments between Cdc45 and putative archaeal orthologues 
show that some similarity can be noticed throughout the entire sequence (Fig. 18). 
Because archaeal species possess multiple RecJ-like proteins, we have selected 
those displaying the closest match to the Candidatus korarchaeum cryptofilum and 
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Methanocella paludicola homologues. To distinguish the archaeal RecJ/DHH 
proteins that may be putative Cdc45 orthologues from other members of the DHH 
family, I will use the notation RecJCdc45. However, most Archaea seem to possess 
two close paralogues of the putative Cdc45 counterpart.  
A study, focused on detecting the archaeal counterpart of E. coli RecJ protein, 
identified two highly similar proteins from Methanocaldococcus jannaschii (MJ0977 
and MJ0831). Although both were able to partially complement a RecJ mutant 
phenotype in E. coli, single-stranded DNA nuclease activity could be observed only 
for the MJ0977 protein [79]. Two highly similar RecJCdc45 proteins (AF0699 and 
AF0735) were also found associated with a replication protein network in 
Archaeoglobus fulgidus [80]. More recently, a RecJ-like single-stranded 5’-3’ DNA 
exonuclease from Thermococcus kodakaraensis was found to physically associate 
with GINS, and this association was found to stimulate its exonuclease activity [81]. 
A putative RecJ homologue has been reported to co-purify with MCM and GINS from 
cellular extracts of Sulfolobus solfataricus (SSO0295 [82]). This sequence is rather 
divergent from most of the archaeal proteins mentioned above and lacks some of the 
characteristic motifs; in particular, some of the conserved residues putatively 
responsible for the nuclease activity are absent. An open reading frame highly similar 
to SSO0295 is present in most Sulfolobales genomes. Divergent sequences are also 
detected in other Crenarchaeota, such as Aeropyrum pernix. 
Both the eukaryotic Cdc45 proteins and the archaeal RecJCdc45 sequences match 
only to the RecJ catalytic core (domains I and II, as defined in the crystal structure of 
Thermus thermophilus RecJ [75], while lacking the 50-residues N-terminal extension 
as well as domains III and IV. These additional elements form a closed-ring structure 
that is predicted to encircle single-stranded DNA. 
Cdc45 sequences only partially retain the motifs typical of the DHH family that are 
involved in metal binding. Whereas in motif I both aspartate residues coordinating the 
metal are conserved (26DVD), the DHH motif III, which gives the name to the family, 
is mutated to 99DTH. Although a number of residues belonging to motifs II and IV are 
conserved suggesting that the protein fold is similar in those regions, the key 
residues for metal binding and catalysis are not conserved, with the aspartate of 
motif II mutated to asparagine, and the aspartate of motif IV to glutamine (Fig. 18). In 
contrast, most of the archaeal RecJCdc45 comprise all of the motifs that are conserved 
in the bacterial RecJ exonucleases, with the exception of the putative orthologues 
from Sulfolobales, whose sequence is rather divergent and lacks most of the RecJ 
canonical residues. 
 
Threading algorithms confirm the presence of a RecJ/DHH-like core fold in 
hCdc45 
A variety of threading/fold recognition algorithms were used to verify the similarity 
among hCdc45 and DHH family members. The Protein Fold Recognition Server 
Phyre [83] identifies a three-dimensional similarity between hCdc45 and a number of 
DHH protein structures such as the RecJ exonuclease from T. thermophilus (PDB 
code: 1IR6), as well as various inorganic pyrophosphatases (PDB codes: 1WPN, 
1I74, and 2HAW), but the similarity was restricted to the first 110 amino acids. 
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When a multiple sequence alignment, including a number of Cdc45 sequences, was 
used as input for the HHPRED server [84], a similarity (involving the first 315 
residues) was detected to an inorganic pyrophosphatase from Bacillus subtilis 
belonging to the DHH family (PDB code: 1WPN). 
The profile-profile alignment and fold-recognition server FFAS03 [85] was also used 
both with the full-length hCdc45 sequence and a number of fragments corresponding 
to putative domains. A score below the recommended threshold (-9) was obtained 
when the first 140 amino acid residues of hCdc45 were used as input, matching the 
N-terminal domain of a number of manganese-dependent inorganic 
pyrophosphatases from the DHH family, with the B. subtilis inorganic pyro- 
phosphatase giving the best agreement (-10.5, PDB code: 1K23). Using as input 
longer hCdc45 fragments still provides a match with the DHH proteins, although the 
scores get progressively higher, indicating a lower degree of confidence; using the 
full-length protein it is possible to detect some similarity to 1K23. 
The sequence-structure homology recognition server FUGUE [86] unambiguously 
identifies both the T. thermophilus RecJ (1IR6) as well as the Streptococcus gordonii 
inorganic pyrophosphatase (1K20) structures as the two best hits along the entire 
sequence with a degree of confidence higher than 99%. When using as input the 
sequences of a variety of archaeal RecJCdc45 proteins, all the servers predicted a 
strong structural similarity to the bacterial RecJ proteins, along the entire sequence, 
as expected from the significant sequence homology and the conservation of the 
characteristic motifs. 
A central region in both Cdc45 (residues 252–363 in hCdc45) and archaeal RecJCdc45 
(residues 188–275 in the sequence from T. kodakaraensis) proteins, appears as a 
long insertion into the RecJ/DHH core. This region is reasonably well conserved 
between eukaryotic and archaeal proteins. Secondary structure predictions suggest a 
helical fold, and threading algorithms tend to find matches with helical bundle 
proteins, such as acyl-CoA-binding proteins and helix-turn-helix transcription factors. 
An additional insertion is unique to the eukaryotic Cdc45 proteins (residues 108–175 
in the human sequence), and the central part includes a large number of charged 
residues (aspartate, glutamate, arginine, and lysine), thus suggesting a partially 
structured region (Fig. 18). Based on the results of both the sequence analysis and 
the threading algorithms, we have produced a sequence alignment that summarizes 
the putative relationships among bacterial RecJ single-stranded DNA exonucleases, 
archaeal RecJCdc45 and the eukaryotic Cdc45 (Fig. 18). 
In the first half of the molecule (up to motif IV) the similarity is strong enough to be 
detected based on sequence alone, whereas for the second half the alignment relies 
on the threading data, which identify similarity patterns in the absence of high 
sequence conservation. Consistent with the threading results, Fig. 18 shows the 
conservation of patterns of hydrophobic residues and an excellent match between 
the experimentally determined α-helices and β-strands of RecJ and the predicted 
Cdc45 secondary structure elements. Although the correspondence is good overall, 
there are a few uncertainties in the central region of the proteins. For example it is 
difficult to establish unambiguously whether the first Cdc45 insertion occurs after β5 
(as depicted in Fig. 18) or after α7. In the same way the second insertion (common to 
eukaryotic and archaeal proteins) may slide from the current position in Fig. 18 (after 
α10) to an alternative position after α11. However the match is very convincing in the 
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first half of domain I as well as in domain II, including the long helix connecting the 
two domains (α14), suggesting that the relationship extends throughout the entire 
sequence. 
While we were finalizing our report, a bioinformatic analysis [87] was published 
suggesting a similarity between Cdc45 and RecJ proteins, limited to the first 100 
amino acid residues. Our report is consistent with that one [87] but further extends 
the analysis by showing that the sequence and structural similarity covers the entire 
length of the protein. 
 
Biochemical characterization of the recombinant hCdc45 
We produced in bacterial cells hCdc45 as a fusion protein with a C-terminal His6-
FLAG tag, using the pNIC-CTHF vector [88]. The tag could be cleaved with the TEV 
protease and the protein purified to homogeneity (Fig. 19).  
 
 
 
 
Although many of the residues that in RecJ/DHH proteins are involved in Mn2+ 
binding and catalysis are not conserved in hCdc45, we examined the possibility that 
the few remaining aspartate and histidine residues (namely D26, D28, D99, and 
H101) may possibly coordinate one metal ion. We have therefore used both 
inductively coupled plasma/atomic emission spectroscopy and atomic absorption 
spectroscopy to test whether the purified protein contains manganese, magnesium, 
or zinc, but we failed to confirm the presence of any of these metals.  
Dr Roberto Udisti (University of Florence) worked for determination of metal ions in 
protein samples by inductively coupled plasma-atomic emission spectroscopy, while 
Dr Spartaco De Gennaro and Dr Achille Palma (Metapontum Agrobios) carried out 
 
Figure 19 - Purification of hCdc45. SDS-PAGE analysis of samples throughout the purification 
protocol (see detailed description under “Experimental Procedures”), starting from the protein 
obtained after the first step of Ni-affinity purification (IMAC  (immobilized metal-ion affinity 
chromatography)), followed by size-exclusion chromatography (SEC); the protein after cleavage of 
the His6-FLAG tag using TEV protease and purification over a heparin column (Heparin) to a final 
round of SEC. 
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the inductively coupled plasma-MS analysis. Dr Marco Trifuoggi (University of 
Naples) collaborated for the atomic absorption spectroscopy analysis. 
We also carried out activity assays to check whether hCdc45 displays either 
pyrophosphatase or exonuclease activity. Consistently with the absence of metal 
ions and some of the putative catalytic residues, we were unable to detect any of the 
above enzymatic activities.  
Both its role in DNA replication and the putative similarity with a single-stranded DNA 
exonuclease, such as RecJ, suggested that Cdc45 could be a DNA-binding protein.  
We used EMSAs to evaluate the DNA-binding properties of hCdc45 (Fig. 20).  
 
 
 
 
Figure 20 - DNA-binding activity of hCdc45. Example of an EMSA on single-stranded DNA is 
shown. The assay was carried out with increasing concentrations of hCdc45 (0.5, 1, 2, 3, 4, and 5 μg 
of protein were present in the mixtures loaded into the lanes from 2 to 7). A radio-labeled 56-mer DNA 
was used as a ligand (see Experimental Procedures section for details). A control mixture without 
protein was run on lane 1. 
 
The purified recombinant protein binds single-stranded synthetic oligonucleotides 
with a weak but detectable affinity, comparable with the one observed for the 
Drosophila GINS complex [12] or for the full-length T. thermophilus RecJ [75].  
No increase in affinity was observed when a fork-containing DNA molecule was used 
as a ligand in the EMSAs, and negligible binding was detected to short blunt double-
stranded DNA (Fig. 21).  
Addition of Mg2+, Mn2+, or Zn2+ ions into the buffer, as well as variation of pH in the 
range 5.5-8.5, were found to have no effect on the hCdc45 DNA-binding activity. 
Preliminary experiments indicated that the affinity of hCdc45 for single-stranded RNA 
is weaker with respect to single-stranded DNA (Fig. 22). 
The protein shows a preference for an oligo(dG) in comparison to oligo(dC), 
oligo(dA), and oligo(dT) (Fig. 23). 
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Figure 21 - Single-stranded versus double-stranded DNA binding. Shifted DNA (either in single- 
(●) or double-stranded (▄) form) is reported versus the amount of hCdc45. Experiments were 
performed in triplicate, and the results are averaged. Curves represent best fits to the data points. The 
error bars on the graphs are the ±S.E. 
 
 
Figure 22 - Binding of hCdc45 on single-stranded RNA. EMSAs on a radio-labeled 20-mer 
synthetic single-stranded RNA (100 fmoles/assay) were carried out using the indicated amounts of 
hCdc45. 
 
 
 
Figure 23 - DNA-binding activity of hCdc45 on various ligands. EMSAs on radio-labeled 20-mer 
synthetic oligo-dA, oligo-dT, oligo-dC and oligo-dG (100 fmoles/assay, as described above) were 
carried out using 0,1, 2.5 and 5 μg of hCdc45 (lanes from 1 to 4 in each gel, respectively).  
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To demonstrate that the weak DNA-binding activity is indeed due to hCdc45, and not 
to trace amounts of a contaminating protein, we analyzed the DNA-binding activity of 
the protein fractions following size-exclusion chromatography. The DNA-binding 
activity profile precisely co-migrates with the protein peak (Fig. 24) suggesting that 
the ability to bind DNA is a truly intrinsic feature of hCdc45. Furthermore, we 
analyzed whether the protein-DNA complex could be super-shifted by a specific 
antibody. For this experiment, we used a FLAG-tagged version of hCdc45 (purified 
according to the same protocol as the untagged protein with the omission of the TEV 
cleavage step) and a monoclonal anti-FLAG antibody. This analysis (Fig. 25) 
revealed that the anti-FLAG antibody was able to super-shift the protein-DNA 
complex. 
 
 
Figure 24 - Gel filtration analysis of hCdc45 and EMSAs of the corresponding peak fractions. 
Gel-filtration chromatography of purified hCdc45 was performed using a Bio-Sil SEC-250 column (Bio 
Rad) as described under “Experimental Procedures.” Peak fractions were analyzed by SDS-PAGE 
(5μl/fraction) and used in a gel shift experiment (1 μl/fraction). On the right a plot of the shifted radio-
labelled DNA versus each fraction is shown. 
 
 
 
Figure 25 - EMSAs with hCdc45-His-FLAG in the presence of anti-FLAG antibody. The assays 
were carried out by adding increasing amounts of a monoclonal anti-FLAG antibody (0.5, 1, and 2 μg, 
lanes 2 and 6, 3 and 7, and 4 and 8, respectively) into mixtures containing the single-stranded DNA 
probe with hCdc45-His-FLAG (lanes 6–8; 5μg of protein) or without the recombinant protein (lanes 2–
4; see text for details). A black arrow indicates the Cdc45-DNA complex, whereas the white arrows 
identify the ternary complexes with the anti-FLAG antibody. 
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SAXS analyses of the recombinant hCdc45 protein are consistent with the 
three-dimensional structure of the RecJ core 
SAXS data were collected from highly purified samples of recombinant hCdc45 and 
corrected for the scattering from the buffer. Ab initio modeling was performed using 
the program DAMMIN [89], with 44 runs being averaged using the program 
DAMAVER [90]. The model obtained can be described as a compact core with two 
lateral extensions (Fig. 26). 
 
 
 
Figure 26 - Small angle x-ray scattering data. Final model reconstructed from the scattering curve 
for hCdc45. 
 
 
Figure 27 - SAXS data are consistent with a RecJ-like fold. On the left, a schematic diagram 
summarizing the result of the bioinformatic analysis and showing the relationship between eukaryotic 
Cdc45 proteins, archaeal RecJCdc45, and bacterial RecJ single-stranded DNA exonucleases is 
shown. The RecJ motifs are shown in red, the Cdc45 charged insertion is in magenta, and the helical 
archaeal/eukaryotic insertion is in yellow. The crystal structure of the core of T. thermophilus RecJ 
(PDB code: 2ZXP, domains I and II) is shown below the diagram, with domain I in blue, domain II in 
dark blue, and the connecting helix in green. The conserved residues in the seven RecJ motifs are 
shown in red. The ab initio calculated SAXS model for hCdc45 (depicted as gray light spheres) is 
superimposed to the crystal structure of the core of T. thermophilus RecJ, in blue. Highlighted in 
magenta and indicated by a magenta asterisk is the putative position of the insertion, which is unique 
to the eukaryotic Cdc45 orthologues; highlighted in yellow and indicated by a yellow asterisk is the 
position of the helical bundle insertion that is common to both archaeal and eukaryotic proteins (see 
Fig. 18). As an example, the helical domain of the acyl-CoAbinding protein (PDB code: 2FDQ) has 
been fitted to the map, consistently with the results of the threading algorithms. The two views are 
roughly related by a 90° rotation around a horizontal axis. 
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One of the two lateral extensions is larger and better defined and can be assigned to 
the putative helical insertion domain that is common to both the eukaryotic Cdc45 
and the archaeal RecJCdc45 proteins (residues 188–275 in hCdc45), as the putative 
insertion loop within the RecJ core is positioned in a manner compatible with this 
interpretation (Figs. 18 and 27). As an example, we choose to fit to this region of the 
map the helical bundle from the acyl-CoA-binding protein (PDB code: 2FDQ) as 
suggested from the results of the threading analysis. The second insertion has a 
more elongated shape and can be allocated to the partially unstructured insertion 
that is unique to the Cdc45 sequences (residues 108–175 in hCdc45, Figs. 18 and 
27). As discussed above, there is some uncertainty in the exact positions of the two 
long insertions with respect to the RecJ core, and alternative insertion points can be 
suggested. However, in both cases the alternative loops are still positioned in a 
manner compatible with the interpretation of the SAXS data.  
 
Production of the human recombinant CMG complex 
It is very useful to reconstitute a recombinant CMG complex to study in vitro the role 
played by Cdc45 together with GINS in the activation of MCM2-7 DNA helicase 
activity.  
We carried out several attempts to produce a stable recombinant CMG complex by 
co-infecting Sf9 cells with 11 baculoviruses codifying for the single subunits of the  
complex. Different constructs expressing the same factors with different tags were 
employed and different strategies were utilized for the first affinity chromatography 
step (e.g. FLAG-, STREP-affinity chromatography). Using these strategies we were 
usually able to identify all the 11 proteins, which were actually expressed in the 
extract got from infected cells, as indicated by western blot analyses. Nevertheless, 
the 11 proteins were never found together in the fractions eluted from the affinity 
chromatography steps, indicating that in our preparations at least the most of these 
factors did not associate to form a stable CMG complex. We figured out that the main 
problem with the production of a stable complex could be due to the fact that only a 
small percentage of the produced proteins associate to form a complex. Most of the 
produced material remains as single proteins or associates to form sub-complexes 
different from the CMG.  
To address this point we tried to modulate the amount of the different viruses used in 
the co-infections, most of the time using an higher amount of the viruses codifying for 
Cdc45 and GINS proteins respect to the ones expressing the 6 MCM proteins, to 
push towards the formation of the CMG complex. However, all these attempts were 
not successful. 
Finally, we decided to use the MultiBacTurbo system, a novel technology that allows 
the construction of multi-gene baculoviruses. We constructed the following multi-
gene baculoviruses: Multi-MCM246, Multi-MCM357 and Multi-GINS/Cdc45 (see 
Experimental Procedures). The rational at the basis of this choice was the idea that 
co-infecting cells with only 3 baculoviruses could provide a more coordinated 
expression of the 11 proteins, bringing to the association of a stable complex. Also 
the cloning of these constructs was designed to reduce the formation of sub-
complexes among the MCM proteins, which could compete with the formation of the 
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MCM2-7 complex. Indeed MCM subunits known to be involved in the formation of 
sub-complexes were cloned into different constructs.  
By using this method (see Experimental Procedures) we were able to pull-down all 
the 11 proteins likely composing a stable CMG complex with a FLAG-affinity 
chromatography step. Nevertheless, we got very low amounts of protein complex 
which were not sufficient so far to undergo a subsequent purification step or any kind 
of analytical assay. 
A western blot analysis after a typical purification round is shown in Fig. 28. 
 
Figure 28 – Western Blot analysis of the CMG complex components in the FLAG specific eluted 
fraction. The presence of all the components of the CMG complex was checked by western blot 
analysis. Note that Psf1 has an altered migration on SDS-PAGE despite its expected molecular mass. 
 
 
The N-terminal portion of hCdc45 is not involved in the DNA binding activity 
We demonstrated that hCdc45 protein retains single-stranded DNA binding activity. 
Structural motifs that are usually present in DNA binding proteins have not been 
identified in hCdc45. We postulated that the weak single-stranded DNA binding 
activity shown by this protein could be due to the presence of several positively 
charged amino acids in the C-terminal region of the protein. 
Thus, to assess which portion of the protein was actually involved in the binding of 
the single-stranded DNA molecules, we produced two different truncated forms of the 
protein. The first construct, hCdc45-A13/1, comprises the first 258 amino acids of the 
wild type protein, while the second one, hCdc45-C-ter codify for the region from the 
residue 394 to the end of the wild type protein. 
Unfortunately the C-terminal truncation form is not stable in solution when produced 
as a recombinant protein. Thus we were not able to carry out any DNA-binding 
assays with it. On the other hand, the hCdc45-A13/1 mutant was produced and found 
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to be very stable as recombinant protein. We checked this construct for single-
stranded DNA binding activity but we did not observe any kind of binding in EMSAs.   
 
 
The hCdc45 L1 aminoacidic insertion loop does not seem to be needed for 
DNA replication 
The Xenopus laevis egg extract experimental system had been employed since 
years for the study of factors involved in the DNA replication process. Indeed it is a 
very powerful system by which DNA replication process can be monitored in vitro.  
In the extracts obtained from the X. laevis eggs all the replicative factors are present 
at high concentration and they can support duplication of an exogenous DNA 
molecule in vitro. When de-membranated sperm nuclei from the male frogs are 
added to the extracts, their tight chromatin structure starts to uncondense and a 
chimeric nuclear structure is formed which can provide the replication of the 
chromatin coming from the sperm nuclei (Fig. 29). 
 
 
 
Figure 29 – Decondensation of a demembranated sperm nucleus in the X. laevis egg extract. 
 
 
I was able to set up an immuno-depletion protocol of the Xenopus endogenous 
Cdc45 factor from the extracts by using specific polyclonal antibodies. When I carried 
out DNA replication assays I could observe a strong decrease in the DNA replication 
activity (followed by incorporation of radio-labeled nucleotides – see Experimental 
Procedures) if Cdc45 had been depleted from the extract, compared to the activity 
shown by a mock-treated extract (immuno-depletion carried out with a rabbit pre-
immune serum). Moreover, when the recombinant Xenopus Cdc45 protein was 
added back to the specifically immuno-depleted extract a rescue of the DNA 
replication activity could be observed (Fig. 30). 
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Figure 30 – DNA replication assays with frog egg extracts after the depletion of the 
endogenous Cdc45 factor. On the left a typical result obtained with phopshorimaging detection of 
the gels is shown. On the right a graphic shows a quantification of the results obtained in three 
different experiments. 
 
 
Also a rescue in the DNA replication activity could be observed even when the 
human Cdc45 recombinant factor was used to supplement the extracts after the 
immuno-depletion of the endogenous frog factor. Even if the level of rescue is about 
the half respect to the one observed for the Xenopus Cdc45 factor, the human 
protein was shown to work in the Xenopus system to give DNA replication. This 
result is consistent with the finding that the primary structure of the frog and human 
Cdc45 share more than 80% identity. 
 
Our bio-informatic analysis suggested that two long aminoacidic insertions were 
introduced during evolution into the eukaryotic Cdc45 protein (Fig. 18), one of which 
is shared with the archaeal RecJCdc45 proteins. These two insertions likely form the 
two lateral extensions which characterize the structure predicted for the human 
Cdc45 protein (Fig. 26). In order to understand whether these two insertions play any 
role during DNA replication in unperturbed conditions, we produced three mutant 
derivatives of human Cdc45. In the mutant referred to as hCdc45_A1_LP1 about 
70% of the first aminoacidic insertion (the one present only in the eukaryotic Cdc45 
proteins) was deleted. In the mutant named hCdc45-LP1 this whole sequence was 
removed. In the derivative named hCdc45-LP2 the second aminoacidic insertion (the 
one present also in the archaeal counterparts) was fully deleted. Unfortunately the 
mutants hCdc45-LP1 and hCdc45-LP2, even if soluble, were found to form 
multimeric protein aggregates in solution as indicated by size exclusion 
chromatography analyses. Therefore, these Cdc45 mutant forms could not be used 
for the analysis with the frog egg extract DNA replication system.   
Thus, only the hCdc45_A1_LP1 mutant protein could be employed to carry out DNA 
replication assays with the Xenopus egg extract system. Our results show that this 
mutant can rescue, as well as the wild type protein, the DNA replication activity after  
immuno-depletion of the endogenous factor from the extracts (Fig. 31). 
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Figure 31 - DNA replication assays carried out with the hCdc45_A1_LP1 mutant. The ability of 
hCdc45_A1_LP1 to rescue the DNA replication activity after depletion of the frog Cdc45 factor was 
assessed and compared to the one of the hCdc45 wild type protein. 
 
  
After the immuno-depletion of the endogenous factor from the extract the system is 
stressed and this explains why usually a good rescue in the DNA replication activity 
can reach at most the 70% of the activity shown by the mock-depleted extract. 
Moreover, even if the human protein is very similar to the frog counterpart of course 
there is a gap between the functionality of the two proteins in the Xenopus system. 
Nevertheless, a rescue in the DNA replication activity after the depletion of an 
endogenous replicative factor can only represent a specific result. As demonstrated 
since years this kind of experimental system can unlikely provide false positive 
results. 
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DISCUSSION 
The analyses that have been carried out on the human Cdc45 replicative factor 
during this work represent a pioneering investigation about the biochemistry of this 
protein. The results of these biochemical and structural analyses suggest that Cdc45 
is evolutionarily linked with the DHH proteins family and the hypothesis that Cdc45 is 
derived from an ancestral pyrophosphatase cannot be completely ruled out.  
It has been long suggested that a pyrophosphatase activity may be associated to the 
DNA replication machinery [93]. Pyrophosphate hydrolysis could enhance the 
catalytic activity of replicative DNA polymerases, because removal of the 
pyrophosphate, a product of dNTPs incorporation, would drive forward the 
polymerization reaction. However, an important clue about the function and the 
evolutionary origin of Cdc45 comes from the finding that some of its putative archaeal 
homologues display a much closer similarity to the DHH subfamily 1 that includes the 
RecJ single-stranded DNA exonucleases. Moreover, the ab initio model obtained 
from SAXS data is more consistent with a compact RecJ core, rather than the more 
“open” conformation of inorganic pyrophosphatases.  
A number of RecJ-like proteins have been found associated with the DNA replication 
machinery in a variety of archaeal organisms, such as S. solfataricus [82], A. fulgidus 
[80], T. kodakaraensis [81]. In particular, the T. kodakaraensis RecJCdc45 homologue 
has been shown to possess a 5’ to 3’ exonuclease activity that is highly stimulated by 
physical interaction with the GINS15 subunit [81]. It has been proposed that this 
enzyme could participate in maturation of the Okazaki fragments in a pathway that is 
redundant with the FEN1- and Dna2-dependent pathways (two factors involved in 
this mechanism respectively in humans and yeast). Out of the multiple RecJ-like 
proteins present in archaeal organisms, it is plausible that some are associated with 
the DNA replication machinery and have a direct role in genome duplication; whereas 
others are “true” RecJ homologues, being involved in DNA repair/recombination 
transactions.  
Based on our biochemical and bioinformatic analyses we suggest that Cdc45 
originated from an ancestral 5’ to 3’ exonuclease loosing during evolution its catalytic 
activity and only retaining the ability to bind single-stranded DNA. The proteins from 
Sulfolobales may have followed a similar evolutionary path, as demonstrated by the 
absence of key catalytic residues and their tight association with GINS15. 
Association with the replication fork and GINS, in particular, may have led Cdc45 to 
loose its enzymatic activity and to acquire the function of “chaperoning” the lagging 
strand that is sterically excluded from the central channel of the MCM2–7 complex, 
as suggested from the cryo-electron microscopy of the CMG complex. In the CMG 
context Cdc45 (together with GINS) contributes to the formation of a tracking channel 
for the lagging strand [66].  
Taking into account this model, the two lateral extensions showed in the hCdc45 
predicted structure (Fig. 26) could be likely involved in contacting GINS and MCM2-7 
on the two sides with the central core of the protein looking at the center of the gap 
formed by this association (Fig. 6). The finding that the hCdc45_A1_LP1 mutant, in 
which about 70% of the left arm of the protein has been deleted (Fig. 26), can still 
work to give in vitro DNA replication activity, could indicate that the contact surface 
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between Cdc45 and the other components of the CMG complex is very restricted, at 
least on one of the two sides. The single-stranded DNA binding activity seems to be 
related to the C-terminal portion of the protein which would be folded in the central 
core of the protein as can be hypothesized by the result got from the super-
imposition of the T. thermophilus RecJ core crystal structure with the predicted 
structure for the human protein.  
It would have been really useful to study the Cdc45 factor in association with GINS 
and MCM2-7 in the formation of a stable recombinant complex. So far, we are able to 
get the co-purification of all the 11 proteins forming the complex but the amount got is 
definitely low. About this, the inability to carry out large suspension cell culture was 
likely another important issue. Indeed if it is expected that the yield of the whole CMG 
complex is low, it is actually needed to start with a massive protein production to get 
amounts of reconstituted complex enough to carry out biochemichal analyses. 
Anyway, the basis for the production of the recombinant complex has been setted up 
and in the future the protocol can be optimized to get relevant amounts of the CMG 
complex. This would allow us to analyse and characterize the role played as an 
auxiliary factor of the MCM2-7 helicase using this reconstituted in vitro system. 
Cdc45 has been shown to be a proliferation-associated antigen [67,68]. Its loading 
onto chromatin coincides with the origin firing and it is actually used by cells to switch 
on the DNA replication process by activating the replicative forks. In cancerous cells 
the normal mechanism by which the association of Cdc45 with the replicative forks is 
tightly regulated is out of control. These cells show high level of expression of the 
Cdc45 protein, which is actually needed to keep the DNA replication process on, 
while in normal cells, in most of the adult normal organs there is no expression at all 
for this factor [68]. Novel anti-cancer therapeutics can be hypothesized for the future, 
in which Cdc45 can be used as a molecular target to get a very specific effect only on 
tumoral cells. By inhibiting the association of Cdc45 with the other components of the 
CMG complex, or interfering with its DNA binding activity (if this is a requirement for 
the DNA replication activity) the DNA helicase function at the fork can be stopped 
and the DNA replication process can be switched off in cells that have escaped the 
normal control mechanisms. 
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Background: Although Cdc45 is a key replication factor, there are no biochemical or structural studies on the isolated protein.
Results:We report the first purification and biochemical characterization of humanCdc45, as well as the first structural data on
the isolated Cdc45 by small angle x-ray scattering.
Conclusion: Cdc45 is related to the RecJ/DHH family of phosphoesterases and binds single-stranded DNA.
Significance: The similarity has important evolutionary implications.
Cdc45 is an essential protein conserved in all eukaryotes and
is involved both in the initiation of DNA replication and the
progression of the replication fork. With GINS, Cdc45 is an
essential cofactor of the Mcm2–7 replicative helicase complex.
Despite its importance, no detailed information is available on
either the structure or the biochemistry of the protein. Intrigu-
ingly, whereas homologues of both GINS and Mcm proteins
have been described in Archaea, no counterpart for Cdc45 is
known. Herein we report a bioinformatic analysis that shows a
weak but significant relationship among eukaryotic Cdc45 pro-
teins and a large family of phosphoesterases that has been
described as theDHH family, including inorganic pyrophospha-
tases andRecJ ssDNAexonucleases. These enzymes catalyze the
hydrolysis of phosphodiester bonds via a mechanism involving
two Mn2 ions. Only a subset of the amino acids that coordi-
nates Mn2 is conserved in Cdc45. We report biochemical and
structural data on the recombinant human Cdc45 protein, con-
sistent with the proposed DHH family affiliation. Like the RecJ
exonucleases, the human Cdc45 protein is able to bind single-
stranded, but not double-strandedDNA. Small angle x-ray scat-
tering data are consistent with a model compatible with the
crystallographic structure of the RecJ/DHH family members.
Cdc45 is an essential factor required for the establishment
(1–3) and progression (4–7) of the DNA replication fork in
eukaryotic cells. Asmany otherDNA replication factors, Cdc45
is more abundant in proliferating cells, whereas it is almost
absent from long term quiescent, terminally differentiated, and
senescent cells (8). Several genetic studies, two-hybrid screens,
and co-immunoprecipitation analyses revealed that Cdc45
interacts with a number of other replication factors, including
the Mcm2–7 complex, GINS, MCM10, replication protein A,
DNA polymerases , , and , the origin recognition complex
subunit 2, and TopBP1 (for a review see Ref. 9). In a variety of
eukaryotic organisms Cdc45 has been found to stably associate
withMcm2–7 andGINS to form a complex (the CMG),4 which
is believed to act as the DNA helicase at the replication fork (7,
10–13). This hypothesis has been reinforced by the demonstra-
tion that the Drosophila melanogaster CMG complex can be
reconstituted by co-producing its protein components in bacu-
lovirus-infected insect cells and is found to possess a robust
DNA-unwinding activity in vitro, whereas the Mcm2–7 com-
plex alone is almost completely unable to unwind duplex DNA
(14). This analysis suggests that Cdc45 and GINS are helicase
auxiliary factors whose association with theMcm hetero-hexa-
meric ring is absolutely required to reconstitute an active
complex.
The critical biological function played by Cdc45 is under-
scored by its ubiquitous distribution and high degree of
sequence conservation from yeast to man. Nevertheless, not
much is known on the exact role of Cdc45 either in the pre-
initiation complex or the CMG helicase, due to the lack of bio-
chemical studies on the isolated protein. The analysis of the
primary structure of Cdc45 has failed to reveal the presence of
any significant similarity to known protein family or any char-
acteristic sequence motif.
Due to the complexity of the eukaryotic DNA replication
machinery, most of the information on the structure and bio-
chemistry of replication proteins has been inferred from the
study of the simpler archaeal system. In fact, Archaea possess a
simplified version of theMcm (15, 16) and GINS (17–19) com-
plexes, but so far no archaeal homologue of Cdc45 has been
identified.
* The work was supported by a Friuli Venezia Giulia grant (DAGEAST to I. K.)
andby theAssociazione Italianaper la Ricerca sul Cancro (Grant IG10646 to
S. O. and Grant IG9087 to F. M. P.).
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EXPERIMENTAL PROCEDURES
Protein Expression and Purification—The nucleotide se-
quence encoding the human Cdc45 (hCdc45) was amplified
using the Platinum Pfx DNA polymerase (Invitrogen), using a
cDNAclone from themammalianGeneCollection (IMAGE ID
2964592) as a template, and the following primers: 5-TTAA-
GAAGGAGATATACTATGTTCGTGTCCGATTTCCGCA-
AAG-3 and 5-GATTGGAAGTAGAGGTTCTCTGCGGA-
CAGGAGGGAAATAAGTGCG-3.
The amplified fragment was then Ligation independent-
cloned into the pNIC-CTHF vector (Structural Genomics Con-
sortium, Oxford (20)) for protein expression as a fusion with a
C-terminal His6-FLAG tag cleavable with tobacco etch virus
(TEV) protease.
Expression of hCdc45 was carried out in Escherichia coli
BL21 (DE3)-R3-Rosetta cells (SGC,Oxford) grownovernight at
25 °C in TB broth, following 0.1 mM isopropyl 1-thio--D-ga-
lactopyranoside induction. A frozen cell pellet (corresponding
to 1 liter of culture) was resuspended in 100 ml of buffer A (50
mM sodium phosphate buffer, pH 7.4, 1 M NaCl, 10% (v/v) glyc-
erol, 2mM-mercaptoethanol) containing EDTA-free protease
inhibitor mixture (Roche Applied Science), 50 units/ml benzo-
nase nuclease (Novagen), and 1 mg/ml lysozyme (Sigma-
Aldrich) and incubated for 2 h at 4 °C. Cells were further dis-
rupted by sonication (Bandelin Sonopuls HD3200 ultrasonic
homogenizer). The insoluble material was removed by centri-
fugation (17,000 rpm for 1 h at 4 °C, BeckmanAllegra 64R), and
the supernatant was loaded onto a 5-ml HiTrap chelating col-
umn (GE Healthcare) previously charged with Ni2 (NiSO4)
and equilibrated with buffer A. An imidazole step gradient (25
mM, 250mM, and 500mM) was applied, and protein elution was
achieved using buffer A plus 250 mM imidazole. Fractions con-
taining the hCdc45 were pooled and subsequently loaded onto
a Superdex 200 16/60 size-exclusion column (GE Healthcare)
equilibrated with buffer B (50 mM sodium phosphate, pH 7.0,
150mMNaCl, 5% (v/v) glycerol, 2mM-mercaptoethanol). The
eluted protein was incubated with TEV protease for overnight
tag cleavage at 4 °C. 12% SDS-PAGE was carried out to check
that the cleavage was complete. The hCdc45-TEV mix was
loaded onto a 5-ml Heparin column (GE Healthcare), previ-
ously equilibrated with buffer B. The cleaved hCdc45 was
eluted from the column applying a linear (150 mM to 1 M) NaCl
gradient. Finally the protein was subjected to size-exclusion
chromatography in buffer D (20 mM Tris-HCl, pH 7.9, 150 mM
NaCl, 5% (v/v) glycerol, 2 mM -mercaptoethanol).
EMSAs—The synthetic oligonucleotide used as single-
stranded DNA had the following sequence: 5-TCTACCT-
GGACGACCGGGTATATAGGGCCCTATATATAGGG-
CCAGCAGGTCCATCA-3. A complementary synthetic
oligonucleotide used to prepare the blunt DNA duplex had
the following sequence: 5-TGATGGACCTGCTGGCCCT-
ATATATAGGGCCCTATATACCCGGTCGTCCAGGT-
AGA-3. The first oligonucleotide was labeled using T4 poly-
nucleotide kinase and [-32P]ATP and annealed to a 2-fold
molar excess of the cold complementary strand to prepare
the double-stranded DNA ligand. For the DNAmobility shift
assays, 10-l mixtures were prepared that contained 100
fmol of 32P-labeled DNA in 20 mM Tris-HCl, pH 7.5, and the
indicated amounts of protein (0.5–5 g). Following incuba-
tion for 20 min at 27 °C, complexes were separated by elec-
trophoresis through 5% polyacrylamide/bis gels (19:1) in
0.5 TBE (1 TBE (89 mM Tris Base, 89 mM Boric Acid, 2
mM EDTA, pH 8.3)). Gels were dried down and analyzed by
phosphorimaging. Experiments were performed in tripli-
cate, and the results were averaged. The error bars on the
graphs are the standard error.
Electrophoretic mobility shift assays (EMSAs) were carried
out after incubation of hCdc45-His-FLAG-DNA complexes
with anti-FLAG monoclonal antibodies (Abcam). For these
experiments 10-l mixtures were prepared that contained 50
fmol of 32P-labeled oligonucleotide in 20 mM Tris-HCl, pH 7.5,
and 5 g of hCdc45-His-FLAG. Following incubation for 20
min at 27 °C, anti-FLAG antibody was added (0.5, 1, and 2g in
2 l of the following buffer: 10 mM sodium phosphate, pH 7.4,
150mMNaCl, 50% glycerol; an equal volumeof buffer (2l) was
added into the samples where the antibody was omitted, and
the incubation was continued for additional 30 min. The
mixtures were subjected to electrophoresis, as previously
described, and the gels were analyzed by phosphorimaging.
Analytical Gel Filtration and DNA-binding Activity of
hCdc45—An aliquot of purified hCdc45 (1.9 mg) was loaded
onto an analytical gel-filtration column (Bio-Sil SEC-250, Bio-
Rad). The columnwas developed with 50mMTris-HCl. pH 8.0,
150 mM NaCl, 2 mM -mercaptoethanol, 5% (v/v) glycerol at a
flow rate of 1.0 ml/min. Fractions (200 l) were collected, and
aliquots (5 l) were run through an 8% (w/v) polyacrylamide-
SDS gel. The gel-filtration column was calibrated using the fol-
lowing markers: tyroglobulin, bovine -globulin, chicken
ovalbumin, equin myoglobin, and vitamin B-12. The DNA-
binding activity of each peak fraction (aliquots of 1 l) was
analyzed by EMSAs using radiolabeled ssDNA as a probe, as
previously described.
SAXS—The synchrotron scattering datawere collected at the
Austrian small angle x-ray scattering (SAXS) beamline of the
electron storage ring ELETTRA (21) at a wavelength  of 1.54
Å. A Pilatus 100K (Tectris, Baden, Switzerland) was used as a
detector, and a sample distance of 0.75 m was set to resolve the
momentum transfer, q (q 4 sin(	)/, with 	 as half scattering
angle), in the range from 0.17 to 4.5 nm1. Samples of recom-
binant hCdc45 at a concentration of 0.44, 0.90 mg/ml, and 1.85
mg/ml in buffer D were used. All samples were kept and mea-
sured in a 1.5-mm glass capillary (Glass, Berlin, Germany) at
8 °C. The three 30-s exposures have been averaged, because the
comparison of the first and last pattern did not show any effect
of radiation damage.
The primary data reduction was performed using IGOR Pro
(Wavemetrics, Lake Oswego, OR), which was also used to esti-
mate the molecular mass of the solutes by comparing them to
the scattering of water. The reduced data were treated further
with the ATSAS program collection (22). The indirect Fourier
transformation was calculated by using the program GNOM
(23), which determines the distance distribution function, the
radius of gyration Rg, the forward scattering I(0), as well as the
maximal dimension Dmax of the proteins. The results are sum-
marized in supplemental Table S1, in which additionally the
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molecularmass of each sample has been calculated. As the sam-
ple c (1.85 mg/ml) showed some evidence of aggregation, as
seen by the SAXS pattern change at q  0.4 nm1 and the
difference in the relativemolecularmass, the low q-data of sam-
ple b (0.9 mg/ml) has been merged with the high q-data of the
sample c (1.85 mg/ml; supplemental Fig. S1). The ab initio
shape of the protein was reconstructed using DAMMIF (24)
with the combined scattering curve bc. The initial volumewas a
sphere with a Dmax of 12.5 nm consisting of 5594 individual
spheres (diameter 0.32 nm). The best 44 models have been
averaged to obtain the final model with the program
DAMAVER (25).
RESULTS ANDDISCUSSION
Cdc45 Shows Sequence Similarity to Archaeal Proteins
Belonging to the DHH Family of Phosphoesterases—We carried
out a bioinformatic analysis on Cdc45. Database searches with
the Position-Specific Interactive BLAST algorithm, using the
human Cdc45 sequence as search model and default parame-
ters, identified weak but significant similarity to two archaeal
sequences on the second iteration run. The proteinswere anno-
tated as “phosphoesterase domain-containing protein” from
Candidatus korarchaeum cryptofilum OPF8 (E-value: 2 
104) and “putative single-stranded DNA-specific exonuclease
RecJ” from Methanocella paludicola SANAE (E-value: 3 
104). They both belong to the DHH family of phosphoesterases
that was first described by Aravind and Koonin (26). Both
sequences have been recently added to the databases, explaining
why the similarity had not been previously identified. Although
the sequence similarity detected by BLAST involved only the first
130–140 residues, multiple alignments between Cdc45 and puta-
tive archaeal orthologues show that some similarity canbenoticed
throughout the entire sequence (Fig. 1).
The DHH family is defined by a number of conserved
sequencemotifs and can be split into two distinct clusters: sub-
family 1 (whose prototype is the Escherichia coli RecJ protein),
is so far represented only in Archaea and Bacteria; subfamily 2
(which includes the Drosophila melanogaster Prune protein
and the Saccharomyces cerevisiae exopolyphosphatase PPX1),
is also found in Eukarya. Crystallographic analysis of some
DHH proteins (27–29) has revealed the presence of a catalytic
core formed by two domains: in the N-terminal domain invari-
ant residues (aspartic acid and histidine residues) coordinate
two metals ions (typically manganese ions), suggesting a two-
metal mediated hydrolysis reaction.
Because Archaea possess multiple RecJ-like proteins, we
have selected the sequences displaying the closest match to the
Candidatus andMethanocella homologues. To distinguish the
archaeal RecJ/DHHproteins thatmay be putativeCdc45 ortho-
logues from other members of the DHH family, we will use the
notation RecJCdc45. However, most Archaea seem to possess
two close paralogues of the putative Cdc45 counterpart. A
study, focused on detecting the archaeal equivalent of E. coli
RecJ, identifies two highly similar proteins from Methanocal-
dococcus jannaschii (MJ0977 andMJ0831).Althoughbothwere
able to partially complement aRecJmutant phenotype inE. coli,
ssDNAnuclease activity could only be observed for theMJ0977
protein (30). Two highly similar RecJCdc45 proteins (AF0699
and AF0735) were also found associated with a replication pro-
tein network in Archaeoglobus fulgidus (31). More recently, a
RecJ-like single-stranded 5-3 DNA exonuclease from Ther-
mococcus kodakaraensis was found to physically associate with
GINS, and this association was found to stimulate its exonu-
clease activity (32).
A putative RecJ homologue has been reported to co-purify
with Mcm and GINS from cellular extracts of Sulfolobus solfa-
taricus (SSO0295 (18)). This sequence is rather divergent from
most of the archaeal proteins mentioned above and lacks some
of the motifs; in particular, some of the conserved residues
putatively responsible for the nuclease activity are absent. An
open reading frame highly similar to SSO0295 is present in
most Sulfolobales genomes. Divergent sequences are also
detected in other Crenarchaeota, such as Aeropyrum pernix.
Both the eukaryotic Cdc45 proteins and the archaeal
RecJCdc45 sequences match only to the RecJ catalytic core
(domains I and II, as defined in the crystal structure ofThermus
thermophilus RecJ (27), while lacking the 50-residues N-termi-
nal extension as well as domains III and IV. These additional
elements form a closed-ring structure that is predicted to encir-
cle ssDNA.
Cdc45 sequences only partially retain the motifs typical of
the DHH family that are involved in metal binding.Whereas in
motif 1 both aspartate residues coordinating themetal are con-
served (26DVD), the DHHmotif 3, which gives the name to the
family, is mutated to 99DTH. Although a number of residues
belonging to motifs 2 and 4 are conserved suggesting that the
protein fold is similar in those regions, the key residues for
metal binding and catalysis are not conserved, with the aspar-
tate ofmotif 2mutated to asparagine, and the aspartate ofmotif
4 to a glutamine (Fig. 1). In contrast, most of the archaeal
RecJCdc45 comprise all of the motifs that are conserved in the
bacterial RecJ exonucleases, with the exception of the putative
orthologues from Sulfolobales, whose sequence is rather diver-
gent and lacks most of the RecJ canonical residues.
Threading Algorithms Confirm the Presence of a RecJ/DHH-
like Core Fold in hCdc45—A variety of threading/fold recogni-
tion algorithms were used to verify the similarity among
hCdc45 and DHH family members. The Protein Fold Recogni-
tion Server Phyre (33) identifies a three-dimensional similarity
between hCdc45 and a number of DHHprotein structures such
as theRecJ exonuclease fromT. thermophilus (PDB code: 1IR6),
as well as various inorganic pyrophosphatases (PDB codes:
1WPN, 1I74, and 2HAW), but the similarity was restricted to
the first 110 amino acids.When amultiple sequence alignment,
including a number of Cdc45 sequences, was used as input for
the HHPRED server (34), a similarity (involving the first 315
residues) was detected to an inorganic pyrophosphatase from
Bacillus subtilis belonging to the DHH family (PDB code:
1WPN). The profile-profile alignment and fold-recognition
server FFAS03 (35) was also used both with the full-length
hCdc45 sequence and a number of fragments corresponding to
putative domains. A score below the recommended threshold
(9) was obtained when the first 140 amino acid residues of
hCdc45were used as input,matching theN-terminal domain of
a number of manganese-dependent inorganic pyrophosphata-
ses from the DHH family, with the B. subtilis inorganic pyro-
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phosphatase giving the best agreement (10.5, PDB code:
1K23). Using as input longer hCdc45 fragments still provides a
match with the DHHproteins, although the scores get progres-
sively higher, indicating a lower degree of confidence; using the
full-length protein it is possible to detect some similarity to
1K23. The sequence-structure homology recognition server
FUGUE (36) unambiguously identifies both the T. thermophi-
lus RecJ (1IR6) as well as the Streptococcus gordonii inorganic
pyrophosphatase (1K20) structures as the two best hits along
the entire sequence with a degree of confidence higher than
99%.When using as input the sequences of a variety of archaeal
RecJCdc45 proteins, all the servers predicted a strong structural
similarity to the bacterial RecJ proteins, along the entire
sequence, as expected from the significant sequence homology
and the conservation of the characteristic motifs.
A central region in bothCdc45 (residues 252–363 in hCdc45)
and archaeal RecJCdc45 (residues 188–275 in the sequence from
T. kodakaraensis) proteins, appears as a long insertion into the
RecJ/DHH core. This region is reasonably well conserved
between eukaryotic and archaeal proteins. Secondary structure
predictions suggest a helical fold, and threading algorithms
tend to find matches with helical bundle proteins, such as acyl-
CoA-binding proteins and helix-turn-helix transcription fac-
tors. An additional insertion is unique to the eukaryotic Cdc45
proteins (residues 108–175 in the human sequence), and the
central part includes a large number of charged residues (aspar-
tate, glutamate, arginine, and lysine), thus suggesting a partially
structured region (Fig. 1).
Based on the results of both the sequence analysis and the
threading algorithms, we have produced a sequence alignment
FIGURE1.SequencealignmentbetweenhCdc45,RecJCdc45 fromT. kodakaraensis, andRecJ fromT. thermophilus.Thealignmentpresentedhere is based
on an extendedmultiple alignment using 15 eukaryotic Cdc45 sequences, 16 archaeal sequences, and 10bacterial RecJ sequences, selected fromevolutionary
diverseorganisms.Only theRecJ core (residues 50–425, comprisingdomains I and II) hasbeenused in thealignment. Residues that are conserved inmore than
70% of the eukaryotic, archaeal, and bacterial sequences are highlighted in green, cyan, and yellow, respectively. The following groups of amino acid residues
were considered similar: Asp/Glu, Lys/Arg, Phe/Tyr, Ser/Thr, Gly/Ala, and Val/Leu/Ile/Met. The position of the secondary structural elements in the T. thermo-
philus RecJ crystal structure (PDB code: 2ZXP) is indicated at the bottom, whereas the predicted secondary structure for human Cdc45 is shown at the top.
Secondary structure elements are named according to the TthRecJ nomenclature (28). The position of the characteristic RecJmotifs is shownby red boxes, with
the residues conserved highlighted in bold. The alignment was carried out using the multiple sequence alignment program MUSCLE (41) and manually
modified to take into account the structural constraints, and the results of the -fold recognition/threading algorithms. Up to motif IV the similarity is strong
enough to be detected based on sequence alone, whereas the second half of the alignment relies on the threading data, which identify similarity patterns in
the absence of high sequence homology, as exemplified by the conservation of the patterns of hydrophobic residues and the excellent match between RecJ
secondary structure elements and the prediction for Cdc45. An insertion unique to eukaryotic Cdc45 orthologues and containing many charged amino acid
residues is shown inmagenta. The putative helical insertion present in both archaeal and eukaryotic proteins is shown in yellow.
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that summarizes the putative relationships among bacterial
RecJ ssDNA exonucleases, archaeal RecJCdc45 and the
eukaryotic Cdc45 (Fig. 1). In the first half of the molecule (up
to motif IV) the similarity is strong enough to be detected
based on sequence alone, whereas for the second half the
alignment relies on the threading data, which identify simi-
larity patterns in the absence of high sequence conservation.
Consistent with the threading results, Fig. 1 shows the con-
servation of patterns of hydrophobic residues and an excel-
lent match between the experimentally determined -heli-
ces and -strands of RecJ and the predicted Cdc45 secondary
structure elements.
Although the correspondence is good overall, there are a few
uncertainties in the central region of the proteins. For example
it is difficult to establish unambiguously whether the first
Cdc45 insertion occurs after 5 (as depicted in Fig. 1) or after
7. In the same way the second insertion (common to eukary-
otic and archaeal proteins) may slide from the current position
in Fig. 1 (after 10) to an alternative position after 11. How-
ever the match is very convincing in the first half of domain I as
well as in domain II, including the long helix connecting the two
domains (14), suggesting that the relationship extends
throughout the entire sequence.
While we were finalizing this report, a bioinformatic analysis
(37) was published suggesting a similarity between Cdc45 and
RecJ proteins, limited to the first 100 amino acid residues. Our
report is consistent with that one (37) but further extends the
analysis by showing that the sequence and structural similarity
covers the entire length of the protein.
Biochemical Characterization of the Recombinant hCdc45—
We produced in bacterial cells hCdc45 as a fusion protein with
a C-terminal His6-FLAG tag, using the pNIC-CTHF vector
(20). The tag could be cleaved with the TEV protease and the
protein purified to homogeneity (Fig. 2A).
FIGURE2.Biochemical characterizationof recombinanthumanCdc45.A, purificationof hCdc45. SDS-PAGEanalysis of samples throughout thepurification
protocol (see detailed description under “Experimental Procedures”), starting from the protein obtained after the first step of Ni-affinity purification (IMAC
(immobilizedmetal-ion affinity chromatography)), followedby size-exclusion chromatography (SEC); the protein after cleavageof theHis6-FLAG tagusing TEV
protease and purification over a heparin column (Heparin) to a final round of SEC. B, DNA-binding activity of hCdc45. Example of an EMSA on single-stranded
DNA is shown. The assay was carried out with increasing concentrations of hCdc45 (0.5, 1, 2, 3, 4, and 5g of protein were present in themixtures loaded into
the lanes from 2 to 7). A radiolabeled 56-mer DNA was used as a ligand (see the text for details). A control mixture without protein was run on lane 1. C,
single-stranded versusdouble-strandedDNAbinding. ShiftedDNA (either in single- (●) or double-stranded (f) form) is reported versus the amount of hCdc45.
Experiments were performed in triplicate, and the results are averaged. Curves represent best fits to the data points. The error bars on the graphs are theS.E.
D, gel-filtration analysis of hCdc45 and EMSAs of the corresponding peak fractions. Gel-filtration chromatography of purified hCdc45 was performed using a
Bio-Sil SEC-250 column (Bio-Rad) as described under “Experimental Procedures.” Peak fractions were analyzed by SDS-PAGE (5 l/fraction) and used in a gel
shift experiment (1 l/fraction). E, EMSA with hCdc45-His-FLAG in the presence of anti-FLAG antibody. The assays were carried out by adding increasing
amounts of a monoclonal anti-FLAG antibody (0.5, 1, and 2 g, lanes 2 and 6, 3 and 7, and 4 and 8, respectively) into mixtures containing the single-stranded
DNA probe with hCdc45-His-FLAG (lanes 6–8; 5g of protein) or without the recombinant protein (lanes 2–4; see text for details). A black arrow indicates the
Cdc45-DNA complex, whereas thewhite arrows identify the ternary complexes with the anti-FLAG antibody.
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Although many of the residues that in RecJ/DHH proteins
are involved inMn2 binding and catalysis are not conserved in
hCdc45, we examined the possibility that the few remaining
aspartate and histidine residues (namely Asp-26, Asp-28, Asp-
99, and His-101) may possibly coordinate one metal ion. We
have therefore used both inductively coupled plasma/atomic
emission spectroscopy and atomic absorption spectroscopy to
test whether the purified protein contains manganese, magne-
sium, or zinc, but we failed to confirm the presence of any of
these metals (data not shown).
We also carried out activity assays to check whether hCdc45
displays either pyrophosphatase or exonuclease activity. Con-
sistentlywith the absence ofmetal ions and someof the putative
catalytic residues, we were unable to detect any of the above
enzymatic activities (data not shown).
Both its role in DNA replication and the putative similarity
with a single-stranded DNA exonuclease, such as RecJ, sug-
gested that Cdc45 could be a DNA-binding protein. We used
EMSAs to evaluate the DNA-binding properties of hCdc45
(Fig. 2B). The purified recombinant protein binds single-
stranded synthetic oligonucleotides with a weak but detectable
affinity, comparable with the one observed for the Drosophila
GINS complex (14) or for the full-length T. thermophilus RecJ
(27). No increase in affinity was observed when a fork-contain-
ing DNA molecule was used as a ligand in the EMSAs, and
negligible binding was detected to short blunt double-stranded
DNA (Fig. 3C). Addition of Mg2, Mn2, or Zn2 ions into the
buffer, as well as variation of pH in the range 5.5–8.5, were
found to have no effect on the hCdc45 DNA-binding activity
(data not shown).
Preliminary experiments indicated that the affinity of
hCdc45 for ssRNA is weaker with respect to ssDNA. The pro-
tein shows a preference for an oligo(dG) in comparison to oli-
go(dC), oligo(dA), and oligo(dT) (supplemental Fig. S2).
To demonstrate that the weak DNA-binding activity is
indeed due to hCdc45, and not to trace amounts of a contami-
nating protein, we analyzed the DNA-binding activity of the
protein fractions following size-exclusion chromatography.
The DNA-binding activity profile precisely co-migrates with
the protein peak (Fig. 2D and supplemental Fig. S3) suggesting
that the ability to bind DNA is a truly intrinsic feature of
hCdc45. Furthermore, we analyzed whether the protein-DNA
complex could be super-shifted by a specific antibody. For this
experiment, we used a FLAG-tagged version of hCdc45 (puri-
fied according to the same protocol as the untagged protein
with the omission of the TEV cleavage step) and a monoclonal
anti-FLAG antibody. This analysis (Fig. 2E) revealed that the
anti-FLAG antibody was able to super-shift the protein-DNA
complex.
The ssDNA-binding properties of hCdc45 are consistent
with the role of the protein as inferred from the single particle
electronmicroscopy structure of theDrosophilaCMGcomplex
(38). In the CMG context Cdc45 (together with GINS) contrib-
utes to the formation of a tracking channel for the lagging
strand. DNA binding is therefore not a property of the isolated
factor but is achieved synergically with Mcm2–7 and GINS.
SAXS Data from Recombinant hCdc45 Are Consistent with
the Three-dimensional Structure of the RecJ Core—SAXS data
were collected from highly purified samples of recombinant
hCdc45 and corrected for the scattering from the buffer. Ab
initio modeling was performed using the program DAMMIN
(39), with 44 runs being averaged using the program
DAMAVER (25). The model obtained can be described as a
compact core with two lateral extensions (Fig. 3).We can fit the
RecJ core (encompassing domains I and II, residues 50–421)
from the T. thermophilus RecJ crystallographic structure (PDB
code: 2ZXP) in the central part of the envelope (Fig. 4). One of
the two lateral extensions is larger and better defined and can be
assigned to the putative helical insertion domain that is com-
mon to both the eukaryotic Cdc45 and the archaeal RecJCdc45
proteins (residues 188–275 in hCdc45), as the putative inser-
tion loop within the RecJ core is positioned in a manner com-
patible with this interpretation (Figs. 1 and 4). As an example,
we choose to fit to this region of themap the helical bundle from
the acyl-CoA-binding protein (PDB code: 2FDQ) as suggested
from the results of the threading analysis. The second insertion
has amore elongated shape and can be allocated to the partially
unstructured insertion that is unique to the Cdc45 sequences
(residues 108–175 in hCdc45, Figs. 1 and 4).
As discussed above, there is some uncertainty in the exact
positions of the two long insertions with respect to the RecJ
core, and alternative insertion points can be suggested. How-
ever, in both cases the alternative loops are still positioned in a
manner compatible with the interpretation of the SAXS data.
Evolutionary Implications—The results of these biochemical
and structural analyses suggest an evolutionary link between
Cdc45 andDHHproteins. The hypothesis thatCdc45 is derived
from an ancestral pyrophosphatase cannot be completely ruled
FIGURE 3. Small angle x-ray scattering data. A, the experimental SAXS pro-
file (log intensity as a function of the momentum transfer) of hCdc45 (red
points) is comparedwith the theoretical scattering curves calculated from the
ab initio model (blue line). B, final model reconstructed from the scattering
curve.
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out. It has been long suggested that a pyrophosphatase activity
may be associated to the replicationmachinery (40). Pyrophos-
phate hydrolysis could enhance the catalytic activity of replica-
tive DNA polymerases, because removal of the pyrophosphate,
a product of dNTPs incorporation, would drive forward the
polymerization reaction.
However, an important clue about the function and the evo-
lutionary origin of Cdc45 comes from the finding that some of
its putative archaeal homologues display amuch closer similar-
ity to the DHH subfamily 1 that includes the RecJ single-
stranded DNA exonucleases. Moreover, the ab initio model
obtained from SAXS data is more consistent with a compact
RecJ core, rather than the more “open” conformation of inor-
ganic pyrophosphatases. A number of RecJ-like proteins have
been found associatedwith theDNA replicationmachinery in a
variety of archaeal organisms, such as S. solfataricus (18), A.
fulgidus (31), T. kodakaraensis (32). In particular, the T. koda-
karaensis RecJCdc45 homologue has been shown to possess a
5-3 exonuclease activity that is highly stimulated by physical
interaction with the GINS15 subunit (32). It has been proposed
that this enzyme could participate inmaturation of theOkazaki
fragments in a pathway that is redundant with the FEN1- and
Dna2-dependent pathways. Out of the multiple RecJ-like pro-
teins present in archaeal organisms, it is plausible that some are
associated with the DNA replication machinery and have a
direct role in genome duplication; whereas others are “true”
RecJ homologues, being involved in DNA repair/recombina-
tion transactions.
Based on our biochemical and bioinformatic analyses we
suggest that Cdc45 originated from an ancestral 5-3 exonu-
clease loosing during evolution its catalytic activity and only
retaining the ability to bind single-strandedDNA. The proteins
from Sulfolobales may have followed a similar evolutionary
path, as demonstrated by the absence of key catalytic residues
and their tight association with GINS15. Association with the
replication fork and GINS, in particular, may have led Cdc45 to
loose its enzymatic activity and to acquire the function of
“chaperoning” the lagging strand that is sterically excluded
from the central channel of the MCM2–7 complex, as sug-
gested from the cryoelectron microscopy of the CMG complex
(38).
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Abstract The gene encoding a novel alcohol dehydroge-
nase that belongs to the short-chain dehydrogenases/
reductases superfamily was identified in the aerobic ther-
moacidophilic crenarchaeon Sulfolobus acidocaldarius
strain DSM 639. The saadh2 gene was heterologously
overexpressed in Escherichia coli, and the resulting pro-
tein (SaADH2) was purified to homogeneity and both
biochemically and structurally characterized. The crystal
structure of the SaADH2 NADH-bound form reveals that
the enzyme is a tetramer consisting of identical 27,024-
Da subunits, each composed of 255 amino acids. The
enzyme has remarkable thermophilicity and thermal sta-
bility, displaying activity at temperatures up to 80 °C and
a 30-min half-inactivation temperature of ∼88 °C. It also
shows good tolerance to common organic solvents and a
strict requirement for NAD(H) as the coenzyme.
SaADH2 displays a preference for the reduction of ali-
cyclic, bicyclic and aromatic ketones and α-ketoesters,
but is poorly active on aliphatic, cyclic and aromatic
alcohols, showing no activity on aldehydes. Interestingly,
the enzyme catalyses the asymmetric reduction of benzil
to (R)-benzoin with both excellent conversion (98 %) and
optical purity (98 %) by way of an efficient in situ
NADH-recycling system involving a second thermophilic
ADH. The crystal structure of the binary complex
SaADH2–NADH, determined at 1.75 Å resolution,
reveals details of the active site providing hints on the
structural basis of the enzyme enantioselectivity.
Keywords Archaea . Sulfolobus acidocaldarius . Short-
chain dehydrogenases/reductases . Crystal structure .
Bioreduction . Benzil
Introduction
Dehydrogenases/reductases are found throughout across a
wide range of organisms where they are involved in a broad
spectrum of metabolic functions (Jörnvall 2008), and a
system of short-, medium- and long-chain dehydrogenase/
reductases has been recently identified based on molecular
size, sequence motifs, mechanistic features and structural
comparisons (Kavanagh et al. 2008; Persson et al. 2009).
Many studies have been addressed to characterize alcohol
dehydrogenases (ADHs) from thermophiles and hyperther-
mophiles, mainly to understand their evolution and struc-
ture/function/stability relationship (Radianingtyas and
Wright 2003) and develop their biotechnological potential
in the synthesis of chiral alcohols (Jones and Beck 1976;
Keinan et al. 1986; Hummel 1999; Kroutil et al. 2004;
Müller et al. 2005; Goldberg et al. 2007). Recently, ADHs
displaying distinct substrate specificity, good efficiency and
high enantioselectivity have been described, such as the
NADP-dependent (R)-specific ADH from Lactobacillus
brevis (LB-RADH) (Schlieben et al. 2005), the NAD-
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dependent ADH from Leifsonia sp. strain S749 (LSADH)
(Inoue et al. 2006), and the NADP-dependent carbonyl
reductase from Candida parapsilosis (Nie et al. 2007).
These enzymes originate from mesophilic microorganisms
and belong to the short-chain dehydrogenases/reductases
(SDRs) superfamily (Kavanagh et al. 2008) which is char-
acterized by ∼250 residue subunits, a Gly-motif in the
coenzyme-binding regions, and a catalytic tetrad formed
by the highly conserved residues Asn, Ser, Tyr and Lys
(Filling et al. 2002; Schlieben et al. 2005; Persson et al.
2009). Representative examples of ADHs from thermophilic
microorganisms are medium-chain enzymes, including
Thermoanaerobacter brockii ADH (Korkhin et al. 1998),
the ADH from Bacillus stearothermophilus strain LLD-R
(BsADH) (Ceccarelli et al. 2004) and two archaeal enzymes,
the ADH from Aeropyrum pernix (Guy et al. 2003) and
Sulfolobus solfataricus (Giordano et al. 2005; Friest et al.
2010). However, two archaeal short-chain ADHs have been
identified in Pyrococcus furiosus, an NADP(H)-dependent
SDR (van der Oost et al. 2001; Machielsen et al. 2008), and
an NAD(H)-preferring ADH, that belongs to the aldo-keto
reductase superfamily (Machielsen et al. 2006; Zhu et al.
2006, 2009). Furthermore, two short-chain NAD(H)-depen-
dent ADHs, TtADH and SaADH, identified in Thermus
thermophilus HB27 and Sulfolobus acidocaldarius, respec-
tively, have been recently purified and characterized in our
laboratory (Pennacchio et al. 2008, 2010a, 2010b, 2011).
With the aim to find novel dehydrogenase/reductases that
are both stable and NAD+ dependent, we focused our atten-
tion on the genomes of thermophilic organisms containing
genes encoding putative ADHs belonging to the SDR su-
perfamily and applied the criteria used for TtADH and
SaADH to select enzymes with a high probability of being
NAD+ dependent (Pennacchio et al. 2008). An open reading
frame coding for a protein belonging to the SDR superfam-
ily with relatively high sequence identity to that of most
representative ADHs (LB-RADH, LSADH, TtADH and
SaADH) was found in the genome of S. acidocaldarius,
an aerobic thermoacidophilic crenarcheon which grows op-
timally at 80 °C and pH 2 (Chen et al. 2005). The amino
acid sequence revealed the presence of a glutamic acid
residue at position 39. Noteworthy, an aspartate residue at
the homologous position plays a critical role in determining
the preference of SDRs for NAD(H) as shown for the LB-
RADH mutant G37D (Schlieben et al. 2005) and by the
evidence that the SDRs LSADH (Inoue et al. 2006), TtADH
and SaADH (Pennacchio et al. 2008, 2010a, b) are strictly
NAD(H)-dependent and have an aspartate residue at the
same position within the sequence (Fig. 1). Due to Glu
and Asp chemical similarity, the putative dehydrogenase/
reductase identified in S. acidocaldarius (SaADH2) was
expected to display a preference for NAD(H) rather than
NADP(H). This preference as well as an intrinsic
thermostability are the features that make an oxidoreductase
more attractive from an application perspective (Kroutil et
al. 2004; Zhu et al. 2006; Huisman et al. 2010).
This report describes cloning, heterologous expression and
structural characterization of the S. acidocaldarius saadh2
gene, which encodes the SDR SaADH2. The purified enzyme
was characterized in terms of substrate specificity, kinetics and
stability as well as enantioselectivity. SaADH2 was found to
be highly efficient and enantioselective in reducing the diaryl
diketone benzil to (R)-benzoin.
Materials and methods
Chemicals
NAD(P)+ and NAD(P)H were obtained from AppliChem
(Darmstadt, Germany). Alcohols, aldehydes, ketones and
keto esters were obtained from Sigma-Aldrich. 1-Butyl-3-
methylimidazolium tetrafluoroborate (BMIMBF4) was a
kind gift from Professor S. Cacchi. Recombinant BsADH
was prepared as previously described (Fiorentino et al.
1998). Other chemicals were A grade substances from
Applichem. Solutions of NADH and NAD+ were prepared
as previously reported (Raia et al. 2001). All solutions were
made up with MilliQ water.
Amplification and cloning of the saadh2 gene
Chromosomal DNA was extracted by caesium chloride pu-
rification as described by Sambrook et al. (1989). Ethidium
bromide and caesium chloride were removed by repeated
extraction with isoamyl alcohol and extensive dialysis
against 10 mM Tris–HCl pH 8.0 and 1 mM EDTA, respec-
tively. DNA concentration was determined spectrophoto-
metrically at 260 nm, and the molecular mass checked by
electrophoresis on 0.8 % agarose gel in 90 mM Tris–borate
pH 8.0 and 20 mM EDTA, using DNA molecular size
markers. The saadh2 gene was amplified by polymerase
chain reaction (PCR) using oligonucleotide primers based
on the saadh2 sequence of S. acidocaldarius strain DSM
639 (GenBank accession no. YP_255871.1). The following
oligonucleotides were used: (5′-TGCATAGTAGCATATG
TCATATCAGAGTTTG-3′) as the forward primer (the Nde
I restriction site is underlined in the sequence) and the
oligonucleotide (5′-AGGAATTCACATTACAGTACAG
TTAAACCACC-3′) as the reverse primer. This latter oligo-
nucleotide introduces a translational stop following the last
codon of the ADH gene, followed by an EcoRI restriction
site, which is underlined in the sequence shown. The PCR
product was digested with the appropriate restriction
enzymes and cloned into the expression vector pET29a
(Novagen, Madison, Wisconsin, USA) to create the
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recombinant pET29a–saADH plasmid. The insert was se-
quenced in order to verify that mutations had not been
introduced during PCR.
Expression and purification of recombinant SaADH2
Recombinant protein was expressed in Escherichia coli
BL21(DE3) cells (Novagen) transformed with the
corresponding expression vector. Cultures were grown at
37 °C in 2 L of LB medium containing 30 μg ml−1 kana-
mycin. When the A600 of the culture reached 1.4, protein
expression was induced by addition of isopropyl β-D-1-
thiogalactopyranoside to a concentration of 1.0 mM. The
bacterial culture was incubated at 37 °C for a further 24 h.
Cells were harvested by centrifugation, and the pellet stored
at −20 °C until use. The cells obtained from 2 L of culture
were suspended in 20 mM Tris–HCl buffer (pH 7.5) con-
taining 0.1 mM phenylmethylsulfonyl fluoride (PMSF) and
were lysed using a French pressure cell (Aminco Co., Silver
Spring, MD) at 2,000 psi (1 psi06.9 kPa). The lysate was
centrifuged, and the supernatant incubated in the presence of
DNase I (50 μg/ml of solution) and 5 mMMgCl2 for 30 min
at 37 °C, followed by protamine sulphate (1 mg/ml of
solution) at 4 °C for 30 min. The nucleic acid fragments
were removed by centrifugation, and the supernatant incu-
bated at 70 °C for 15 min. The host protein precipitate was
removed by centrifugation. The supernatant was dialysed
overnight at 4 °C against 20 mM Tris–HCl, pH 8.4 (buffer
SaADH2          ---MSYQSLKNKVVIVTGAGSGIGRAIAKKFALNDSIVVAVELLEDRLNQIVQELRGMGK 57 
SaADH           MDIDRLFSVKGMNAVVLGASSGIGKAIAEMFSEMGGKVVLSDIDEEGLKRLSDSLRSRGH 60 
LB-RADH         ----MSNRLDGKVAIITGGTLGIGLAIATKFVEEGAKVMITGRHSDVGEK-AAKSVGTPD 55 
LSADH           ---MAQYDVADRSAIVTGGGSGIGRAVALTLAASGAAVLVTDLNEEHAQAVVAEIEAAGG 57 
TtADH           ---MGLF--AGKGVLVTGGARGIGRAIAQAFAREGALVALCDLRPEGKE--VAEAIGGAF 53 
                          .  .:: *.  *** *:*  :   .. *   *    :  :    .  .    
SaADH2          EVLGVKADVSKKKDVEEFVRRTFETYSRIDVLCNNAGIMDGVTPVAEVSDELWERVLAVN 117 
SaADH           EVNHMKCDITDLNQVKKLVNFSLSVYGNVDALYVTPSIN-VRKSIENYTYEDFEKVINVN 119 
LB-RADH         QIQFFQHDSSDEDGWTKLFDATEKAFGPVSTLVNNAGIA-VNKSVEETTTAEWRKLLAVN 114 
LSADH           KAAALAGDVTDPAFGEASVA-GANALAPLKIAVNNAGIGGEAATVGDYSLDSWRTVIEVN 116
TtADH           FQVDLEDERERVRFVEE----AAYALGRVDVLVNNAAIAAPGSAL-TVRLPEWRRVLEVN 108 
                    .  :                . . :.    ...*     .:       :. :: ** 
SaADH2          LYSAFYSSRAVIPIMLKQGKGV-IVNTASIAGIRGGFAGAPYTVAKHGLIGLTRSIAAHY 176 
SaADH           LKGNFMVVKEFLSVMKNNKGGGSVVLFSSIRGTVVEPGQSVYAMTKAGIIQLAKVAAAEY 179 
LB-RADH         LDGVFFGTRLGIQRMKNKGLGASIINMSSIEGFVGDPSLGAYNASKGAVRIMSKSAALDC 174 
LSADH           LNAVFYGMQPQLKAMAANGGGA-IVNMASILGSVGFANSSAYVTAKHALLGLTQNAALEY 175 
TtADH           LTAPMHLSALAAREMRKVGGGA-IVNVASVQGLFAEQENAAYNASKGGLVNLTRSLALDL 167 
                * . :         *     *  ::  :*: *       . *  :* .:  :::  * .  
SaADH2          GDQ--GIRAVAVLPGTVKTN---IGLGSSKPSELGMRTLTKLMSLSSRLAEPEDIANVIV 231 
SaADH           GKY--NIRVNVIAPGVVDTP-----LTRQIKSDPEWFKAYTEKTILKRWATPEEIANVAL 232 
LB-RADH         ALKDYDVRVNTVHPGYIKTP-----LVDDLPGAEEAMSQRTKTPMG-HIGEPNDIAYICV 228 
LSADH           AAD--KVRVVAVGPGFIRTP--LVEANLSAD---ALAFLEGKHALG-RLGEPEEVASLVA 227 
TtADH           APL--RIRVNAVAPGAIATEAVLEAIALSPDPERTRRDWEDLHALR-RLGKPEEVAEAVL 224 
                .     :*. .: ** : *         .              .:  : . *:::*     
SaADH2          FLASDEASFVNGDAVVVDGGLTVL-------- 255 
SaADH           FLAMPASSYITGTVIYVDGGWTAIDGRYDPKV 264 
LB-RADH         YLASNESKFATGSEFVVDGGYTAQ-------- 252 
LSADH           FLASDAASFITGSYHLVDGGYTAQ-------- 251 
TtADH           FLASEKASFITGAILPVDGGMTASFMMAGRPV 256 
                :**   :.: .*    **** *.          
Fig. 1 Multiple-sequence alignment of the S. acidocaldarius ADH
(SaADH2) and ADHs belonging to the SDR family, including S.
acidocaldarius ADH (SaADH; NCBI accession no. YP_256716.1),
L. brevis ADH (LB-RADH; PDB code 1ZK4), Leifsonia sp. strain
S749 ADH (LSADH; NCBI accession no. BAD99642) and T. thermo-
philus ADH (TtADH; PDB code 2D1Y). The sequences were aligned
using the ClustalW2 program. Grey shading indicates residues highly
conserved in the SDR family. The four members of the catalytic tetrad
are indicated by a black background. The following positions are
indicated by bold type: the glycine-rich consensus sequence and the
sequence motif Dhx[cp] that (in all SDRs) have a structural role in
coenzyme binding (Kallberg et al. 2002). The star indicates the major
determinant of the coenzyme specificity. The LB-RADH G37D mutant
shows preference for NAD+ over NADP+ (Schlieben et al. 2005)
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A) containing 1 mM PMSF. The dialysed solution was
applied to a DEAE-Sepharose Fast Flow (1.6×12 cm) col-
umn equilibrated in buffer A at 120 ml h−1. The active pool
did not bind to the column matrix. The flowthrough frac-
tions were combined and dialysed against buffer A, concen-
trated 5-fold with a 30,000 MWCO centrifugal filter device
(Millipore), and applied to a Sephadex G-75 (1.6×30 cm)
column equilibrated in buffer A containing 0.15 M NaCl.
The active pool was dialysed against buffer A and concen-
trated to obtain 2.0 mg protein·ml−1 as described previously.
SaADH2 was stored at −20 °C in buffer A containing 50 %
glycerol, without loss of activity following several months
of storage. SDS-PAGE was carried out according to the
Laemmli method (1970). The subunit molecular mass was
determined by electrospray ionization mass spectrometry
(ESI-MS) with a QSTAR Elite instrument (Applied Biosys-
tems, USA). The protein concentration was determined with
a Bio-Rad protein assay kit using BSA as a standard.
Sucrose density gradient centrifugation
One hundred microlitres of a 1 mg/ml purified SaADH2
solution was layered on top of a 10-ml 5–20 % preformed
sucrose gradient in 50 mM Tris–HCl, pH 8.4. The standards
were also prepared by layering 100 μl of 1 mg/ml chymotrip-
sinogen (25 kDa), BSA (67 kDa), T. thermophilus ADH (a
108-kDa tetramer) and S. solfataricus ADH (a 150-kDa tetra-
mer) on top of another identical sucrose gradient. By using a
Beckman SW 41 Ti rotor, the tubes containing the samples
were spun at 37,000 rpm for 18 h at 4 °C in a Beckman LE-80
ultracentrifuge. Immediately after centrifugation, gradients
were collected in 250-μl fractions and assayed for absorption
at 280 nm to determine the position of the marker protein. The
mass of SaADH2 was estimated from the position of the peak
relative to those of the markers.
Enzyme assay
SaADH2 activity was assayed spectrophotometrically at
65 °C by measuring the change in absorbance of NADH at
340 nm using a Cary 1E spectrophotometer equipped with a
Peltier effect-controlled temperature cuvette holder. The
standard assay for the reduction reaction was performed by
adding 5−25 μg of the enzyme to 1 ml of preheated assay
mixture containing 20 mM ethyl 3-methyl-2-oxobutyrate
(EMO) and 0.2 mM NADH in 37.5 mM sodium phosphate,
pH 5.0. The standard assay for the oxidation reaction was
performed using a mixture containing 18 mM cycloheptanol
and 3 mM NAD+ in 50 mM glycine/NaOH, pH 10.5.
Screening of the substrates was performed using 1 ml of
assay mixture containing either 10 mM alcohol and 3 mM
NAD+ in 50 mM glycine/NaOH, pH 10.5, or 10 mM car-
bonyl compound and 0.1 mM NADH in 37.5 mM sodium
phosphate, pH 5.0. One unit of SaADH2 represented 1 μmol
of NADH produced or utilized per minute at 65 °C, on the
basis of an absorption coefficient of 6.22 mM−1 cm−1 for
NADH at 340 nm.
Effect of pH on activity
The optimum pH value for the reduction and oxidation
reactions was determined at 65 °C under the conditions
used for EMO and cycloheptanol, respectively, except
that different buffer were used. The concentration of
each buffer solution was diluted to get the similar
conductivity (∼1.1 mS). The pH was controlled in each
assay mixture at 65 °C.
Kinetics
The SaADH2 kinetic parameters were calculated from
measurements determined in duplicate or triplicate and by
analysing the kinetic results using the program GraFit
(Leatherbarrow 2004). The turnover value (kcat) for
SaADH2 was calculated on the basis of a molecular mass
of 27 kDa, assuming that the four subunits are catalytically
active.
Thermophilicity and thermal stability
SaADH2 was assayed in a temperature range of 25–90 °C
using standard assay conditions and 22 μg protein·ml–1 of
assay mixture. The stability at various temperatures was
studied by incubating 0.2 mg ml–1 protein samples in
50 mM Tris–HCl, pH 9.0, at temperatures between 25 and
95 °C for 30 min. Each sample was then centrifuged at 5 °C,
and the residual activity assayed as described above.
The effect of chelating agents on enzyme stability was
studied by measuring the activities before and after exhaus-
tive dialysis of the enzyme against buffer A, containing
1 mM EDTA, and then against buffer A alone. An aliquot
of the dialysed enzyme was then incubated at 70 °C in the
absence and presence of 1 mM EDTA, and the activity
assayed at different times.
Effects of compounds on enzyme activity
The effects of salts, metal ions and chelating agents on
SaADH2 activity were investigated by assaying the enzyme
in the presence of an appropriate amount of each compound
in the standard assay mixture used for the oxidation
reaction.
The effects of organic solvents were investigated by
measuring the activity in enzyme samples (0.2 mg ml–1 in
100 mM sodium phosphate, pH 7.0) immediately after the
addition of organic solvents at different concentrations and
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after incubation for 6 and 24 h at 50 °C. The percentage
activity for each sample was calculated by comparison with
the value measured prior to incubation. The volume of the
solution in a tightly capped test tube did not change during
incubation.
Enantioselectivity
The enantioselectivity of SaADH2 was determined by ex-
amining the reduction of acetophenone, the bicyclic ketones
benzyl and 2,2′-dichlorobenzil using an NADH regeneration
system consisting of BsADH and a substrate alcohol (see
below). The reaction mixture contained 2 mM NAD+, 5 mM
carbonyl compound, 4 to 18 %v/v alcohol, 250 μg SaADH2
and 50 μg of BsADH in 1 ml of 100 mM sodium phosphate,
pH 7.0. The reactions were carried out at 50 °C for 24 h in a
temperature-controlled water bath. Upon termination of the
reaction, the reaction mixture was extracted twice with ethyl
acetate. The percentage of conversion and enantiomeric
purity of the product were determined on the basis of the
peak areas of ketone substrates and alcohol products by
HPLC, on a Chiralcel OD-H column (Daicel Chemical
Industries, Ltd., Osaka, Japan). The absolute configuration
of product alcohols was identified by comparing the chiral
HPLC data with the standard samples. Products were ana-
lyzed with isocratic elution, under the following conditions:
hexane/2-propanol (9:1) (mobile phase), flow rate of
1 ml min−1, detection at 210 nm. Retention times were the
following: 5.6, 11.9 and 16.7 for benzil, (S)- and (R)-ben-
zoin, respectively; 6.98, 12.73 and 15.13, for 2,2′-dichlor-
obenzil , (S)- and (R)-1,2-bis(2-chlorophenyl)-2-
hydroxyethanone, respectively and 5.27, 6.2 and 7.5 for
acetophenone, (R)- and (S)-1-phenylethanol, respectively.
The absolute stereochemistry of 1,2-bis(2-chlorophenyl)-2-
hydroxyethanone enantiomers was assigned by analogy to
the values of (S)- and (R)-benzoin.
Structural characterization
The purified protein was concentrated to 8–10 mg ml−1 in
20 mM Tris/HCl buffer at pH 8.4. The protein solution was
added with NADH to obtain a 8.5-mg ml−1 protein solution
containing 2.2 mM NADH in the above buffer. Crystalliza-
tion was performed by hanging-drop vapour diffusion meth-
od at 296 K. The best crystals were grown by mixing 1 μl of
protein solution with the same volume of a solution con-
taining 2.0 M ammonium sulphate in 0.1 M HEPES buffer
(pH 7.5). The crystals belong to P21 space group with unit
cell parameters a083.80 Å, b060.48 Å, c0107.1 Å and β0
99.8°. Crystals were transferred to a stabilizing solution
containing 20 % glycerol as cryoprotectant and X-ray data
were then collected in-house at 100 K using a Rigaku
Micromax 007 HF generator producing Cu Kα radiation
and equipped with a Saturn944 CCD detector. Intensity data
up to 1.75 Å resolution were processed and scaled using
program HKL2000 (HKL Research). Data collection statis-
tics are shown in Table 1.
The crystal structure was solved by MR methods by
using as a search model the coordinates of a putative
glucose/ribitol dehydrogenase from Clostridium thermo-
cellum (PDB code 2HQ1), which showed the best se-
quence alignment with SaADH2 (39 % sequence
identity). Model building was first performed with ARP/
WARP package using the warpNtrace automated proce-
dure. Later model building and refinement was performed
by the program CNS version 1.1. The final structure
shows R and R-free factors of 16.8 and 19.1 %, respec-
tively. Refinement statistics are summarized in Table 1.
Fold similarities searches were performed with the DALI
server (http://ekhidna.biocenter.helsinki.fi/dali_server).
Results
Expression and protein purification
Analysis of the S. acidocaldarius genome (Chen et al. 2005)
for genes encoding short-chain ADHs resulted in identifica-
tion of a putative oxidoreductase gene. The sequence of the
27,024-Da protein, named SaADH2, showed the highest
level of identity to four typical SDRs, LB-RADH (29 %
identity), LSADH (34 %), TtADH (35 %) and SaADH
(30 %; Fig. 1). The saadh2 gene was successfully expressed
in E. coli cells, yielding an active enzyme accounting for
Table 1 Data collection and refinement statistics
Data collection
Space group P21
Cell dimensions (Å;°) a083.80, b060.48,
c0107.1; β099.78
Resolution range (Å) 40.0–1.75 (1.81–1.75)
No. of unique reflections 106,431 (10,388)
Average redundancy 4.2 (2.8)
Completeness 99.7 (98.0)
<I/σ(I)> 19.8 (3.6)
Rmerge 0.065 (0.36)
Refinement
No. of reflections used (with |F| > 0) 101,786
No. of reflections working/test set 96,639/5,147
Resolution range (Å) 40.0–1.75
R-factor/R-free (%) 16.8/19.1
No. of protein atoms 7,512
No. of water/glycerol/sulphate/NADH 687/5/1/4
RMS deviation on bond distances (Å) 0.007
RMS deviation on bond angles (°) 1.4
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about 9 % of the total protein content of the cell extract
(Supplementary material Table S1). Host protein precipita-
tion at 70 °C was found to be the most effective purification
step. An overall purification of 5.4-fold was achieved from
crude-cell-free extracts with an overall yield of 48 %. SDS-
PAGE of the purified protein showed a single band
corresponding to a molecular mass of ∼29 kDa (data not
shown).
The quaternary structure of the enzyme was investigated
by sucrose density gradient centrifugation. SaADH2 sedi-
mented as one peak nearly overlapping that of TtADH
(Supplementary Material Fig. S1). The plot of molecular
mass of the markers vs fraction number (inset Fig. S1)
allowed to determine an apparent molecular mass of 109±
10 kDa for SaADH2. The molecular mass of the subunit
determined by ESI-MS analysis proved to be 27,024.0 Da
(average mass), in agreement with the theoretical value of
the sequence.
Optimal pH
The pH dependence of SaADH2 in the reduction and oxi-
dation reaction was analysed (Fig. S2). The SaADH2 activ-
ity was found to be closely dependent on pH in the reduction
reaction, displaying a peak of maximum activity at around
pH 5.0. The oxidation reaction showed a less marked de-
pendence on pH, displaying a peak with a maximum at
around pH 10.0.
Thermophilicity and thermal stability
The effect of temperature on SaADH2 activity is shown in
Fig. 2. The reaction rate increases up to 78 °C and then
decreases rapidly due to thermal inactivation. This optimal
temperature value is similar to that of TtADH (73 °C) and
SaADH (75 °C) (Pennacchio et al. 2008, 2010a, b), and
lower than that of P. furiosus aldo-keto reductase (100 °C)
(Machielsen et al. 2006). The thermal stability of SaADH2
was determined by measuring the residual enzymatic activ-
ity after 30 min of incubation over a temperature range from
25 to 95 °C (Fig. 2). SaADH2 was shown to be quite stable
up to a temperature of ∼75 °C, above which its activity
decreased abruptly, resulting in a T1/2 value (the temperature
of 50 % inactivation) of ∼88 °C.
Coenzyme and substrate specificity
The enzyme showed no activity with NADP(H) and full
activity with NAD(H).
The specificity of SaADH2 for various alcohols, aldehydes
and ketones was examined (Table 2). The enzyme showed a
poor activity on a discrete number of aliphatic linear and
branched alcohols, such as 2-propyn-1-ol, 4-methyl-1-
pentanol, the S enantiomers of 2-butanol and 2-pentanol as
well as on aliphatic cyclic and bicyclic alcohols, except for
isoborneol and cycloheptanol which rank first and second,
respectively, among the tested alcohols. Benzyl alcohol and
substituted benzyl alcohols were found to be poor substrates.
Among the aromatic secondary alcohols tested SaADH2
showed a low activity on (S)-1-phenylethanol and no activity
with the R enantiomer, whereas displayed similar poor activ-
ities towards the (S)- and (R)- forms of α-(trifluoromethyl)-
benzyl alcohol, 1-(2-naphthyl)ethanol and methyl and ethyl
mandelates. Moreover, the enzyme showed poor activity on
(±)-1-phenyl-1-propanol and its ortho-chloro derivative, and
para-halogenated 1-phenylethanols. However, SaADH2
showed a relatively high activity with 1-indanol and α-
tetralol, but a poor activity on the β-hydroxy ester ethyl (R)-
4-chloro-3-hydroxybutyrate.
The enzyme was not active on aliphatic and aromatic
aldehydes, and on aliphatic linear, and branched ketones
(data not shown). However, it was active on aliphatic
cyclic and bicyclic ketones such as cyclohexanone,
methyl-substituted cyclohexanones and decalone (Table 2).
Two aryl diketones, 1-phenyl-1,2-propanedione and benzil
were good substrates of SaADH2 which also showed a
relatively high reduction rate with 2,2-dichloro- and
2,2,2-trifluoroacetophenone and penta-substituted fluoro-
acetophenone (Table 2). The electronic factor accounts
for the relatively high activity measured with the
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Fig. 2 Effect of temperature on activity and stability of SaADH2
monitored by dehydrogenase activity. The assays at the increasing
temperature values (triangles) were carried out as described in Materi-
als and methods, using cycloheptanol as the substrate. The thermal
stability (circles) was studied by incubating 0.2 mg ml−1 protein sam-
ples in 50 mM Tris–HCl, pH 9.0 for 30 min at the indicated temper-
atures. Activity measurements were carried out under the conditions of
the standard assay using cycloheptanol as the substrate. The assay
temperature was 65 °C. The percentage of residual activity was
obtained by the ratio to the activity without heating
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halogenated acetophenones, as compared to the apparent
zero activity observed with acetophenone. The electron
withdrawing character of fluorine (or chlorine) favours
hydride transfer, inductively decreasing electron density
at the acceptor carbon C1. On the other hand, the
corresponding ketones of cycloheptanol and isoborneol,
cycloheptanone and camphor did not show any apparent
activity due to the deactivating effect exerted by the
Table 2 Substrate specificity of SaADH2 in the oxidation and reduction reactionsa
Substrate Relative activity (%)b Substrate Relative activity (%)b
Alcohols
2-Propyn-1-ol 5 1-(2-Chlorophenyl)-1-propanolc 2
4-Methyl-1-pentanol 2 (±)-1-Indanold 26
(S)-2-Butanol 3 (±)-α-Tetralolc 51
(R)-2-Butanol 0 (±)-1-(2-Naphthyl)ethanol 2
2,3-Butanediol 2 (S)-1-(2-Naphthyl)ethanol 3
(±)-2-Pentanol 2 (R)-1-(2-Naphthyl)ethanol 2
(S)-2-Pentanol 7 Benzoin 0
(R)-2-Pentanol 0 trans-1,3-Diphenyl-2-propen-1-ol 5
3-Pentanol 1 Ethyl (R)-4-chloro-3-hydroxybutyrate 2
2-Hexanolc 2 Methyl (S)-(−)-mandelate 4
2-Heptanolc 2 Methyl (R)-(+)-mandelate 3
6-Methyl-5-hepten-2-olc 3 Ethyl (S)-(−)-mandelate 2
1-Octanol 1 Ethyl (R)-(+)-mandelate 2
Geraniol 2 Ketonesc
Cyclopentanol 2 Cyclohexanone 13
Cyclohexanol 6 2-Methylcyclohexanone 33
3-Methylcyclohexanolc 10 3-Methylcyclohexanone 60
Cycloheptanol 55 4-Methylcyclohexanone 41
Cyclohexylmethanolc 2 Cycloheptanone 0
2-Cyclohexylethanol 1 1-Decalone 85
Chrysanthemyl alcohol 1 (±)-Camphor 0
cis-Decahydro-1-naphthol 3 Acetophenone 0
Isoborneol 100 2,2-Dichloroacetophenone 30
Benzyl alcohol 7 2,2,2-Trifluoroacetophenone 35
2-Methoxybenzyl alcohol 5 2′,3′,4′,5′,6′-Pentafluoroacetophenone 45
3-Methoxybenzyl alcohol 6 1-Phenyl-1,2-propanedione 100
4-Methoxybenzyl alcohol 3 1-Indanoned 0
4-Bromobenzyl alcoholc 9 α-Tetralone 0
(R,S)-1-Phenylethanolc 2 Benzil 62
(S)-(−)-1-Phenylethanol 6 2,2′-Dichlorobenzil 0
(R)-(+)-1-Phenylethanol 0 Chalcone 0
(R,S)-α-(Trifluoromethyl)benzyl alcohol 2 Keto estersc
(S)-α-(Trifluoromethyl)benzyl alcohol 2 Ethyl pyruvate 16
(R)-α-(Trifluoromethyl)benzyl alcohol 2 Ethyl 3-methyl-2-oxobutyrate 100
1-(4-Fluorophenyl)ethanolc 5 Ethyl 4-chloroacetoacetate 0
1-(4-Chlorophenyl)ethanolc 2 Methyl benzoylformate 8
(±)-1-Phenyl-1-propanolc 2 Methyl o-chlorobenzoylformate 5
trans-Cinnamyl alcoholc 2 Ethyl benzoylformate 23
a The activity was measured at 65 °C as described in Materials and methods. The concentration of each substrate was 5 mM
bThe percent values refer to cycloheptanol for alcohols, benzil for ketones and to ethyl 3-methyl-2-oxobutyrate for keto esters
c The substrates were dissolved in 100 % 2-propanol
d The substrate was dissolved in 100 % acetonitrile
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electron donating alkyl groups on the acceptor carbon
C1. SaADH2 was also active on aliphatic and aryl α-
keto esters but not on β-ketoesters (Table 2).
Kinetic studies
The kinetic parameters of SaADH2 determined for the most
active substrates are shown in Table 3. Based on the specificity
constant (kcat/Km), isoborneol is the best substrate in the oxi-
dation reaction; compared to the alicyclic cycloheptanol and
aromatic bicyclic alcohols, it displays a higher affinity to the
active site probably due to its alicyclic bridged structure.
However, the enzyme shows a 6-fold greater preference for
(S)- than (R)-1-indanol and a 23-fold greater preference for (S)-
than (R)-α-tetralol. In the reduction reaction, 2,2-dichloroace-
tophenone was preferred 22-fold more than 2,2,2-trifluoroace-
tophenone and 2′,3′,4′,5′,6′-pentafluoroacetophenone, and 1.6-
and 6-fold more than the two diketones, benzil and 1-phenyl-
1,2-propanedione, respectively, due to its higher affinity. Ethyl
3-methyl-2-oxobutyrate shows the highest turnover among the
carbonyl compound tested, although it binds to the catalytic
site with relatively low affinity. Moreover, the specificity con-
stant value is 6-fold higher for NADH than NAD+.
Effects of various compounds
The effects of salts, ions and reagents on SaADH2 activity were
studied by adding each compound to the standard assay mix-
ture. The enzyme activity in the presence of 1 mM of the Li+,
Na+, K+, Ca++, Mg++ and Mn++ chlorides was 115, 113, 102,
101, 101 and 110 %, respectively, and in the presence of 1 mM
of the sulphate of heavy metal ions such as Fe++, Co++, Ni++,
Cu++ and Zn++ was 93, 108, 104, 102 and 107 %, correspond-
ingly, when compared to the enzyme activity measured in the
absence of additional metal ions. The presence of 5 % ionic
liquid (BMIMBF4) inactivated by 50 % the enzyme presum-
ably due to a competition of the BF4
− ion with the coenzyme
phosphate moiety for the anion-binding site of the enzyme.
The addition of 4 mM iodoacetate and 1 mM Hg++ had no
significant influence on the enzyme activity, which resulted in
101 and 113 % of the control activity, respectively, suggesting
that the only Cys residue per monomer, C90, has no functional
role. Even the metal-chelating agents did not affect enzyme
activity. The enzyme activity in the presence of either 1 mM o-
phenanthroline, or 10 mM EDTA was 98 and 87 %, respec-
tively, suggesting that either the protein does not require
metals for its activity or the chelating molecule was not able
to remove the metal under the assay conditions. Furthermore,
the enzyme showed no loss in activity following exhaustive
dialysis against EDTA. The EDTA-dialysed enzyme turned
out to be quite stable at 70 °C for 5 h, both in the absence and
the presence of EDTA (data not shown).
Stability in organic solvents
The effects of common organic solvents, such as acetonitrile,
DMSO, 1,4-dioxane and ethyl acetate on SaADH2 were in-
vestigated at 50 °C, at two different time points and 18 %
concentration (Fig. 3). SaADH2 activated after 6 and 24 h
incubation in aqueous buffer (120 and 105 % the initial values,
respectively), and inactivated by 15 and 30% in the presence of
18 % acetonitrile following incubation for 6 and 24 h,
Table 3 Steady-state kinetic
constants of SaADH2
The activity was measured at
65 °C as described in Materials
and methods. Kinetic constants
for NAD+ and NADH were de-
termined with 15 mM isoborneol
and 30 mM ethyl 3-methyl-2-
oxobutyrate, respectively
Substrate kcat (s
−1) Km (mM) kcat/Km (s
−1 mM−1)
Cyclohepthanol 7.0 5.1 1.37
Isoborneol 16.6 0.81 20.5
(±)-1-Indanol 6.2 8.7 0.71
(R)-Indanol 2.7 15.3 0.18
(S)-Indanol 10.6 10.0 1.06
α-Tetralol 9.6 8.5 1.13
(R)-α-Tetralol 1.15 9.2 0.13
(S)-α-Tetralol 6.0 2.0 3.0
NAD+ 19.3 0.18 107
Benzil 1.6 0.43 3.72
1-Phenyl-1,2-propanedione 5.3 5.0 1.06
2,2-Dichloroacetophenone 0.65 0.11 5.91
2,2,2-Trifluoroacetophenone 1.7 6.3 0.27
2′,3′,4′,5′,6′-Pentafluoroacetophenone 3.2 11.9 0.27
Ethyl 3-methyl-2-oxobutyrate 26 16.6 1.57
Ethyl benzoylformate 1.9 4.2 0.45
NADH 26.2 0.04 655
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respectively. A slightly reduced activity (∼95%) remained after
6 and 24 h incubation in aqueous solution containing 18 %
ethyl acetate. Interestingly, significant increases in enzyme
activity occurred after 6 h incubation in the presence of 18 %
DMSO (>140%) and 1,4-dioxane (135 %). After 24 h incuba-
tion in the presence of these two solvents, the enzyme activity
remained nearly unchanged with respect to the initial value.
Enantioselectivity
The enantioselectivity of SaADH2 was tested on benzil using
an NADH recycling system consisting of thermophilic NAD
(H)-dependent BsADH (Fig. 4). The latter enzyme is mainly
active on aliphatic and aromatic primary and secondary alco-
hols and aldehydes (Guagliardi et al. 1996), but not on ali-
phatic and aromatic ketones, nor on the carbonyl substrates of
SaADH2 and corresponding alcohols (data not shown). Since
2-propanol is not a substrate of SaADH2, it may be a suitable
substrate for BsADH in NADH recycling, as well as being
used as a co-solvent. Bioconversions were carried out for 24 h
using 5 mM benzil as substrate and 2-propanol at three dif-
ferent concentrations. Sodium phosphate buffer, pH 7.0 and
50 °C was chosen as a compromise between cofactor stability
and catalytic activity of the two ADHs at suboptimal pH
(Pennacchio et al. 2008, 2011). Chiral HPLC analysis of the
extracts obtained from the bioconversions showed that benzil
was reduced by the archaeal enzyme to the (R)-enantiomer of
benzoin with a level of conversion of 35, 100 and 99% and an
enantiomeric excess (ee) of 85, 82 and 80 % using 4, 14 and
18 % (v/v) 2-propanol as ancillary substrate, respectively.
In addition to 2-propanol (kcat/Km09 s
−1 mM−1), BsADH
oxidizes other alcohols with even greater efficiency such as
ethanol (kcat/Km064 s
−1 mM−1), 1-propanol (286 s−1 mM−1),
1-butanol (437 s−1 mM−1), 1-pentanol (64 s−1 mM−1) and 1-
hexanol (64 s−1 mM−1; Raia, unpublished data). We therefore
tested these alcohols as alternative hydride source for NADH
recycling and also to improve the solubility of the substrate in
the aqueous phase. Moreover, these alcohols and the respec-
tive aldehydes are not substrates of SaADH2. Thus, only the
cofactor is the co-substrate of SaADH2 and BsADH.
Figure 5 summarizes the results of the bioconversions
carried out using different alcohol substrates at 18 % con-
centrations. As for the case of 2-propanol, benzil was re-
duced to the (R)-alcohol with excellent conversion (>99 %)
but modest enantioselectivity using ethanol and 1-propanol.
However, in the presence of 1-butanol, 1-pentanol and 1-
hexanol excellent optical purity (98–99 % ee) and levels of
conversion decreasing from 98 to 93 % and 66 %, respec-
tively, were obtained. This suggests that ethanol and linear/
branched propanol acted as good substrates and solvents for
the bioconversion system, but negatively affected the pro-
chiral selectivity of SaADH2 that was instead enhanced by
longer chain-linear alcohols (four to six carbons). The de-
crease in conversion rate with 1-pentanol and 1-hexanol
could be due to different effects: (1) substrate excess inhi-
bition, (2) BsADH deactivation and (3) reduced substrate
solubility.
The SaADH2 enantioselectivity was further examined
with other aromatic ketones using the system BsADH/1-
butanol. Table 4 shows that SaADH2 preferably reduced
benzil to (R)-benzoin with an ee of 98 % and 98 %
conversion after 24 h of reaction, and that the selectiv-
ity was reduced when 2-propanol instead of 1-butanol
was used. However, 2,2′-dichlorobenzil was reduced to
(R)-1,2-bis(2-chlorophenyl)-2-hydroxyethanone with
lower conversion (33 %) and ee of 91 %, despite the
apparent inactivity under different assay conditions (Ta-
ble 2). Presumably, the presence of chlorine, a bulky
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Fig. 3 Effects of various solvents on SaADH2. Samples of enzyme
(0.20 mg/ml) were incubated at 50 °C in the absence and presence of
the organic solvents at 18 % concentrations, and the assays were
performed after 6 h (white bars) and 24 h (grey bars). The activity
assays were performed at 50 °C as described in Materials and methods
using cycloheptanol as the substrate. The data obtained in the absence
and presence of organic solvents are expressed as percentage of activ-
ity relative to the value determined prior to incubation
O
O O
NADH NAD+
SaADH2
BsADH
1-ButanolButyraldehyde
OH
Benzil (R)-(_)-Benzoin
Fig. 4 Coenzyme recycling in the production of chiral diaryl alcohol with
SaADH2 utilizing B. stearothermophilus ADH (BsADH) and 1-butanol
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atom with electron-withdrawing properties, disturbs the
fitting of the diketone molecule in the substrate-binding
pocket as well as the interactions that stabilize the
transition state. Acetophenone was reduced to (S)-1-phe-
nylethanol with a 4 % conversion and an ee of 92 %,
while no conversion was observed for camphor, the
ketone corresponding to the highly preferred alcohol
isoborneol (Table 3). Kinetic tests showed that neither
racemic benzoin nor (R)-benzoin was oxidized in the
presence of NAD+ as well as both were not reduced in
the presence of NADH. Accordingly, the HPLC analysis
indicated that no further reduction of benzoin occurred
since no trace of hydrobenzoin could be found within
the detection limits (data not shown).
Structural characterization
The determined crystal structure reveals a tetrameric
organization similar to other members of the short-
chain dehydrogenase/reductase (SDR) family. Although
SaADH2 has low sequence similarities with other SDR
proteins, it shares common structural features with them
(Kallberg et al. 2002; Kavanagh et al 2008). The overall
structure is typical of SDRs that is an α/β fold with
characteristic Rossmann-fold motifs for the binding of
the dinucleotide cofactor at the N-terminal region of the
chain. Indeed, the structure confirmed that SaADH2 is a
NAD-dependent enzyme with a cofactor-binding domain
composed of a seven-stranded parallel sheet flanked by
helices on each side.
Overall tertiary and quaternary structure
The structural comparison of SaADH2 with other SDRs
demonstrated that SaADH2 exhibits a high degree of overall
structural homology. Indeed, when aligning the monomeric
structures by the DALI server the first 100 best superimpo-
sitions showed RMS deviations on Cα atoms ranging from
1.5 to 2.5 Å (with a minimum of 222/255 aligned residues).
Some structural neighbours are superimposed onto a single
chain of SaADH2 in Fig. S3. Major conformational differ-
ences are found on the molecular surface and at the terminal
region of the polypeptide chain.
Analysis of the crystal packing (using PISA server:http://
www.ebi.ac.uk/pdbe/prot_int/pistart.html), indicates that the
tetramer is the biologically active form. The tetramer
shows 222 point group symmetry and approximate
dimensions of 80×70×55 Å (Fig. S4). The largest di-
meric interface is the one involving AB or CD assem-
blies (∼1,630 Å2). The central elements in this interface
are the long α6 helices (residues 156–179, Fig. S5)
facing each other from adjacent subunits. Other seg-
ments involved in this interface are α4 and α5 helices
(Fig. S5). The second large interface involving AC or
BD assemblies (∼1,250 Å2) mainly comprises the C-
terminal regions (residues 216–255) of the two subunits.
The very terminal segment (residue 253–255) also
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Fig. 5 Reduction of benzil catalyzed by SaADH2. Biotransformations
were carried out at 50 °C with different alcohols at 18 % (v/v) concen-
trations. The reactions were stopped after 24 h by addition of ethyl
acetate. The dried extracts were analysed by chiral HPLC to determine
the relative conversion (RC, grey bars) and the enantiomeric excess (ee,
dark grey bars). Error limit, 2 % of the stated values. The alcohols are
plotted according to increasing log P (P0partition coefficient) values;
from left to right: log P0−0.24, 0.07, 0.28, 0.8, 1.3 and 1.8. Log P values
were from Laane et al. (1987)
Table 4 Asymmetric reduction of carbonyl compounds by SaADH2
Substrate Product Conversion (%) ee (%) R/S
Benzil Benzoin 98 (99) 98 (80) R
2,2′-Dichlorobenzil 1,2-Bis(2-chlorophenyl)-2-hydroxyethanone 33 91 R
Acetophenone 1-Phenylethanol 4 92 S
Reactions were performed at 50 °C for 24 h as described in Materials and methods, using 18 % 1-butanol as ancillary substrate. Conversion and
enantiomeric excess were determined by chiral HPLC analysis. Configuration of product alcohol was determined by comparing the retention time with
that of standard samples as described in Material and methods. Values in parentheses refer to data obtained with 18 % 2-propanol as ancillary substrate
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contributes to the smallest interface involving AD or
BC assemblies (∼445 Å2); indeed, this segment forms
inter-subunit interactions with residues belonging to
150–153 segment. It is worth noting that residues from
the 209–218 region of the structure also mediate inter-
subunit interactions in this interface.
Cofactor-binding site
A highly defined electron density was observed for the
whole NAD(H) molecule thus allowing unambiguous iden-
tification of the positions of the cofactor in all the four
molecules of the asymmetric unit (Fig. S6). The cofactor-
binding site is located at the C-terminal end of the central
parallel β-sheet.
The NAD(H) cofactor specificity is explained by the
presence of Glu39 whose side chain oxygen atoms form
hydrogen bonds with two oxygen atoms of the adenosine
ribose of NAD(H).
The adenine ring of NAD binds in a hydrophobic pocket
on the enzyme surface formed by the side chains of Val116,
Leu40, Val66, Ala93 and Gly15. Hydrogen bonds are
formed by N6 of adenine and the Asp65 side chain and by
N1 and the peptide nitrogen of Val66. The segment 14-
TGAGSGIG-21 corresponds to the glycine-rich sequence
(TGxxx[AG]xG) present in NAD-binding site of “classical”
SDR (Kavanagh et al 2008). This region interacts with the
adenine ribose and the diphosphate moiety of NAD(H). The
phosphate groups also interact with Thr193-Ala194. The 2′-
and 3′-hydroxyls of the second ribose, attached to the nico-
tinamide ring, form a bifurcated hydrogen bond with
Lys162. The 3′-hydroxyl is also hydrogen bonded to the
active site Tyr158. The syn face of the nicotinamide ring
displays vdW contacts with the hydrophobic side-chains of
Ile20, Pro188 and Val191. The amide part of the nicotin-
amide portion is anchored to the protein by hydrogen bonds
to Thr193 and Val191.
Substrate-binding site
The SaADH2 contains the conserved catalytic residues,
Ser145, Tyr158 and Lys162, located in the active-site cleft
with a spatial arrangement that is common to that found in
other SDRs. SaADH2 also shows the conserved Asn residue
(Asn117) which has been suggested as a key residue in a
catalytic mechanism based on a tetrad instead of a triad
(Filling et al. 2002). Its side chain atoms form hydrogen
bonds with main chain atoms of Ile95.
In many SDRs the substrate-binding site is a deep cleft
with a floor created by the NADH molecule and the right-
side and left-side walls formed by the substrate-binding
region (residues 193-221 in SaADH2 numbering) and the
loop between β5 and β6 strands (Fig. 6).
In three out of four subunits of the asymmetric unit there
is a glycerol molecule occupying the position that is approx-
imately suited for the binding of substrate. Indeed, the
glycerol O2 and O3 oxygen atoms are hydrogen bonded to
the oxygen of the NAD carboxamide and to the oxygen of
Tyr158 side chain, respectively. Glycerol was used as cryo-
protectant agent and therefore diffused through the water
channels of the crystals up to the binding site. The lacking of
glycerol binding in one of the subunits (chain B) of the
tetramer is due to crystal packing which restricts the access
to NADH in subunit B. Indeed, a nearby symmetric mole-
cule (#B) inserts its 50–57 region into the substrate-binding
region (residues 193–221) that covers the access to the
NADH site. On the other hand, the other subunits of the
tetramer do not show direct interactions with adjacent sym-
metric molecules through the substrate-binding loop.
It is worth noting that, despite the different crystal envi-
ronments experienced by the four molecules of the asym-
metric unit, the substrate-binding loops adopt similar
conformations in the four subunits of the tetramer with
pairwise RMSDs calculated on Cα atoms lying in the range
0.36–0.68 Å.
Fig. 6 Overall tertiary structure of one of the subunits of SaADH2.
Bound NADH is shown in stick representation (magenta). The
substrate-binding loop, the stretches 152–155 and 96–101 are high-
lighted in blue, yellow and red, respectively. The arrows point toward
the substrate-binding cleft; the directions of approach are shown in
magenta and black (see the text for details)
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Furthermore, the structure of the loop (in blue in Fig. 6)
represents the most significant difference between SaADH2
and the other SDR structures aligned with it. Indeed, as can
be seen in Fig. S3, this loop (in cyan) is remarkably different
from the other structures. In most of SDR structures the
substrate-binding loop contains two segments of α-helix
on opposite sides of the loop. In addition, part of the loop
is often disordered thus revealing a considerable mobility. In
SaADH2 the loop shows the following features: (1) it is well
defined in the electron density; (2) it contains only one
stretch of α-helix lacking the one usually present at the C-
terminal end and (3) it partially obstructs the access to the
substrate-binding cleft indicated with a magenta arrow in
Fig. 6. Indeed, a detailed comparison with other SDR
aligned structures reveals that three stretches (193–221,
96–101 and 152–155) of SaADH2 structure adopt a differ-
ent conformation by getting closer to the NADH nicotin-
amide ring which becomes inaccessible to solvent/substrate
from the top of the molecule (magenta arrow in Fig. 6). The
cofactor ring is, however, still accessible to ligands through
a side cavity (black arrow in Fig. 6) lined by residues
Met96, Ser145, Ile146, Ala147, Phe153, Ala154, Tyr158,
Gly189, Thr190, Ile195, Gly196, Leu197, Leu210 and
Met214 (Fig. S7). The mouth of the cavity is composed of
atoms from residues 190, 195–197, 210 and 214, as con-
firmed by CastP server (http://sts.bioengr.uic.edu/castp/
calculation.php).
The benzil molecule is an interesting substrate of the
enzyme that reduces it to R-benzoin in the presence of
NADH with excellent conversion (>99 %). Several attempts
were performed to crystallize a ternary complex of the
enzyme bound to a benzil molecule, but they were unsuc-
cessful. To envision how the enzyme binds the substrate and
to probe the stereoselectivity of the hydride transfer we have
manually modelled the benzil molecule in the active site.
The starting structure for the alpha-diketone modelling
was the crystal structure present in the small molecule
structure database (Allen 2002). This structure shows a
conformation of the molecule with the two aromatic rings
forming a dihedral angle of 114° around the diketo bond. A
single benzil carbonyl group is bonded to two substituents: a
smaller phenyl group and a larger carbophenyl group. In
order to obtain a (R)-alcohol, the hydride has to be added to
the Si face of the carbonyl ketone and this means that the
smaller group is located opposite to the bulky carboxamide
group of NADH.
A rigid docking of the benzil compound performed by
the patchdock server identifies an orientation in the substrate
site which is consistent with the stereoselectivity of the
reduction reaction leading to (R)-benzoin. However, it has
to be noted that in the best docked conformational ensemble
of benzil, the carbonyl C atom, to be attacked by hydride, is
still rather far from the hydrogen at the NADH C4 position
(>5.5 Å). In addition, the oxygen atom of the carbonyl is not
hydrogen bonded to the catalytic Tyr158 side chain (4.7 Å
apart) as expected in case of a fully productive state of the
enzyme–substrate complex.
Due to the steric hindrance of the benzil molecule an
efficient accommodation in the substrate site would require
a structural rearrangement of residues from the three seg-
ments (193–221, 96–101, and 152–155) which line the site
and/or a change in the conformation of the diketone. A
better packing of benzil in the site can be indeed obtained
when the torsional angle around the carbon–carbon bond
linking the two carbonyl moieties is reduced to values
around 80–90°. Although approximate, this manually
docked substrate position identifies a small pocket deep into
the active site (Fig. 7) which is lined by Ser145, Leu146,
Ala147, Tyr158, Phe153, Ala154 and Gly189. This pocket
can accommodate the small phenyl group of benzil. Indeed,
this phenyl ring would display mostly favourable contacts
with Phe153, Ile146 and Ala147; the phenyl ring lies with
its ring between two main-chain oxygen atoms from resi-
dues Phe153 and Glu189. On the other hand, the large
carbophenyl group of benzil would point toward the channel
opened to the solvent and lined by Met96, Thr190, Ile195,
Gly196, Leu197, Leu210 and Met214. However, this bulky
carbophenyl group would display steric clashes with the
NADH and Thr190 when the intercarbonyl dihedral angle
is about 80°. Some bad contacts can be relieved by a
deviation of the phenyl group from the plane defined by
the carbonyl moiety as well as by small rearrangements of
the carboxyamide group of the nicotinamide ring (Fig. 7).
Conformational rearrangements with respect to the crys-
tal structure of benzil can be accessible at a reasonable
energetic cost since both experimental and theoretical stud-
ies have indicated a significant flexibility of the molecular
structure even depending on the environmental conditions
(Pawelka et al. 2001; Lopes et al. 2004).
The presence of the deep pocket in the active site, well
suited for an aromatic ring, also explains why, in the case of
acetophenone and its derivatives, the alcohol obtained by
the reduction reaction is the (S)-enantiomer.
Discussion
In search of novel dehydrogenase/reductases that are both
stable and NAD+ dependent, a short-chain dehydrogenase
(SDR) from S. acidocaldarius was identified and overex-
pressed. The enzyme was successfully purified and func-
tionally/structurally characterized.
The enzyme is endowed with a high thermal stability
showing a T1/2 value of ∼88 °C. It is rather stable in
common organic solvents also exhibiting an increased ac-
tivity in presence of DMSO and 1,4-dioxane. The activation
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of thermophilic enzymes by loosening of their rigid struc-
ture in the presence of protein perturbants is a well-
documented phenomenon (Fontana et al. 1998; Liang et al.
2004). The two organic solvents discussed above (Fig. 3)
may induce a conformational change in the protein molecule
to a more relaxed and flexible state that is optimal for
activity.
The analysis of the effects of ions reveals that SaADH2
does not require metals for its activity or structural stabili-
zation; this is typical of non-metal SDR enzymes, although
the well-known LB-RADH shows strong Mg++ dependency
(Niefind et al. 2003).
Kinetic data show that SaADH2 is a strictly NAD(H)-
dependent oxidoreductase with discrete substrate specificity.
SaADH2 is more similar to the archaeal thermophilic
TtADH and SaADH (Pennacchio et al. 2008; 2010a, b),
than to the two representative SDR mesophilic ADHs, i.e.
LB-RADH (Schlieben et al. 2005) and LSADH (Inoue et al.
2006), which are active on a variety of aliphatic as well as
aromatic alcohols, ketones, diketones and keto esters. In-
deed, the SaADH2 catalytic activity against various putative
substrates was checked. Poor activity was observed on
aliphatic linear and branched alcohols as well as on most
of cyclic and bicyclic alcohols with the exception of cyclo-
heptanol and isoborneol (Tables 2 and 3). Significant activ-
ity was found on alicyclic alcohols fused to an aromatic ring
such as tetralol and indanol substrates. The kinetic data
show that for most of chiral substrates SaADH2 is (S)-
stereospecific and that the physiological direction of the
catalytic reaction is reduction rather than oxidation (Table 3).
The enzyme was active on aliphatic cyclic and bicyclic
ketones such as cyclohexanone, methyl-substituted cyclo-
hexanones and decalone (Table 2). It also showed a good
reduction rate on halogenated acetophenone derivatives
(Table 2) probably due to the electron withdrawing character
of halogens which favours hydride transfer by decreasing
electron density at the carbonyl carbon.
Interestingly, two aryl diketones, 1-phenyl-1,2-propane-
dione and benzil are good substrates of SaADH2. Although
the natural substrates and function of SaADH2 remain un-
known, the catalyzed reduction of the benzil α-diketone to
(R)-benzoin with high yield and optical purity makes
SaADH2 an interesting and biotechnologically relevant en-
zyme. Bioconversion studies have shown that SaADH2 can
be conveniently coupled with a thermophilic bacillar ADH
(BsADH) resulting in an efficient regeneration of NADH.
Moreover, it is noteworthy that the SaADH2 enantioselec-
tivity changes from moderate to excellent on going from
ethanol to 1-hexanol (Fig. 5), i.e. that enantioselectivity
increases as the hydrophobicity of the medium increases.
The finely tuned solvent dependence of the prochiral selec-
tivity shown by SaADH2 is remarkable and agrees with the
general observation that enzyme selectivity (enantiomeric,
prochiral and regiomeric) can change, or even reverse, from
one solvent to another (Carrea and Riva 2000; Klibanov
2001). Overall, the solvent enantioselectivity study empha-
sizes the versatility and high efficiency of the BsADH/
alcohol substrate system in recycling the reduced cofactor.
α-Hydroxy ketones are highly valuable building blocks
for many applications for the fine chemistry sector as well as
pharmaceuticals (Hoyos et al. 2010). It is noteworthy that
optically pure (R)-benzoin is useful as urease inhibitor
(Tanaka et al. 2004), and to prepare amino alcohols used
as important chiral synthons (Aoyagi et al. 2000), or to
synthesize different heterocycles (Wildemann et al. 2003).
Many examples of stereoselective reduction of several ben-
zils to the corresponding benzoins using whole microbial
cells have been recently reviewed (Hoyos et al. 2010). The
microorganisms Bacillus cereus, Pichia glucozyma, Asper-
gillus oryzae, Fusarium roseum, Rhizopus oryzae (at
pH 4.5–5.0) and B. cereus Tm-r01 were reported to give
(S)-benzoin while the microorganisms R. oryzae (at pH 6.8–
8.5) and Xanthomonas oryzae were reported to transform
benzil to (R)-benzoin with different yields and optical purity
Fig. 7 Surface representation
of a single chain of SaADH2.
The NADH molecule is
highlighted in magenta, as both
stick and surface
representations. The black
arrow indicates the channel by
which the nicotinamide ring is
accessible. The green box is a
close-up view of the binding
site with the benzil molecule (in
orange) manually docked into
it. The figure was prepared us-
ing the PyMOL software
(www.pymol.org)
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(Hoyos et al. 2010 and references therein). However, re-
combinant B. cereus NADPH-dependent benzil reductase
belonging to SDR superfamily which reduces benzil to
97 % optically pure (S)-benzoin in vitro was character-
ized (Maruyama et al. 2002). To our knowledge, this
study represents the first biochemical characterization of
an NAD(H)-dependent archaeal short-chain ADH reduc-
ing the diketone compound benzil to (R)-benzoin with
high yield and optical purity.
The functional characterization of SaADH2 was comple-
mented by the determination of the crystal structure of
SaADH2–NADH complex at 1.75 Å resolution.
The determined crystal structure reveals a tetrameric or-
ganization that corroborates the results obtained by sucrose
density gradient centrifugation. The structural comparison
of SaADH2 with other SDRs demonstrated that SaADH2
exhibits a high degree of overall structural homology de-
spite the low sequence similarities. The largest differences
with other SDR structures are on the surface and at the C-
terminal region of the polypeptide chain which contributes
to the shaping of the active site.
The reductase activity measurements showed that the
protein is not active with NADP(H), having a definite pref-
erence for NAD(H) cofactor. This cofactor specificity is
consistent with structural results. Indeed, the side chain
oxygen atoms of Glu39 form hydrogen bonds with two
oxygen atoms of the adenosine ribose of NAD(H), thus
hampering the binding of NADP(H). Therefore, the Glu
residue plays the same role of the corresponding Asp resi-
due found in many SDR structures.
The active site of SaADH2 structure contains the con-
served catalytic residues, Ser145, Tyr158 and Lys162,
which adopt position and orientation similar to those found
in other SDRs (Schlieben et al. 2005). Besides the catalytic
triad, also Asn117 is structurally conserved; this residue has
been suggested to play a role in maintaining the active-site
architecture and the building up of a proton-relay system in
SDR structures (Filling et al. 2002; Schlieben et al. 2005).
A comparison with other structures of the SDR super-
family reveals that the substrate-binding loop (residues 193–
221) is the most different region of the subunit structure
(Fig. S3). This is not unexpected since the conformation, the
length and the composition of the substrate-binding loop are
rather variable in SDR proteins thus conferring different
substrate specificity. Besides this loop, also the segment
152–155 shows a different conformation by getting closer
to the NADH nicotinamide ring (Fig. 6). Interestingly, this
region contains a Phe residue (Phe153) which points deep
into the active site and can play a relevant role for substrate
specificity. The region 96–101 is also closer to the nicotin-
amide ring thus contributing to the reduced accessibility of
the site where hydride transfer has to occur (Fig. 6). As a
consequence, the manual modelling of the bulky benzil
molecule in the active site, guided by the position of glyc-
erol molecule bound and by preliminary results of rigid
docking, cannot avoid the presence of unfavourable con-
tacts. However, it can be suggested that minor changes in
the three segments of the protein structure discussed above
as well as in the conformation of the benzil α-diketone may
well accommodate this substrate in the site (Fig. 7).
The elucidation of the ternary complex structure will
ultimately provide details of the conformational changes in
both the enzyme and the substrate necessary to obtain a fully
productive state which guarantees high enantioselectivity.
Nonetheless, the modelling explains the enantioselectivity
of the benzil reduction. The (R)-benzoin is obtained since
the hydride transfer occurs on the Si-face of the carbonyl
ketone attacked. There is a deep pocket in the active site
which can accommodate the small phenyl group of benzil
(Fig. 7). Indeed, this phenyl ring would display mostly
favourable contacts with Phe153, Ile146 and Ala147. On
the other hand, the large carbophenyl group of benzil would
point toward the channel opened to the solvent (Fig. 7) and
lined with hydrophobic residues (Fig. S7).
Furthermore, the modelling of benzil provides clues on the
different stereoselective course of the reduction reaction for
other substrates such as acetophenone and its derivatives.
Indeed, the deep pocket in the active site, well suited for an
aromatic ring, can efficiently accommodate the phenyl group
of the acetophenone whereas the methyl group can point
toward the channel; this orientation of the substrate in the site
leads to the (S)-1-phenylethanol product (Table 4).
In conclusion, a new short-chain dehydrogenase from S.
acidocaldarius was identified and overexpressed. The puri-
fied enzyme was shown to possess remarkable thermal
resistance as well as high enantioselectivity on the aryl
diketone benzil molecule. It shows many advantages with
regard to its preparative application: ease of purification,
preservability of the biocatalyst and absolute preference
for NAD(H). It is also amenable for coupling with a ther-
mophilic bacillar ADH (BsADH) in an efficient and sustain-
able bioconversion process based on coenzyme recycling,
where both enzymes have only the coenzyme as co-
substrate. The remarkable resistance of SaADH2 to organic
solvents proves the sturdiness of this biocatalyst and sug-
gests exploratory investigations on conversions of poorly
water-soluble prochiral substrates. In addition, the availabil-
ity of the crystal structure of the enzyme provides the
opportunity to rationalize the stereospecificity and stereo-
selectivity of the enzyme and to design proper mutations to
broaden the scope of possible substrates.
Acknowledgments This work was funded by FIRB (Fondo per gli
Investimenti della Ricerca di Base) RBNE034XSW and by the ASI
project MoMa n. 1/014/06/0.
Atomic coordinates as well as structure factors have been deposited
within the PDB under the accession code 4FN4.
Appl Microbiol Biotechnol
References
Allen FH (2002) The Cambridge Structural Database: a quarter of a
million crystal structures and rising. Acta Crystallogr B 58:380–
388
Aoyagi Y, Agata N, Shibata N, Horiguchi M, Williams RM (2000)
Lipase TL-mediated kinetic resolution of benzoin: facile synthesis
of (1R,2S)-erythro-2-amino-1,2-diphenylethanol. Tetrahedron
Lett 41:10159–10162
Carrea G, Riva S (2000) Properties and synthetic applications of
enzymes in organic solvents. Angew Chem Int Ed Engl
39:2226–2254
Ceccarelli C, Liang ZX, Strickler M, Prehna G, Goldstein BM,
Klinman JP, Bahnson BJ (2004) Crystal structure and amide
H/D exchange of binary complexes of alcohol dehydrogenase
from Bacillus stearothermophilus: insight into thermostability
and cofactor binding. Biochemistry 43:5266–5277
Chen L, Brügger K, Skovgaard M, Redder P, She Q, Torarinsson E,
Greve B, Awayez M, Zibat A, Klenk HP, Garrett RA (2005) The
genome of Sulfolobus acidocaldarius, a model organism of the
Crenarchaeota. J Bacteriol 187:4992–4999
Filling C, Berndt KD, Benach J, Knapp S, Prozorovski T, Nordling E,
Ladenstein R, Jörnvall H, Oppermann U (2002) Critical residues
for structure and catalysis in short-chain dehydrogenases/reduc-
tases. J Biol Chem 277:25677–25684
Fiorentino G, Cannio R, Rossi M, Bartolucci S (1998) Decreasing the
stability and changing the substrate specificity of the Bacillus
stearothermophilus alcohol dehydrogenase by single amino acid
replacements. Protein Eng 11:925–930
Fontana A, De Filippis V, Polverino de Laureto P, Scaramella E,
Zambonin M (1998) Rigidity of thermophilic enzymes. In: Bal-
lestreros A, Plou FJ, Iborra JL, Halling PJ (eds) Stability and
stabilization in biocatalysis, vol 15. Elsevier Sciences, Amster-
dam, pp 277–294
Friest JA, Maezato Y, Broussy S, Blum P, Berkowitz DB (2010) Use of
a robust dehydrogenase from an archael hyperthermophile in
asymmetric catalysis–dynamic reductive kinetic resolution entry
into (S)-profens. J Am Chem Soc 132:5930–5931
Giordano A, Febbraio F, Russo C, Rossi M, Raia CA (2005) Evidence
for co-operativity in coenzyme binding to tetrameric Sulfolobus
solfataricus alcohol dehydrogenase and its structural basis: fluo-
rescence, kinetic and structural studies of the wild-type enzyme
and non-co-operative N249Y mutant. Biochem J 388:657–667
Goldberg K, Schroer K, Lütz S, Liese A (2007) Biocatalytic ketone
reduction—a powerful tool for the production of chiral alcohols—
part I: processes with isolated enzymes. Appl Microbiol Biotech-
nol 76:237–248
Guagliardi A, Martino M, Iaccarino I, De Rosa M, Rossi M, Bartolucci
S (1996) Purification and characterization of the alcohol dehydro-
genase from a novel strain of Bacillus stearothermophilus grow-
ing at 70 °C. Int J Biochem Cell Biol 28:239–246
Guy JE, Isupov MN, Littlechild JA (2003) The structure of an alcohol
dehydrogenase from the hyperthermophilic archaeon Aeropyrum
pernix. J Mol Biol 331:1041–1051
Hoyos P, Sinisterra JV, Molinari F, Alcántara AR, Domínguez de María
P (2010) Biocatalytic strategies for the asymmetric synthesis of
alpha-hydroxy ketones. Acc Chem Res 43:288–299
Huisman GW, Liang J, Krebber A (2010) Practical chiral alcohol
manufacture using ketoreductases. Curr Opin Chem Biol
14:122–129
Hummel W (1999) Large-scale applications of NAD(P)-dependent
oxidoreductases: recent developments. Trends Biotechnol
17:487–492
Inoue K, Makino Y, Dairi T, Itoh N (2006) Gene cloning and expres-
sion of Leifsonia alcohol dehydrogenase (LSADH) involved in
asymmetric hydrogen–transfer bioreduction to produce (R)-form
chiral alcohols. Biosci Biotechnol Biochem 70:418–426
Jones JB, Beck JF (1976) Applications of biochemical systems in
organic chemistry. In: Jones JB, Sih CJ, Perlman D (eds) Techni-
ques of chemistry series, part I, vol 10. Wiley, New York, pp 248–
401
Jörnvall H (2008) Medium- and short-chain dehydrogenase/reductase
gene and protein families: MDR and SDR gene and protein
superfamilies. Cell Mol Life Sci 65:3873–3878
Kallberg Y, Oppermann U, Jörnvall H, Persson B (2002) Short-chain
dehydrogenases/reductases (SDRs). Eur J Biochem 269:4409–
4417
Kavanagh KL, Jörnvall H, Persson B, Oppermann U (2008) The SDR
superfamily: functional and structural diversity within a family of
metabolic and regulatory enzymes. Cell Mol Life Sci 65:3895–
3906
Keinan E, Hafeli EK, Seth KK, Lamed R (1986) Thermostable
enzymes in organic synthesis. 2. Asymmetric reduction of ketones
with alcohol dehydrogenase from Thermoanaerobium brockii. J
Am Chem Soc 108:162–169
Klibanov AM (2001) Improving enzymes by using them in organic
solvents. Nature 409(6817):241–246
Korkhin Y, Kalb(Gilboa) AJ, Peretz M, Bogin O, Burstein Y, Frolow F
(1998) NADP-dependent bacterial alcohol dehydrogenases: crys-
tal structure, cofactor-binding and cofactor specificity of the
ADHs of Clostridium beijerinckii and Thermoanaerobacter
brockii. J Mol Biol 278:967–981
Kroutil W, Mang H, Edegger K, Faber K (2004) Recent advances in
the biocatalytic reduction of ketones and oxidation of sec-
alcohols. Curr Opin Chem Biol 8:120–126
Laane C, Boeren S, Hilhorst R, Veeger C (1987) Optimization of
biocatalysis in organic media. In: Laane C, Tramper J, Lilly MD
(eds) Biocatalysis in organic media, vol 29. Elsevier, Amsterdam,
pp 65–84
Laemmli UK (1970) Cleavage of structural proteins during the assem-
bly of the head of bacteriophage T4. Nature 227:680–685
Leatherbarrow RJ (2004) GraFit version 5.0.11. Erithacus Software
Ltd, Horley
Liang ZX, Lee T, Resing KA, Ahn NG, Klinman JP (2004) Thermal-
activated protein mobility and its correlation with catalysis in
thermophilic alcohol dehydrogenase. Proc Natl Acad Sci U S A
101:9556–9561
Lopes S, Gòmez-Zavaglia A, Lapinski L, Chattopadhyay N, Fausto R
(2004) Matrix-isolation FTIR spectroscopy of benzil: probing the
flexibility of the C–C torsional coordinate. J Phys Chem A
108:8256–8263
Machielsen R, Uria AR, Kengen SW, van der Oost J (2006) Production
and characterization of a thermostable alcohol dehydrogenase that
belongs to the aldo-keto reductase superfamily. Appl Environ
Microbiol 72:233–238
Machielsen R, Leferink NG, Hendriks A, Brouns SJ, Hennemann HG,
Daussmann T, van der Oost J (2008) Laboratory evolution of
Pyrococcus furiosus alcohol dehydrogenase to improve the pro-
duction of (2S,5S)-hexanediol at moderate temperatures. Extrem-
ophiles 12:587–594
Maruyama R, Nishizawa M, Itoi Y, Ito S, Inoue M (2002) The enzymes
with benzil reductase activity conserved from bacteria to mam-
mals. J Biotechnol 94:157–169
Müller M, Wolberg M, Schubert T, Hummel W (2005) Enzyme-
catalyzed regio- and enantioselective ketone reductions. Adv Bio-
chem Eng Biotechnol 92:261–287
Nie Y, Xu Y, Mu XQ, Wang HY, Yang M, Xiao R (2007)
Purification, characterization, gene cloning, and expression
of a novel alcohol dehydrogenase with anti-prelog stereospec-
ificity from Candida parapsilosis. Appl Environ Microbiol
73:3759–3764
Appl Microbiol Biotechnol
Niefind K, Müller J, Riebel B, Hummel W, Schomburg D (2003) The
crystal structure of R-specific alcohol dehydrogenase from Lac-
tobacillus brevis suggests the structural basis of its metal depen-
dency. J Mol Biol 327:317–328
Pawelka Z, Koll A, Zeegers-Huyskens Th (2001) Solvent effect on
conformation of benzil. J Mol Struct 597:57–66
Pennacchio A, Pucci B, Secundo F, La Cara F, Rossi M, Raia CA
(2008) Purification and characterization of a novel recombinant
highly enantioselective, short-chain NAD(H)-dependent alcohol
dehydrogenase from Thermus thermophilus. Appl Environ Micro-
biol 74:3949–3958
Pennacchio A, Giordano A, Pucci B, Rossi M, Raia CA (2010a)
Biochemical characterization of a recombinant short-chain NAD
(H)-dependent dehydrogenase/reductase from Sulfolobus acido-
caldarius. Extremophiles 14:193–204
Pennacchio A, Giordano A, Esposito L, Langella E, Rossi M, Raia CA
(2010b) Insight into the stereospecificity of short-chain Thermus
thermophilus alcohol dehydrogenase showing pro-S hydride
transfer and prelog enantioselectivity. Protein Pept Lett 17:437–
443
Pennacchio A, Giordano A, Rossi M, Raia CA (2011) Asymmetric
reduction of α-keto esters with Thermus thermophilus NADH-
dependent carbonyl reductase using glucose dehydrogenase and
alcohol dehydrogenase for cofactor regeneration. Eur J Org Chem
23:4361–4366
Persson B, Kallberg Y, Bray JE, Bruford E, Dellaporta SL, Favia AD,
Duarte RG, Jörnvall H, Kavanagh KL, Kedishvili N, Kisiela M,
Maser E, Mindnich R, Orchard S, Penning TM, Thornton JM,
Adamski J, Oppermann U (2009) The SDR (short-chain dehydro-
genase/reductase and related enzymes) nomenclature initiative.
Chem Biol Interact 178:94–98
Radianingtyas H, Wright PC (2003) Alcohol dehydrogenases from
thermophilic and hyperthermophilic archaea and bacteria. FEMS
Microbiol Rev 27:593–616
Raia CA, Giordano A, Rossi M (2001) Alcohol dehydrogenase from
Sulfolobus solfataricus. Methods Enzymol 331:176–195
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a
laboratory manual, 2nd edn. Cold Spring Harbor Laboratory,
New York
Schlieben NH, Niefind K, Muller J, Riebel B, Hummel W, Schomburg
D (2005) Atomic resolution structures of R-specific alcohol de-
hydrogenase from Lactobacillus brevis provide the structural
bases of its substrate and cosubstrate specificity. J Mol Biol
349:801–813
Tanaka T, Kawase M, Tani S (2004) Alpha-hydroxyketones as inhib-
itors of urease. Bioorg Med Chem 12:501–505
van der Oost J, Voorhorst WG, Kengen SW, Geerling AC, Wittenhorst
V, Gueguen Y, de Vos WM (2001) Genetic and biochemical
characterization of a short-chain alcohol dehydrogenase from the
hyperthermophilic archaeon Pyrococcus furiosus. Eur J Biochem
268:3062–3068
Wildemann H, Dünkelmann P, Müller M, Schmidt B (2003) A short
olefin metathesis-based route to enantiomerically pure arylated
dihydropyrans and alpha, beta-unsaturated delta-valero lactones. J
Org Chem 68:799–804
Zhu D, Malik HT, Hua L (2006) Asymmetric ketone reduction by a
hyperthermophilic alcohol dehydrogenase. The substrate specific-
ity, enantioselectivity and tolerance of organic solvents.
Tetrahedron-Asymmetry 17:3010–3014
Zhu D, Hyatt BA, Hua L (2009) Enzymatic hydrogen transfer reduc-
tion of α-chloro aromatic ketones catalyzed by a hyperthermo-
philic alcohol dehydrogenase. J Mol Catal B: Enzym 56:272–276
Appl Microbiol Biotechnol
